
<html lang="en"     class="pb-page"  data-request-id="43aba7e1-a13b-4242-9c01-8c40d09dbbb9"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2001.44.issue-3;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;article:article:10.1021/jm000372i;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Tyrosine Kinase Inhibitors. 18. 6-Substituted 4-Anilinoquinazolines and 4-Anilinopyrido[3,4-d]pyrimidines as Soluble, Irreversible Inhibitors of the Epidermal Growth Factor Receptor" /></meta><meta name="dc.Creator" content="Jeff B.  Smaill,†" /></meta><meta name="dc.Creator" content="H. D. Hollis  Showalter,#" /></meta><meta name="dc.Creator" content="Hairong  Zhou,#" /></meta><meta name="dc.Creator" content="Alexander J.  Bridges,#" /></meta><meta name="dc.Creator" content="Dennis J.  McNamara,#" /></meta><meta name="dc.Creator" content="David W.  Fry,#" /></meta><meta name="dc.Creator" content="James M.  Nelson,#" /></meta><meta name="dc.Creator" content="Veronika  Sherwood,#" /></meta><meta name="dc.Creator" content="Patrick W.  Vincent,#" /></meta><meta name="dc.Creator" content="Bill J.  Roberts,#" /></meta><meta name="dc.Creator" content="William L.  Elliott,# and" /></meta><meta name="dc.Creator" content="William A.  Denny*,†" /></meta><meta name="dc.Description" content="4-Anilinoquinazoline- and 4-anilinopyrido[3,4-d]pyrimidine-6-acrylamides are potent pan-erbB tyrosine kinase inactivators, and one example (CI-1033) is in clinical trial. A series of analogues with..." /></meta><meta name="Description" content="4-Anilinoquinazoline- and 4-anilinopyrido[3,4-d]pyrimidine-6-acrylamides are potent pan-erbB tyrosine kinase inactivators, and one example (CI-1033) is in clinical trial. A series of analogues with..." /></meta><meta name="dc.Publisher" content=" American Chemical Society " /></meta><meta name="dc.Date" scheme="WTN8601" content="December 30, 2000" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm000372i" /></meta><meta name="dc.Identifier" scheme="crossover-key" content="JMCMAr-44-3-429" /></meta><meta name="dc.Identifier" scheme="pii" content="S0022-2623(00)00372-1" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2001 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm000372i" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm000372i" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm000372i" /></link>
        
    
    

<title>Tyrosine Kinase Inhibitors. 18. 6-Substituted 4-Anilinoquinazolines and 4-Anilinopyrido[3,4-d]pyrimidines as Soluble, Irreversible Inhibitors of the Epidermal Growth Factor Receptor | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm000372i" /></meta><meta property="og:title" content="Tyrosine Kinase Inhibitors. 18. 6-Substituted 4-Anilinoquinazolines and 4-Anilinopyrido[3,4-d]pyrimidines as Soluble, Irreversible Inhibitors of the Epidermal Growth Factor Receptor" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2001/jmcmar.2001.44.issue-3/jm000372i/production/images/large/jm000372in00001.jpeg" /></meta><meta property="og:description" content=" 4-Anilinoquinazoline- and 4-anilinopyrido[3,4-d]pyrimidine-6-acrylamides are potent pan-erbB tyrosine kinase inactivators, and one example (CI-1033) is in clinical trial. A series of analogues with a variety of Michael acceptor units at the 6-position were prepared to define the structural requirements for irreversible inhibition. A particular goal was to determine whether additional functions to increase solubility could be appended to the Michael acceptor. Substituted acrylamides were prepared by direct acylation of the corresponding 6-amines with the requisite acid or acid chloride. Vinylsulfonamide derivatives were obtained by acylation of the amines with chloroethylsulfonyl chloride followed by base-promoted elimination. Vinylsulfone and vinylsulfine derivatives were prepared by oxidation and base elimination of a hydroxyethylthio intermediate. The compounds were evaluated for their inhibition of phosphorylation of the isolated EGFR enzyme and for inhibition of EGF-stimulated autophosphorylation of EGFR in A431 cells and of heregulin-stimulated autophosphorylation of erbB2 in MDA-MB 453 cells. Substitution at the nitrogen of the acrylamide was tolerated only with a methyl group; larger substituents were dystherapeutic, and no substitution at all was tolerated at the acrylamide α-carbon. In contrast, while electron-donating groups at the acrylamide β-carbon were not useful, even quite large electron-withdrawing groups (which increase its electrophilicity) were tolerated. A series of derivatives with solubility-enhancing substituents linked to the acrylamide β-carbon via amides were potent irreversible inhibitors of isolated EGFR (IC50s = 0.4−1.1 nM), with weakly basic morpholine and imidazole derivatives being the best. Vinylsulfonamides were also potent and irreversible inhibitors, but vinylsulfones and vinylsulfines were reversible and only poorly active. Two compounds were evaluated against A431, H125, and MCF-7 xenografts in nude mice but were inferior in these assays to the clinical trial compound CI-1033.  " /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm000372i"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm000372i">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm000372i&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm000372i&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm000372i&amp;href=/doi/10.1021/jm000372i" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2001</span><span class="cit-fg-volume">, 44</span><span class="cit-fg-issue">, 3</span><span class="cit-fg-pageRange">, 429-440</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/44/3" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm001059j" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm000387g" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Tyrosine Kinase Inhibitors. 18. 6-Substituted 4-Anilinoquinazolines and 4-Anilinopyrido[3,4-<i>d</i>]pyrimidines as Soluble, Irreversible Inhibitors of the Epidermal Growth Factor Receptor</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jeff+B.++Smaill">Jeff B. Smaill</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=H.+D.+Hollis++Showalter">H. D. Hollis Showalter</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hairong++Zhou">Hairong Zhou</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alexander+J.++Bridges">Alexander J. Bridges</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dennis+J.++McNamara">Dennis J. McNamara</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David+W.++Fry">David W. Fry</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=James+M.++Nelson">James M. Nelson</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Veronika++Sherwood">Veronika Sherwood</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Patrick+W.++Vincent">Patrick W. Vincent</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bill+J.++Roberts">Bill J. Roberts</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=William+L.++Elliott">William L. Elliott</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=William+A.++Denny">William A. Denny</a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info"><span class="aff-text">Auckland Cancer Society Research Centre, Faculty of Medicine and Health Science, The University of Auckland, Private Bag 92019, Auckland, New Zealand, and Pfizer Global Research and Development, Ann Arbor Laboratories, 2800 Plymouth Road, Ann Arbor, Michigan 48106-1047 </span></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="JMCMAr" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm000372i&amp;href=/doi/10.1021%2Fjm000372i" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2001</span></span><span class="cit-volume">, 44</span><span class="cit-issue">, 3</span><span class="cit-pageRange">, 429–440</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">December 30, 2000</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>28 August 2000</li><li><span class="item_label"><b>Published</b> online</span>30 December 2000</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 1 February 2001</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm000372i" title="DOI URL">https://doi.org/10.1021/jm000372i</a></div><div class="article_header-article-copyright"><strong>Copyright © 2001 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D429%26pageCount%3D12%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DJeff%2BB.%2BSmaill%252C%2BH.%2BD.%2BHollis%2BShowalter%252C%2BHairong%2BZhou%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D44%26issueNum%3D3%26contentID%3Djm000372i%26title%3DTyrosine%2BKinase%2BInhibitors.%2B18.%2B6-Substituted%2B4-Anilinoquinazolines%2Band%2B4-Anilinopyrido%255B3%252C4-d%255Dpyrimidines%2Bas%2BSoluble%252C%2BIrreversible%2BInhibitors%2Bof%2Bthe%2BEpidermal%2BGrowth%2BFactor%2BReceptor%26numPages%3D12%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D440%26publicationDate%3DFebruary%2B2001">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm000372i"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1554</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">69</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm000372i" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Tyrosine Kinase Inhibitors. 18. 6-Substituted 4-Anilinoquinazolines and 4-Anilinopyrido[3,4-d]pyrimidines as Soluble, Irreversible Inhibitors of the Epidermal Growth Factor Receptor&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Jeff&quot;,&quot;last_name&quot;:&quot;B. Smaill&quot;},{&quot;first_name&quot;:&quot;H.&quot;,&quot;last_name&quot;:&quot;D. Hollis Showalter&quot;},{&quot;first_name&quot;:&quot;Hairong&quot;,&quot;last_name&quot;:&quot;Zhou&quot;},{&quot;first_name&quot;:&quot;Alexander&quot;,&quot;last_name&quot;:&quot;J. Bridges&quot;},{&quot;first_name&quot;:&quot;Dennis&quot;,&quot;last_name&quot;:&quot;J. McNamara&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;W. Fry&quot;},{&quot;first_name&quot;:&quot;James&quot;,&quot;last_name&quot;:&quot;M. Nelson&quot;},{&quot;first_name&quot;:&quot;Veronika&quot;,&quot;last_name&quot;:&quot;Sherwood&quot;},{&quot;first_name&quot;:&quot;Patrick&quot;,&quot;last_name&quot;:&quot;W. Vincent&quot;},{&quot;first_name&quot;:&quot;Bill&quot;,&quot;last_name&quot;:&quot;J. Roberts&quot;},{&quot;first_name&quot;:&quot;William&quot;,&quot;last_name&quot;:&quot;L. Elliott&quot;},{&quot;first_name&quot;:&quot;William&quot;,&quot;last_name&quot;:&quot;A. Denny&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2000&quot;,&quot;month&quot;:&quot;12&quot;,&quot;day&quot;:&quot;30&quot;,&quot;issue&quot;:&quot;3&quot;,&quot;volume&quot;:&quot;44&quot;,&quot;pages&quot;:&quot;429-440&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm000372i&quot;},&quot;abstract&quot;:&quot;4-Anilinoquinazoline- and 4-anilinopyrido[3,4-d]pyrimidine-6-acrylamides are potent pan-erbB tyrosine kinase inactivators, and one example (CI-1033) is in clinical trial. A series of analogues with a variety of Michael acceptor units at the 6-position were prepared to define the structural requirements for irreversible inhibition. A particular goal was to determine whether additional functions to increase solubility could be appended to the Michael acceptor. Substituted acrylamides were prepared by direct acylation of the corresponding 6-amines with the requisite acid or acid chloride. Vinylsulfonamide derivatives were obtained by acylation of the amines with chloroethylsulfonyl chloride followed by base-promoted elimination. Vinylsulfone and vinylsulfine derivatives were prepared by oxidation and base elimination of a hydroxyethylthio intermediate. The compounds were evaluated for their inhibition of phosphorylation of the isolated EGFR enzyme and for inhibition of EGF-stimulated autophosphorylation of EGFR &quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm000372i&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm000372i" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm000372i&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm000372i" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm000372i&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm000372i" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm000372i&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm000372i&amp;href=/doi/10.1021/jm000372i" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm000372i" /></input><a href="/doi/pdf/10.1021/jm000372i" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (160 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm000372i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm000372i%26sid%3Dliteratum%253Aachs%26pmid%3D11462982%26genre%3Darticle%26aulast%3DSmaill%26date%3D2001%26atitle%3DTyrosine%2BKinase%2BInhibitors.%2B18.%2B6-Substituted%2B4-Anilinoquinazolines%2Band%2B4-Anilinopyrido%255B3%252C4-d%255Dpyrimidines%2Bas%2BSoluble%252C%2BIrreversible%2BInhibitors%2Bof%2Bthe%2BEpidermal%2BGrowth%2BFactor%2BReceptor%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D44%26issue%3D3%26spage%3D429%26epage%3D440%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=290658" title="Amides">Amides</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/44/3" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2001/jmcmar.2001.44.issue-3/jm000372i/production/images/medium/jm000372in00001.gif" alt="" id="_i2" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2001/jmcmar.2001.44.issue-3/jm000372i/production/images/large/jm000372in00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm000372i&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">4-Anilinoquinazoline- and 4-anilinopyrido[3,4-<i>d</i>]pyrimidine-6-acrylamides are potent pan-<i>erb</i>B tyrosine kinase inactivators, and one example (CI-1033) is in clinical trial. A series of analogues with a variety of Michael acceptor units at the 6-position were prepared to define the structural requirements for irreversible inhibition. A particular goal was to determine whether additional functions to increase solubility could be appended to the Michael acceptor. Substituted acrylamides were prepared by direct acylation of the corresponding 6-amines with the requisite acid or acid chloride. Vinylsulfonamide derivatives were obtained by acylation of the amines with chloroethylsulfonyl chloride followed by base-promoted elimination. Vinylsulfone and vinylsulfine derivatives were prepared by oxidation and base elimination of a hydroxyethylthio intermediate. The compounds were evaluated for their inhibition of phosphorylation of the isolated EGFR enzyme and for inhibition of EGF-stimulated autophosphorylation of EGFR in A431 cells and of heregulin-stimulated autophosphorylation of <i>erb</i>B2 in MDA-MB 453 cells. Substitution at the nitrogen of the acrylamide was tolerated only with a methyl group; larger substituents were dystherapeutic, and no substitution at all was tolerated at the acrylamide α-carbon. In contrast, while electron-donating groups at the acrylamide β-carbon were not useful, even quite large electron-withdrawing groups (which increase its electrophilicity) were tolerated. A series of derivatives with solubility-enhancing substituents linked to the acrylamide β-carbon via amides were potent irreversible inhibitors of isolated EGFR (IC<sub>50</sub>s = 0.4−1.1 nM), with weakly basic morpholine and imidazole derivatives being the best. Vinylsulfonamides were also potent and irreversible inhibitors, but vinylsulfones and vinylsulfines were reversible and only poorly active. Two compounds were evaluated against A431, H125, and MCF-7 xenografts in nude mice but were inferior in these assays to the clinical trial compound CI-1033. </p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div class="extra-info-sec fnGroup"><div class="fnGroupItem" id="jm000372iAF2"><span><h4><span class="NLM_fn-symbol">†</span></h4></span><span><p class="last">  The University of Auckland.</p></span></div><div class="fnGroupItem" id="jm000372iAF10"><span><h4><span class="NLM_fn-symbol">#</span></h4></span><span><p class="last">  Pfizer Global Research and Development.</p></span></div><div class="fnGroupItem" id="jm000372iAF1"><span><h4><span class="NLM_fn-symbol">*</span></h4></span><span><p class="last">  To whom correspondence should be addressed. Tel:  64 9 3737 599, ext. 6144. Fax:  64 9 3737 502. E-mail:  <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="593b773d3c37372019382c3a323538373d77383a77372377">[email protected]</a></p></span></div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32351" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32351" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Overexpression of the epidermal growth factor receptor (EGFR) has been reported in a significant number of human tumors and is associated with poor prognosis.<sup><a onclick="showRef(event, 'jm000372ib00001 jm000372ib00002'); return false;" href="javascript:void(0);" class="ref jm000372ib00001 jm000372ib00002">1,2</a></sup> Inhibition of growth signal pathways mediated through EGFR tyrosine autophosphorylation is thus of therapeutic interest, and inhibitors of this process have been widely sought as potential anticancer drugs.<sup><a onclick="showRef(event, 'jm000372ib00003 jm000372ib00004 jm000372ib00005'); return false;" href="javascript:void(0);" class="ref jm000372ib00003 jm000372ib00004 jm000372ib00005">3-5</a></sup> 4-Anilinoquinazolines and related 4-anilinopyrido[<i>d</i>]pyrimidines have been shown to be potent and selective reversible inhibitors of both isolated EGFR and EGF-stimulated EGFR autophosphorylation in cells, via competitive binding to the ATP site,<sup><a onclick="showRef(event, 'jm000372ib00006 jm000372ib00007'); return false;" href="javascript:void(0);" class="ref jm000372ib00006 jm000372ib00007">6,7</a></sup> and two compounds of this type, CP-358,774 (<b>1</b>) and ZD 1839 (Iressa) (<b>2</b>), are in clinical trial.<sup><a onclick="showRef(event, 'jm000372ib00008 jm000372ib00009'); return false;" href="javascript:void(0);" class="ref jm000372ib00008 jm000372ib00009">8,9</a></sup><a data-tab="pane-pcw-Figures" href="#jm000372if1" id="" class=" internalNav"></a><div id="_i4"><figure id="jm000372if1" data-index="1" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2001/jmcmar.2001.44.issue-3/jm000372i/production/images/medium/jm000372if1.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2001/jmcmar.2001.44.issue-3/jm000372i/production/images/large/jm000372if1.jpeg" id="_i5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2001/jmcmar.2001.44.issue-3/jm000372i/production/images/large/jm000372if1.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm000372i&amp;id=jm000372if1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p">In expectation that the high levels of intracellular ATP in some cell lines may make it difficult to achieve sufficiently high intracellular levels of such inhibitors to shut-down EGF-stimulated autophosphorylation for long periods, we<sup><a onclick="showRef(event, 'jm000372ib00010 jm000372ib00011'); return false;" href="javascript:void(0);" class="ref jm000372ib00010 jm000372ib00011">10,11</a></sup> and others<sup><a onclick="showRef(event, 'jm000372ib00012'); return false;" href="javascript:void(0);" class="ref jm000372ib00012">12</a></sup> have been exploring the use of irreversible inhibitors. We have recently reported<sup><a onclick="showRef(event, 'jm000372ib00013 jm000372ib00014 jm000372ib00015'); return false;" href="javascript:void(0);" class="ref jm000372ib00013 jm000372ib00014 jm000372ib00015">13-15</a></sup> that 6- and (to a lesser extent) 7-acrylamide analogues of the 4-anilinoquinazolines and pyrido[<i>d</i>]pyrimidines (e.g., <b>3</b> and <b>4</b>) act at the ATP binding domain of EGFR, specifically alkylating an adjacent Cys-773 residue and irreversibly shutting down kinase activity. The 6-acrylamides are irreversible inhibitors of both EGFR and <i>erb</i>B2 autophosphorylation and show significantly improved in vivo antitumor activity compared to closely related reversible analogues.<sup>13</sup> They tolerate a wide range of structural variations in the molecule with retention of irreversibility and potency, including substitution at the vacant 7-position of the quinazoline nucleus with a range of amine-bearing side <a name="jm004400300430" id="jm004400300430"></a> chains, and provide a class of soluble, orally active, potent, selective, and irreversible inhibitors of the EGFR family of tyrosine kinases.<sup>15</sup> This novel class of compounds is exemplified by CI-1033 (<b>5</b>) which has recently begun phase I clinical trials.<sup><a onclick="showRef(event, 'jm000372ib00016'); return false;" href="javascript:void(0);" class="ref jm000372ib00016">15,16</a></sup><a data-tab="pane-pcw-Figures" href="#jm000372if2" id="" class=" internalNav"></a><div id="_i6"><figure id="jm000372if2" data-index="2" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2001/jmcmar.2001.44.issue-3/jm000372i/production/images/medium/jm000372if2.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2001/jmcmar.2001.44.issue-3/jm000372i/production/images/large/jm000372if2.jpeg" id="_i7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2001/jmcmar.2001.44.issue-3/jm000372i/production/images/large/jm000372if2.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm000372i&amp;id=jm000372if2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p">Attempts to develop a soluble pyrido[<i>d</i>]pyrimidine analogue of <b>5</b>, by introducing amine-bearing soluble side chains at the 7-position of a pyrido[3,2-<i>d</i>]pyrimidine nucleus, met with only limited success.<sup>15</sup> While these compounds (e.g., <b>6</b>) showed excellent potency for inhibition of isolated EGFR enzyme, they were considerably less potent in cellular assays when compared to the analogous quinazolines. This lack of potency has in part been attributed to the increased reactivity of the acrylamide moiety toward cellular glutathione.<sup>15</sup><a data-tab="pane-pcw-Figures" href="#jm000372ih00001" id="" class=" internalNav"></a><div id="_i8"><figure id="jm000372ih00001" data-index="3" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2001/jmcmar.2001.44.issue-3/jm000372i/production/images/medium/jm000372ih00001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2001/jmcmar.2001.44.issue-3/jm000372i/production/images/large/jm000372ih00001.jpeg" id="_i9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 1 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> (i) R<sub>3</sub>CH<img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>C(R<sub>2</sub>)CO<sub>2</sub>H/EDCl·HCl/pyridine/THF/DMA; (ii) R<sub>3</sub>CH<img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>C(R<sub>2</sub>)COCl/DMAP (cat.)/THF/Et<sub>3</sub>N; (iii) ClCH<sub>2</sub>CH<sub>2</sub>SO<sub>2</sub>Cl/DMAP (cat.)/THF/Et<sub>3</sub>N.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2001/jmcmar.2001.44.issue-3/jm000372i/production/images/large/jm000372ih00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm000372i&amp;id=jm000372ih00001"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p last">In further development of this class, we now report the synthesis and biological activity of a range of 4-anilinoquinazolines and pyrido[3,4-<i>d</i>]pyrimidines substituted at the 6-position with a variety of Michael acceptors apart from the parent acrylamide. This work sought to define the structural requirements of the Michael acceptor necessary to provide irreversible inhibition of EGFR, with the aim of developing one that can tolerate substitution with a solubility-enhancing side chain while retaining irreversible inhibition, potency, and selectivity for EGFR. </div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42106" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42106" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The substituted acrylamides <b>7</b>−<b>20</b> of Table 1 were obtained by direct acylation of the known 6-amino derivatives <b>37</b>−<b>39</b>, with either the requisite acid under EDCI·HCl-promoted coupling or with the acid chloride in the presence of catalytic DMAP and a base such as triethylamine or pyridine. The vinylsulfonamide derivatives <b>32 </b>and<b> 33</b> of Table 1 were similarly obtained by acylation of the amines <b>38</b> and <b>39</b> with chloroethylsulfonyl chloride, followed by base-promoted in situ elimination of HCl, to generate the vinyl moiety (Scheme 1). The pyrido[3,4-<i>d</i>]pyrimidines <b>21</b> and <b>22 </b>of Table 1 were obtained by acylation of the known amines <b>40</b> and <b>41</b> with acrylic acid (EDCI·HCl-promoted) and acryloyl chloride, respectively (Scheme 2<a data-tab="pane-pcw-Figures" href="#jm000372ih00002" id="" class=" internalNav"></a>). <div id="_i11"><figure id="jm000372ih00002" data-index="4" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2001/jmcmar.2001.44.issue-3/jm000372i/production/images/medium/jm000372ih00002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2001/jmcmar.2001.44.issue-3/jm000372i/production/images/large/jm000372ih00002.jpeg" id="_i12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 2 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> (i) CH<sub>2</sub><img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>CHCO<sub>2</sub>H/EDCl·HCl/pyridine; (ii) CH<sub>2</sub><img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>CHCOCl/DMAP (cat.)/Et<sub>3</sub>N.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2001/jmcmar.2001.44.issue-3/jm000372i/production/images/large/jm000372ih00002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm000372i&amp;id=jm000372ih00002"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p">Synthesis of the quinazoline <b>23</b> required first the synthesis of amine <b>43</b>. This was obtained by the acid-catalyzed Michael addition of morpholine to acrylamide <b>4</b>, followed by borane−dimethyl sulfide reduction of the amide functionality. Amine <b>43</b> was then coupled with acrylic acid using EDCI·HCl to give acrylamide <b>23 </b>of Table 1 (Scheme 3<a data-tab="pane-pcw-Figures" href="#jm000372ih00003" id="" class=" internalNav"></a>). Compounds <b>24</b> and <b>25</b> of Table 1, bearing an acrylamide moiety substituted in the 3-position with a solubility-enhancing ester and amide functionality, respectively, were obtained from the reaction of 3-(<i>N,N</i>-dimethylamino)propan-1-ol and <i>N,N</i>-dimethyl-1,3-propanediamine. The key intermediate was acid chloride <b>44</b>, in turn prepared from acylation of amine <b>39</b> with fumaryl chloride (Scheme 4<a data-tab="pane-pcw-Figures" href="#jm000372ih00004" id="" class=" internalNav"></a>). <div id="_i13"><figure id="jm000372ih00003" data-index="5" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2001/jmcmar.2001.44.issue-3/jm000372i/production/images/medium/jm000372ih00003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2001/jmcmar.2001.44.issue-3/jm000372i/production/images/large/jm000372ih00003.jpeg" id="_i14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 3 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> (i) Morpholine/<i>p</i>-TsOH/THF; (ii) BH<sub>3</sub>·DMS/THF; (iii) CH<sub>2</sub><img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>CHCO<sub>2</sub>H/EDCl·HCl/Et<sub>3</sub>N/DMF.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2001/jmcmar.2001.44.issue-3/jm000372i/production/images/large/jm000372ih00003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm000372i&amp;id=jm000372ih00003"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="jm000372ih00004" data-index="6" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2001/jmcmar.2001.44.issue-3/jm000372i/production/images/medium/jm000372ih00004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2001/jmcmar.2001.44.issue-3/jm000372i/production/images/large/jm000372ih00004.jpeg" id="_i15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 4 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> (i) ClOCCH<img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>CHCOCl/THF; (ii) Me<sub>2</sub>N(CH<sub>2</sub>)<sub>3</sub>OH/THF; (iii) Me<sub>2</sub>N(CH<sub>2</sub>)<sub>3</sub>NH<sub>2</sub>/THF.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2001/jmcmar.2001.44.issue-3/jm000372i/production/images/large/jm000372ih00004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm000372i&amp;id=jm000372ih00004"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p last">EDCI·HCl-promoted coupling of acids <b>47a</b><b>−</b><b>d</b> with the amines <b>37</b>, <b>38</b>, and <b>48</b> provided compounds <b>26</b><b>−</b><b>31</b> of Table 1. The acids <b>47a</b><b>−</b><b>d</b> needed for this work were synthesized from (<i>E</i>)-but-2-enedioic acid monoethyl ester (<b>45</b>). Conversion to the acid chloride with oxalyl chloride and then condensation with the required amine <a name="jm004400300431" id="jm004400300431"></a> side chains gave the amide esters <b>46a</b><b>−</b><b>d</b>, which were subsequently converted to the acids <b>47a</b><b>−</b><b>d</b> by alkaline hydrolysis (Scheme 5<a data-tab="pane-pcw-Figures" href="#jm000372ih00005" id="" class=" internalNav"></a>). Synthesis of the vinylsulfone <b>35</b> and vinylsulfine <b>36</b> of Table 1 was achieved by base-catalyzed elimination of the respective mesylates of the hydroxyethyl compounds <b>34</b> and <b>51</b>. These were in turn prepared from the reaction of 2-mercaptoethanol with 6-fluoropyrido[3,4-<i>d</i>]pyrimidine (<b>49</b>) to give the hydroxyethyl sulfide <b>50</b>, which was oxidized with either MCPBA to give <b>34</b> or Davis' reagent to give <b>51 </b>(Scheme 6<a data-tab="pane-pcw-Figures" href="#jm000372ih00006" id="" class=" internalNav"></a><a class="ref showTableEvent internalNav" data-ID="jm000372it00001" href="#jm000372it00001"></a>). <div id="_i16"><figure id="jm000372ih00005" data-index="7" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2001/jmcmar.2001.44.issue-3/jm000372i/production/images/medium/jm000372ih00005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2001/jmcmar.2001.44.issue-3/jm000372i/production/images/large/jm000372ih00005.jpeg" id="_i17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 5 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> (i) Oxalyl chloride/THF/20 °C/1 h, then RNH<sub>2</sub>; (ii) aq Et<sub>3</sub>N/60 °C/45 min or LiOH/aq MeOH/20 °C/2 h; (iii) EDCl·HCl/pyridine/0 °C/1 h and <b>37</b>, <b>38</b>, or <b>48</b>.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2001/jmcmar.2001.44.issue-3/jm000372i/production/images/large/jm000372ih00005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm000372i&amp;id=jm000372ih00005"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="jm000372ih00006" data-index="8" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2001/jmcmar.2001.44.issue-3/jm000372i/production/images/medium/jm000372ih00006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2001/jmcmar.2001.44.issue-3/jm000372i/production/images/large/jm000372ih00006.jpeg" id="_i18" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 6 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> (i) HSCH<sub>2</sub>CH<sub>2</sub>OH/Cs<sub>2</sub>CO<sub>3</sub>/DMSO/50 °C/2 h; (ii) MCPBA/CHCl<sub>3</sub>/20 °C/4 h; (iii) MsCl/Et<sub>3</sub>N/CH<sub>2</sub>Cl<sub>2</sub>/0−5 °C/2.5 h; (iv) Davis' reagent/CHCl<sub>3</sub>.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2001/jmcmar.2001.44.issue-3/jm000372i/production/images/large/jm000372ih00006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm000372i&amp;id=jm000372ih00006"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div class="NLM_table-wrap" id="jm000372it00001"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 1.  EGFR Inhibitory Properties of 6-Substituted 4-Anilinoquinazolines and 4-Anilinopyrido[3,4-<i>d</i>]pyrimidines Bearing Various Michael Acceptors<img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2001/jmcmar.2001.44.issue-3/jm000372i/production/images/medium/jm000372iu00001a.gif" alt="" id="_i19" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table " width="100%"><colgroup><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2">IC<sub>50[app]</sub> (nM)<i><sup>a</sup></i><sup></sup></td><td class="colsep2 rowsep2">IC<sub>50</sub> (nM)<i><sup>b</sup></i><sup></sup></td></tr></tbody></table><table class="table " width="100%"><colgroup><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">no.</td><td class="colsep2 rowsep2">family</td><td class="colsep2 rowsep2">X</td><td class="colsep2 rowsep2">R<sub>1</sub></td><td class="colsep2 rowsep2">R<sub>2</sub></td><td class="colsep2 rowsep2">R<sub>3</sub></td><td class="colsep2 rowsep2">EGFR</td><td class="colsep2 rowsep2">A431</td><td class="colsep2 rowsep2">irrev inhib<i><sup>c</sup></i><sup></sup></td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>3</b><i><sup>d</sup></i><sup></sup></td><td class="colsep2 rowsep2">I </td><td class="colsep2 rowsep2">N </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">0.91 </td><td class="colsep2 rowsep2">3.4 </td><td class="colsep2 rowsep2">yes </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>4</b><i><sup>d</sup></i><sup></sup></td><td class="colsep2 rowsep2">I </td><td class="colsep2 rowsep2">C </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">0.70 </td><td class="colsep2 rowsep2">2.7 </td><td class="colsep2 rowsep2">yes </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>5</b><i><sup>e</sup></i><sup></sup></td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2">1.5 </td><td class="colsep2 rowsep2">7.4 </td><td class="colsep2 rowsep2">yes </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>7</b></td><td class="colsep2 rowsep2">I </td><td class="colsep2 rowsep2">N </td><td class="colsep2 rowsep2">Me </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">0.17 </td><td class="colsep2 rowsep2">13 </td><td class="colsep2 rowsep2">yes </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>8</b></td><td class="colsep2 rowsep2">I </td><td class="colsep2 rowsep2">N </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">Me </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">1.6 </td><td class="colsep2 rowsep2">44 </td><td class="colsep2 rowsep2">no </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>9</b></td><td class="colsep2 rowsep2">I </td><td class="colsep2 rowsep2">C </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">Me </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">1.2 </td><td class="colsep2 rowsep2">16 </td><td class="colsep2 rowsep2">no </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>10</b></td><td class="colsep2 rowsep2">I </td><td class="colsep2 rowsep2">N </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">Me </td><td class="colsep2 rowsep2">0.50 </td><td class="colsep2 rowsep2">7.7 </td><td class="colsep2 rowsep2">partially </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>11</b></td><td class="colsep2 rowsep2">I </td><td class="colsep2 rowsep2">C </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">Me </td><td class="colsep2 rowsep2">0.55 </td><td class="colsep2 rowsep2">8.7 </td><td class="colsep2 rowsep2">partially </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>12</b></td><td class="colsep2 rowsep2">I </td><td class="colsep2 rowsep2">N </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2"><i>cis</i>-Cl </td><td class="colsep2 rowsep2">0.69 </td><td class="colsep2 rowsep2">20 </td><td class="colsep2 rowsep2">yes </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>13</b></td><td class="colsep2 rowsep2">I </td><td class="colsep2 rowsep2">C </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">CF<sub>3</sub></td><td class="colsep2 rowsep2">1.75 </td><td class="colsep2 rowsep2">35 </td><td class="colsep2 rowsep2">yes </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>14</b></td><td class="colsep2 rowsep2">I </td><td class="colsep2 rowsep2">N </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">CH<img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>CH<sub>2</sub></td><td class="colsep2 rowsep2">1.1 </td><td class="colsep2 rowsep2">27 </td><td class="colsep2 rowsep2">partially </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>15</b></td><td class="colsep2 rowsep2">I </td><td class="colsep2 rowsep2">C </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2"><img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>CH<sub>2</sub></td><td class="colsep2 rowsep2">1.6 </td><td class="colsep2 rowsep2">120 </td><td class="colsep2 rowsep2">partially </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>16</b></td><td class="colsep2 rowsep2">I </td><td class="colsep2 rowsep2">N </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">Ph </td><td class="colsep2 rowsep2">9.1 </td><td class="colsep2 rowsep2">77 </td><td class="colsep2 rowsep2">partially </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>17</b></td><td class="colsep2 rowsep2">I </td><td class="colsep2 rowsep2">C </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">COMe </td><td class="colsep2 rowsep2">1.2 </td><td class="colsep2 rowsep2">1039 </td><td class="colsep2 rowsep2">partially </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>18</b></td><td class="colsep2 rowsep2">I </td><td class="colsep2 rowsep2">C </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">COOH </td><td class="colsep2 rowsep2">0.37 </td><td class="colsep2 rowsep2">>500 </td><td class="colsep2 rowsep2">yes </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>19</b></td><td class="colsep2 rowsep2">I </td><td class="colsep2 rowsep2">C </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">COOEt </td><td class="colsep2 rowsep2">2.7 </td><td class="colsep2 rowsep2">64 </td><td class="colsep2 rowsep2">partially </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>20</b></td><td class="colsep2 rowsep2">I </td><td class="colsep2 rowsep2">N </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">COOEt </td><td class="colsep2 rowsep2">1.5 </td><td class="colsep2 rowsep2">51 </td><td class="colsep2 rowsep2">yes </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>21</b></td><td class="colsep2 rowsep2">I </td><td class="colsep2 rowsep2">N </td><td class="colsep2 rowsep2">(CH<sub>2</sub>)<sub>2</sub>NMe<sub>2</sub></td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">4.2 </td><td class="colsep2 rowsep2">2282 </td><td class="colsep2 rowsep2">partially </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>22</b></td><td class="colsep2 rowsep2">I </td><td class="colsep2 rowsep2">N </td><td class="colsep2 rowsep2">(CH<sub>2</sub>)<sub>3</sub>-<i>N</i>-morpholinyl </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">2.7 </td><td class="colsep2 rowsep2">156 </td><td class="colsep2 rowsep2">no </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>23</b></td><td class="colsep2 rowsep2">I </td><td class="colsep2 rowsep2">C </td><td class="colsep2 rowsep2">(CH<sub>2</sub>)<sub>3</sub>-<i>N</i>-morpholinyl </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">3.3 </td><td class="colsep2 rowsep2">194 </td><td class="colsep2 rowsep2">no </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>24</b></td><td class="colsep2 rowsep2">I </td><td class="colsep2 rowsep2">C </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">COO(CH<sub>2</sub>)<sub>3</sub>NMe<sub>2</sub></td><td class="colsep2 rowsep2">2.4 </td><td class="colsep2 rowsep2">108 </td><td class="colsep2 rowsep2">yes </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>25</b></td><td class="colsep2 rowsep2">I </td><td class="colsep2 rowsep2">C </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">CONH(CH<sub>2</sub>)<sub>3</sub>NMe<sub>2</sub></td><td class="colsep2 rowsep2">0.44 </td><td class="colsep2 rowsep2">59 </td><td class="colsep2 rowsep2">yes </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>26</b></td><td class="colsep2 rowsep2">I </td><td class="colsep2 rowsep2">N </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">CONH(CH<sub>2</sub>)<sub>3</sub>NMe<sub>2</sub></td><td class="colsep2 rowsep2">1.1 </td><td class="colsep2 rowsep2">57 </td><td class="colsep2 rowsep2">yes </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>27</b></td><td class="colsep2 rowsep2">I </td><td class="colsep2 rowsep2">N </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">CONH(CH<sub>2</sub>)<sub>3</sub>NEt<sub>2</sub></td><td class="colsep2 rowsep2">0.73 </td><td class="colsep2 rowsep2">21 </td><td class="colsep2 rowsep2">yes </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>28</b></td><td class="colsep2 rowsep2">I </td><td class="colsep2 rowsep2">N </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">CONH(CH<sub>2</sub>)<sub>3</sub>-<i>N</i>-morpholinyl </td><td class="colsep2 rowsep2">0.81 </td><td class="colsep2 rowsep2">8.8 </td><td class="colsep2 rowsep2">yes </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>29</b></td><td class="colsep2 rowsep2">I </td><td class="colsep2 rowsep2">N </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">CONH(CH<sub>2</sub>)<sub>3</sub>-<i>N</i>-imidazolyl </td><td class="colsep2 rowsep2">0.56 </td><td class="colsep2 rowsep2">14 </td><td class="colsep2 rowsep2">yes </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>30</b></td><td class="colsep2 rowsep2">I </td><td class="colsep2 rowsep2">N </td><td class="colsep2 rowsep2">Me </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">CONH(CH<sub>2</sub>)<sub>3</sub>NMe<sub>2</sub></td><td class="colsep2 rowsep2">1.45 </td><td class="colsep2 rowsep2">193 </td><td class="colsep2 rowsep2">partially </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>31</b></td><td class="colsep2 rowsep2">II </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2">0.61 </td><td class="colsep2 rowsep2">14 </td><td class="colsep2 rowsep2">yes </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>32</b></td><td class="colsep2 rowsep2">III </td><td class="colsep2 rowsep2">N </td><td class="colsep2 rowsep2">NHSO<sub>2</sub>CH<img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>CH<sub>2</sub></td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2">0.76 </td><td class="colsep2 rowsep2">2.4 </td><td class="colsep2 rowsep2">yes </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>33</b></td><td class="colsep2 rowsep2">III </td><td class="colsep2 rowsep2">C </td><td class="colsep2 rowsep2">NHSO<sub>2</sub>CH<img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>CH<sub>2</sub></td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2">1.4 </td><td class="colsep2 rowsep2">2.7 </td><td class="colsep2 rowsep2">yes </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>34</b></td><td class="colsep2 rowsep2">III </td><td class="colsep2 rowsep2">N </td><td class="colsep2 rowsep2">SO<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>OH </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2">93.5 </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2">no </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>35</b></td><td class="colsep2 rowsep2">III </td><td class="colsep2 rowsep2">N </td><td class="colsep2 rowsep2">SO<sub>2</sub>CH<img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>CH<sub>2</sub></td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2">0.43 </td><td class="colsep2 rowsep2">>500 </td><td class="colsep2 rowsep2">yes </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>36</b></td><td class="colsep2 rowsep2">III </td><td class="colsep2 rowsep2">N </td><td class="colsep2 rowsep2">SOCH<img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>CH<sub>2</sub></td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2">4.6 </td><td class="colsep2 rowsep2">340 </td><td class="colsep2 rowsep2">no</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-"><p class="first last"><i><sup>a</sup></i><sup></sup> Concentration to inhibit by 50% the phosphorylation of a polyglutamic acid/tyrosine random copolymer by EGFR enzyme (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography). Values are the averages from at least two independent dose−response curves; variation was generally ±15%.<i><sup>b</sup></i><sup></sup> Concentration to inhibit by 50% the autophosphorylation of EGFR in A431 cells (detected by immunoblotting).<i><sup>c</sup></i><sup></sup> Irreversible inhibition is defined as >80% inhibition of formation of phosphorylated EGFR in A431 cells 8 h after washing cells free of the inhibitor.<i><sup>d</sup></i><sup></sup> Data from ref 14.<i><sup>e</sup></i><sup></sup> Data from ref 15.</p></div></div></div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21148" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21148" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p"><b>Alternative Michael Acceptors.</b> Table 1 lists the structures and physicochemical properties of a series of 4-(3-bromoanilino)quinazolines and pyrido[3,4-<i>d</i>]pyrimidines substituted at the 6-position with a variety of Michael acceptors. We have previously shown<sup>14</sup> that quinazoline- and pyrido[3,4-<i>d</i>]pyrimidine-6-acrylamides (e.g., <b>3</b> and <b>4</b>) show broadly similar results in these assays, and the anilino ring was kept constant in order to facilitate intercomparisons of the different Michael acceptors. Potencies (IC<sub>50[app]</sub> in nM) were determined for both inhibition of phosphorylation of a random glutamic acid/tyrosine copolymer substrate by isolated EGFR enzyme and inhibition of EGF-stimulated autophosphorylation of EFGR in A431 cells. The type of inhibition of the isolated EGFR enzyme is also listed. Irreversible inhibition is defined<sup>13-15</sup> as 80% or greater inhibition after a 10-min exposure to drug, followed by drug washout and re-stimulation by EGF 8 h later. Drugs that produced 20−80% inhibition were designated as partially irreversible (although in reality they can almost certainly fully inactivate the enzyme via alkylation given enough time). Those that produced less than 20% inhibition were classified as reversible. For compounds capable of rapid and complete alkylation of the enzyme, the IC<sub>50</sub> values derive essentially from titrating the enzyme activity in a stoichiometric manner and for this reason are designated as apparent IC<sub>50</sub>s (IC<sub>50[app]</sub>).<sup>14,15</sup> The concentration of EGFR in the isolated enzyme assays is calculated at 1.18 nM and was held as constant as possible (<10% variation). The IC<sub>50[app]</sub> values are an average of at least two separate determinations. </div><div class="NLM_p">The present study investigated several different types of Michael acceptors in addition to the original acrylamides <b>3</b> and <b>4</b>. Compounds <b>7</b><b>−</b><b>20</b> represent 11 modifications of the parent acrylamide itself, using both quinazoline and pyrido[3,4-<i>d</i>]pyrimidine chromophores, seeking acceptable positions for substitution that would allow attachment of a solubility-enhancing function. The <i>N</i>-methyl analogue <b>7</b> showed irreversible inhibition of the isolated enzyme with high potency (IC<sub>50[app]</sub> = 0.17 nM compared with 0.91 nM for <b>3</b>). Although there was a small loss of potency in the cellular assay, this position appeared suitable for further substitution (but see later). In contrast, the α-methylacrylamides <b>8</b> and <b>9</b> showed lower potencies in both the enzyme and cellular assays compared to <b>3</b> and <b>4</b> and a complete loss of irreversibility, indicating that substitution at this position of the Michael acceptor is not tolerated. </div><div class="NLM_p">A larger number of different substitutions were investigated at the acrylamide β-position (compounds <b>10</b><b>−</b><b>20</b>). Compounds <b>10</b> and <b>11</b> show that a β-methyl substituent gives a small (2−3-fold) reduction in potency in the autophosphorylation assay, but more importantly resulted in a reduction in the rate of enzyme alkylation, providing only partially irreversible inhibition of EGFR. This is consistent with introduction of a small amount of steric bulk and electron donation to the Michael acceptor double bond, reducing its electrophilicity and therefore its alkylating ability. This is supported by the data for the <i>cis</i>-chloro and trifluoromethyl analogues <b>12</b> and <b>13</b>. These groups have similar steric properties to the methyl groups in <b>10</b> and <b>11</b>, but these more electron-withdrawing groups increase the electrophilicity of the double bond of the Michael acceptor, resulting in fully <a name="jm004400300432" id="jm004400300432"></a> irreversible compounds. We have previously reported<sup>15</sup> that increased reactivity of the Michael acceptor can result in increased background alkylation of cellular thiols, such as glutathione, and therefore a reduction in cellular potency for inhibition of EGFR. It is likely therefore that a balance is required, between increased reactivity of the Michael acceptor and increased steric bulk, to provide compounds that are still capable of rapid alkylation of the target Cys-773 without displaying significantly increased background alkylation. The irreversibility assay in conjunction with the cellular assay for inhibition of EGFR autophosphorylation provides a measure of the success of this balancing act. </div><div class="NLM_p">Substitution at the β-position with an unsaturated double bond, an allene functionality, or a phenyl group (compounds <b>14</b>−<b>16</b>, respectively) resulted in only partially irreversible inhibition, suggesting the mild electron-withdrawing abilities of these groups was not sufficient to overcome their respective steric hindrances. Compounds possessing more strongly electron-withdrawing β-carbonyl substituents such as methyl ketone (<b>17</b>), acid (<b>18</b>), and ethyl ester (<b>19</b> and <b>20</b>) groups at the 3-position showed more promise, with <b>18</b> and <b>20</b> possessing potent activity against the isolated enzyme (IC<sub>50[app]</sub> = 0.37 and 1.5 nM, respectively) while also being fully irreversible. However, acid <b>18 </b>showed a large loss of potency in the cellular assay (IC<sub>50</sub> > 500 nM), presumably due to its lack of ability to permeate the cell membrane. Ester <b>20</b> also showed a 15-fold loss of potency when compared to the parent acrylamide <b>3</b> in the cellular assay, possible due to partial ester hydrolysis to the nonpotent acid. </div><div class="NLM_p"><b>Attachment of Soluble Side Chains at the Acrylamide Nitrogen.</b> The <i>N</i>-methyl analogue <b>7</b> retained potent irreversible inhibitory activity against the EGFR enzyme. However, substitution of the acrylamide nitrogen with the larger <i>N,N</i>-dimethylaminoethyl or morpholinopropyl groups (compounds <b>21</b>−<b>23</b>, respectively) resulted in a much larger attenuation of potency (46−671-fold), with an associated loss of irreversible inhibition of cellular autophosphorylation. This suggests that there is only minimal steric tolerance (no bigger than a methyl group) for substitution at the acrylamide nitrogen. </div><div class="NLM_p"><b>Attachment of Soluble Side Chains at the Acrylamide </b><b>β</b><b>-Carbon.</b> The tolerance for carbonyl substituents at the acrylamide β-position led to the synthesis of a small subset of such carbonyl-linked soluble side chain derivatives (<b>24</b><b>−</b><b>31</b>). The ester-linked quinazoline <a name="jm004400300433" id="jm004400300433"></a><b>24</b> was fully irreversible but not particularly potent in the cellular assay (IC<sub>50</sub> = 108 nM). This loss of potency may be due to partial ester hydrolysis to the (nonpotent) parent acid <b>18</b>. The more stable amide derivatives (<b>25</b><b>−</b><b>29</b>,<b> 31</b>), containing a variety of cationic side chains, were all fully irreversible, displayed good potency against isolated EGFR (IC<sub>50[app]</sub> = 0.4−1.1 nM), and were more potent than the ester analogue <b>24</b>. The most potent of these were the weakly basic morpholine and imidazole derivatives <b>28</b> and <b>29</b> (IC<sub>50</sub>s for inhibition of autophosphorylation = 8.8 and 14 nM, respectively). A comparison of the 3-bromo- and 3-chloro-4-fluoroanilino (the anilino substituents employed in <b>5</b>), in analogues <b>28</b> and <b>31</b>, showed that the 3-bromo side chain gives a slight advantage in outright potency in the cellular assay (IC<sub>50</sub> = 8.8 compared to 14 nM). Interestingly, the soluble <i>N</i>-methyl analogue <b>30</b> showed a large loss of potency (IC<sub>50</sub> = 193 nM) and a partial loss of irreversibility in the cellular assay compared to the <i>N</i>-methyl compound <b>7</b> (which was fully irreversible). Presumably the introduction of the methyl group at the acrylamide nitrogen, in combination with the bulky soluble side chain at the acrylamide 3-position, is too much of a steric impediment, preventing the positioning of the Michael acceptor in a conformation where it can alkylate the enzyme effectively. The solubility-enhanced analogues showing irreversible inhibition (<b>24</b><b>−</b><b>29</b>, <b>31</b>) were compared for their ability to inhibit both EGF-stimulated autophosphorylation of EGFR in A431 cells and heregulin-stimulated autophosphorylation of <i>erb</i>B2 in MDA-MB 453 cells (Table 2<a class="ref showTableEvent internalNav" data-ID="jm000372it00002" href="#jm000372it00002"></a>). With the exception of <b>25</b>, the compounds were equipotent inhibitors of both receptors, with IC<sub>50</sub> values comparable to those of <b>5</b>. Such broad-spectrum inhibition of different <i>erb</i>B family members is a potential advantage, since signaling through this pathway occurs via both homo- and heterodimers. <div class="NLM_table-wrap" id="jm000372it00002"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 2.  Comparative Inhibition of Autophosphorylation of EGFR and <i>e</i><i>rb</i>B2 by Selected Analogues</p></div></div><div class="scrollable-table-wrap"><table class="table " width="100%"><colgroup><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2" colspan="2">IC<sub>50</sub> (nM)</td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2" colspan="2">IC<sub>50</sub> (nM)</td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">no.</td><td class="colsep2 rowsep2">EGFR<i><sup>a</sup></i><sup></sup></td><td class="colsep2 rowsep2"><i>erb</i>B2<i><sup>b</sup></i><sup></sup></td><td class="colsep2 rowsep2">no.</td><td class="colsep2 rowsep2">EGFR<i><sup>a</sup></i><sup></sup></td><td class="colsep2 rowsep2"><i>erb</i>B2<i><sup>b</sup></i><sup></sup></td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>5</b><i><sup>c</sup></i><sup></sup></td><td class="colsep2 rowsep2">7.4 </td><td class="colsep2 rowsep2">9.0 </td><td class="colsep2 rowsep2"><b>27</b></td><td class="colsep2 rowsep2">21 </td><td class="colsep2 rowsep2">14 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>24</b></td><td class="colsep2 rowsep2">108 </td><td class="colsep2 rowsep2">110 </td><td class="colsep2 rowsep2"><b>28</b></td><td class="colsep2 rowsep2">8.8 </td><td class="colsep2 rowsep2">5.0 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>25</b></td><td class="colsep2 rowsep2">59 </td><td class="colsep2 rowsep2">207 </td><td class="colsep2 rowsep2"><b>29</b></td><td class="colsep2 rowsep2">14 </td><td class="colsep2 rowsep2">8.1 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>26</b></td><td class="colsep2 rowsep2">57 </td><td class="colsep2 rowsep2">13 </td><td class="colsep2 rowsep2"><b>31</b></td><td class="colsep2 rowsep2">14 </td><td class="colsep2 rowsep2">24</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-"><p class="first last"><i><sup>a</sup></i><sup></sup> Concentration to inhibit by 50% the EGF-stimulated autophosphorylation of EGFR in A431 cells. Values are the averages from at least two independent dose−response curves; variation was generally ±15%.<i><sup>b</sup></i><sup></sup> Concentration to inhibit by 50% the heregulin-stimulated autophosphorylation of <i>erb</i>B2 in MDA-MB 453 cells. Values are the averages from at least two independent dose−response curves; variation was generally ±15%.<i><sup>c</sup></i><sup></sup> Data from ref 15.</p></div></div></div><div class="NLM_p"><b>Comparison of Quinazoline and Pyrido[3,4-</b><b><i>d</i></b><b>]pyrimidine Chromophores.</b> Several pairs of quinazolines and pyrido[3,4-<i>d</i>]pyrimidines (<b>8/9</b>, <b>10/11</b>, <b>19/20</b>, <b>22/23</b>, and <b>32/33</b>) were evaluated to determine the influence of the 7-aza atom. We have previously<sup>14</sup> shown little activity difference between these chromophore classes, and the present results confirm this (Table 1). </div><div class="NLM_p"><b>Non-</b><b>Acrylamide Michael Acceptors.</b> The vinylsulfonamide was studied as an alternate Michael acceptor that would allow subsequent substitution with soluble cationic side chains. Compounds <b>32</b> and <b>33</b> were both able to irreversibly inhibit EGFR autophosphorylation and were very potent in the cellular assay (IC<sub>50</sub>s = 2.4 and 2.7 nM, respectively). However, subsequent in vivo experiments with vinylsulfonamide <b>32</b> suggested that it was unstable in biological systems, and this avenue was therefore not pursued. The vinylsulfone <b>35</b> was an irreversible inhibitor but showed very poor potency in the cellular assay (IC<sub>50</sub> > 500 nM), while its hydroxyethyl precursor <b>34</b> and the vinylsulfine <b>36</b> were poorly active and were reversible inhibitors. </div><div class="NLM_p">The above results show that both <i>N</i>-methyl-substituted and β-substituted acrylamides retain good potency and ability for irreversible inhibition of EGFR and that the latter are suitable templates for the introduction of a wide range of solubility-enhancing groups. </div><div class="NLM_p last"><b>In Vivo Studies.</b> The <i>N</i>-methyl- and β-morpholinopropylbutenediamide analogues (<b>7</b> and <b>31</b>, respectively) were evaluated against A431 epidermoid, H125 non-small-cell lung, and MCF-7 estrogen-dependent breast xenografts in mice, and the results are given in Table 3<a class="ref showTableEvent internalNav" data-ID="jm000372it00003" href="#jm000372it00003"></a>. The <i>N</i>-methyl compound <b>7</b> was selected as it was the most active against the isolated EGFR enzyme, while <b>31</b> was selected for direct comparison with the clinical candidate <b>5</b> (same anilino ring substitution pattern). Both compounds proved ineffective against the A431 xenograft, while the clinical candidate <b>5</b> (CI-1033) was highly active. Neither <b>7</b> nor <b>31</b> showed any meaningful antitumor effects against the H125 or MCF-7 xenografts. Other than the weight loss noted in Table 3, there were no clinical signs of toxicity associated with the 200 mg/kg dosage level for either compound. The fact that 200 mg/kg doses were tolerated by the tumor-bearing animals may indicate that these compounds were not highly bioavailable when dosed as suspensions. The pyrido[3,4-<i>d</i>]pyrimidine <b>31</b> is clearly inferior<sup>15,16</sup> to the clinical evaluation compound <b>5</b>, a quinazoline which has the same anilino substitution pattern but bears the solubility-enhancing group separately off the 7-position, rather than off the end of the acrylamide. Since we have shown above and previously<sup>14</sup> that the chromophore has little effect, it appears that the positioning of the solubility-enhancing group is an important factor. <div class="NLM_table-wrap" id="jm000372it00003"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 3.  In Vivo Antitumor Properties of Selected 4-Anilinoquinazolines and 4-Anilinopyrido[3,4-<i>d</i>]pyrimidine- 6-acrylamides</p></div></div><div class="scrollable-table-wrap"><table class="table " width="100%"><colgroup><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">no.</td><td class="colsep2 rowsep2">tumor</td><td class="colsep2 rowsep2">dose (mg/kg)</td><td class="colsep2 rowsep2">schedule<i><sup>a</sup></i><sup></sup></td><td class="colsep2 rowsep2">wt change (g)<i><sup>b</sup></i><sup></sup></td><td class="colsep2 rowsep2">T/C (%) last therapy day<i><sup>c</sup></i><sup></sup></td><td class="colsep2 rowsep2">T−C<i><sup>d</sup></i><sup></sup> (days) </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>5</b><i><sup>e</sup></i><sup></sup></td><td class="colsep2 rowsep2">A431 </td><td class="colsep2 rowsep2">18<i><sup>f</sup></i><sup></sup></td><td class="colsep2 rowsep2">days 10−24 </td><td class="colsep2 rowsep2">−1.0 </td><td class="colsep2 rowsep2">0 </td><td class="colsep2 rowsep2">41.3 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>7</b></td><td class="colsep2 rowsep2">A431 </td><td class="colsep2 rowsep2">200 HDT<i><sup>g</sup></i><sup></sup></td><td class="colsep2 rowsep2">days 12−26 </td><td class="colsep2 rowsep2">−0.1 </td><td class="colsep2 rowsep2">62 </td><td class="colsep2 rowsep2">5.2 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2">H125 </td><td class="colsep2 rowsep2">200 HDT </td><td class="colsep2 rowsep2">days 15−29 </td><td class="colsep2 rowsep2">−0.4 </td><td class="colsep2 rowsep2">56 </td><td class="colsep2 rowsep2">7.3 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2">MCF-7 </td><td class="colsep2 rowsep2">200 HDT </td><td class="colsep2 rowsep2">days 11−25 </td><td class="colsep2 rowsep2">−0.3 </td><td class="colsep2 rowsep2">88 </td><td class="colsep2 rowsep2">1.5 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>31</b></td><td class="colsep2 rowsep2">A431 </td><td class="colsep2 rowsep2">200 HDT </td><td class="colsep2 rowsep2">days 12−26 </td><td class="colsep2 rowsep2">−0.1 </td><td class="colsep2 rowsep2">70 </td><td class="colsep2 rowsep2">5.2 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2">H125 </td><td class="colsep2 rowsep2">200 HDT </td><td class="colsep2 rowsep2">days 15−29 </td><td class="colsep2 rowsep2">−0.3 </td><td class="colsep2 rowsep2">23 </td><td class="colsep2 rowsep2">7.9 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2">MCF-7 </td><td class="colsep2 rowsep2">200 HDT </td><td class="colsep2 rowsep2">days 17−31 </td><td class="colsep2 rowsep2">+ </td><td class="colsep2 rowsep2">124 </td><td class="colsep2 rowsep2">6.8</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-"><p class="first last"><i><sup>a</sup></i><sup></sup> Compound <b>5</b> was administered as a solution of the isethionate salt in 50 mM sodium lactate buffer, pH 4.0. Compounds <b>7</b> and <b>31</b> were administered as suspensions in 0.5% methylcellulose in water. All three compounds were administered orally on the indicated schedule. Therapy was initiated when tumor masses in the respective experiments reached 100−150 mg. Differences in treatment schedules indicate data from separate experiments. It is important to initiate therapy in different experiments at an equivalent tumor mass rather than fix the days of therapy.<i><sup>b</sup></i><sup></sup> Maximum therapy-induced weight loss. A net weight gain is indicated by a “+”.<i><sup>c</sup></i><sup></sup> Ratio of median treated tumor mass/median control tumor mass × 100.<i><sup>d</sup></i><sup></sup> The difference in days for the treated (T) and control (C) tumors to reach a fixed evaluation size of 750 mg.<i><sup>e</sup></i><sup></sup> Data from ref 15.<i><sup>f</sup></i><sup></sup> Maximum tolerated dose (≤LD<sub>10</sub>).<i><sup>g</sup></i><sup></sup> HDT, highest dose tested.</p></div></div></div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24750" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24750" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last"><a name="jm004400300434" id="jm004400300434"></a>These results show that a range of Michael acceptors, apart from the unsubstituted acrylamide at the 6-position of 4-anilinoquinazolines and pyrido[3,4-<i>d</i>]pyrimidines, provide irreversible inhibitors of the EGFR enzyme. Of the non-acrylamide Michael acceptors studied, only the vinylsulfonamide provided comparably potent irreversible inhibitors, but these were less stable. Within the modified acrylamides, there was very limited bulk tolerance for substitution at the acrylamide nitrogen, with only the <i>N</i>-methyl analogue <b>7</b> retaining irreversible activity, and there was no tolerance at all for substitution at the acrylamide α-carbon (compounds <b>8/9</b>). In contrast, quite large electron-withdrawing groups (which increase acrylamide electrophilicity) were acceptable at the β-carbon. These amide-derived soluble analogues were potent irreversible inhibitors of isolated EGFR and effective inhibitors of both EGF-stimulated autophosphorylation of EGFR and heregulin-stimulated autophosphorylation of <i>erb</i>B2 in cellular assays, with activity profiles comparable to that of the clinical agent <b>5</b>. However, the best of these (<b>31</b>) was not nearly as active as <b>5 </b>in vivo. Thus positioning the solubility-enhancing group off the β-carbon of the acrylamide may not be as useful as positioning it separately off the 7-position, since it may raise the general alkylating ability of the inhibitor. </div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73130" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73130" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Analyses were performed by the Microchemical Laboratory, University of Otago, Dunedin, NZ, or by the Analytical Department, Pfizer Global Research and Development, Ann Arbor Laboratories. Melting points were determined using an Electrothermal model 9200 or Gallenkamp digital melting point apparatus and are as read. NMR spectra were measured on Bruker AC-200 or AM-400 or Varian Unity 400-MHz spectrometers and referenced to Me<sub>4</sub>Si. Mass spectra were recorded either on a Varian VG 7070 spectrometer at nominal 5000 resolution or on a Finnigan MAT 900Q spectrometer. </div><div class="NLM_p"><b><i>N</i></b><b>-[4-(3-Bromoanilino)pyrido[3,4-</b><b><i>d</i></b><b>]pyrimidin-6-yl]-</b><b><i>N</i></b><b>-methylacrylamide (7):  Example of </b><b>Method of Scheme 1.</b> 1-(3-Dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDCI·HCl) (294 mg, 1.5 mmol) was added in one portion to a stirred solution of 4-(3-bromoanilino)-6-methylaminopyrido[3,4-<i>d</i>]pyrimidine<sup><a onclick="showRef(event, 'jm000372ib00017'); return false;" href="javascript:void(0);" class="ref jm000372ib00017">17</a></sup> (<b>37</b>) (100 mg, 0.3 mmol), redistilled acrylic acid (75 μL, 1.05 mmol) and pyridine (0.3 mL) in THF/DMA (3:2, 1.8 mL) under N<sub>2</sub> at 0 °C. After 30 min the reaction was warmed to 25 °C, and after 3.75 h further acrylic acid (25 μL) was added. The mixture was stirred for an additional 3 h, then quenched with water. The precipitate was collected, air-dried, and triturated in hot CH<sub>2</sub>Cl<sub>2</sub>/EtOAc to give <b>7</b> (67 mg, 56%):  mp 215−223 °C dec; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 10.11 (s, 1 H, NH), 9.14 (s, 1 H), 8.80 (s, 1 H), 8.45 (s, 1 H), 8.22 (s, 1 H), 7.91 (br d, <i>J</i> = 7.7 Hz, 1 H), 7.43−7.36 (m, 2 H), 6.36−6.23 (m, 2 H), 5.66 (dd, <i>J</i> = 9.5, 3.0 Hz, 1 H), 3.44 (s, 3 H, CH<sub>3</sub>); CIMS <i>m</i>/<i>z</i> (relative %) 383 (23), 384 (100), 385 (40), 386 (99), 387 (20). Anal. (C<sub>17</sub>H<sub>14</sub>BrN<sub>5</sub>O·0.5H<sub>2</sub>O) C, N; H:  found 3.5, calcd 4.1. </div><div class="NLM_p"><b><i>N</i></b><b>-[4-(3-Bromoanilino)pyrido[3,4-</b><b><i>d</i></b><b>]pyrimidin-6-yl]-2-methylacrylamide (8):  Example of </b><b>Method of Scheme 1.</b> To a solution of 6-amino-4-(3-bromoanilino)pyrido[3,4-<i>d</i>]pyrimidine<sup>17</sup> (<b>38</b>) (250 mg, 0.82 mmol), Et<sub>3</sub>N (excess, 2.0 mL) and DMAP (catalytic) in THF (30 mL) under nitrogen was added methacryloyl chloride (88 μL, 0.90 mmol). The reaction was stirred at room temperature for 1.5 h over which time two further amounts (88 μL) of methacryloyl chloride were added. The reaction was then diluted with saturated NaHCO<sub>3</sub> and extracted with EtOAc. The combined organic extracts were dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, concentrated under reduced pressure and passed through a crude column of silica gel before preparative layer chromatography on silica gel eluting with EtOAc/CH<sub>2</sub>Cl<sub>2</sub> (1:1), gave <b>8</b> (18 mg, 6%):  mp (CH<sub>2</sub>Cl<sub>2</sub>/hexane) 177−178 °C; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 10.61 (s, 1 H, NH), 10.29 (s, 1 H, NH), 9.06 (s, 1 H), 8.93 (s, 1 H), 8.67 (s, 1 H), 8.19 (t, <i>J</i> = 1.6 Hz, 1 H, H-2‘), 7.91 (dt, <i>J</i> = 7.6, 1.6, 1.6 Hz, 1 H, H-6‘), 7.38 (t, <i>J</i> = 7.9 Hz, 1 H, H-5‘), 7.34 (dt, <i>J</i> = 8.1, 1.4, 1.4 Hz, 1 H, H-4‘), 6.04 (s, 1 H, C<i>H</i><sub>2</sub>C(CH<sub>3</sub>)CO), 5.64 (s, 1 H, C<i>H</i><sub>2</sub>C(CH<sub>3</sub>)CO), 2.03 (s, 1 H, CH<sub>2</sub>C(C<i>H</i><sub>3</sub>)CO); HRMS (DEI) C<sub>17</sub>H<sub>14</sub><sup>81</sup>BrN<sub>5</sub>O requires 385.03613, found 385.03595. </div><div class="NLM_p"><b><i>N</i></b><b>-[4-(3-Bromoanilino)quinazolin-6-yl]-2-methylacrylamide (9):  Example of Method of </b><b>Scheme 1. </b>To a stirred solution of 6-amino-4-(3-bromoanilino)quinazoline<sup><a onclick="showRef(event, 'jm000372ib00018'); return false;" href="javascript:void(0);" class="ref jm000372ib00018">18</a></sup> (<b>39</b>) (0.50 g, 1.59 mmol) in THF (20 mL) under nitrogen were added Et<sub>3</sub>N (excess, 1.0 mL), a catalytic amount of DMAP and methacryloyl chloride (171 μL, 1.75 mmol) dropwise. The reaction was stirred at room temperature for 1.5 h over which time two further amounts (50 μL) of methacryloyl chloride were added. Workup as above followed by chromatography on silica gel eluting with CH<sub>2</sub>Cl<sub>2</sub>/EtOAc (1:1) to MeOH/CH<sub>2</sub>Cl<sub>2</sub>/EtOAc (5:45:50) and recrystallization from EtOAc gave <b>9</b> (195 mg, 32%):  mp 244−245 °C; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 10.15 (s, 1 H, NH), 9.90 (s, 1 H, NH), 8.80 (br s, 1 H, H-5), 8.60 (s, 1 H, H-2), 8.20 (br s, 1 H, H-2‘), 7.97 (br d, <i>J</i> = 8.6 Hz, 1 H, H-7), 7.89 (br d, <i>J</i> = 7.7 Hz, 1 H, H-6‘), 7.80 (d, <i>J</i> = 8.9 Hz, 1 H, H-8), 7.35 (t, <i>J</i> = 8.0 Hz, 1 H, H-5‘), 7.30 (br d, <i>J</i> = 7.5 Hz, 1 H, H-4‘), 5.94 (s, 1 H, C<i>H</i><sub>2</sub>C(CH<sub>3</sub>)CO), 5.62 (s, 1 H, C<i>H</i><sub>2</sub>C(CH<sub>3</sub>)CO), 2.02 (s, 3 H, CH<sub>2</sub>C(C<i>H</i><sub>3</sub>)CO). Anal. (C<sub>18</sub>H<sub>15</sub>BrN<sub>4</sub>O) C, H, N. </div><div class="NLM_p"><b>(2</b><b><i>E</i></b><b>)-</b><b><i>N</i></b><b>-[4-(3-Bromoanilino)pyrido[3,4-</b><b><i>d</i></b><b>]pyrimidin-6-yl]-2-butenamide (10).</b> EDCI·HCl (98 mg, 0.5 mmol) was added to a stirred solution of <b>38 </b>(32 mg, 0.1 mmol) and <i>trans</i>-crotonic acid (35 mg, 0.4 mmol) in pyridine (0.4 mL) under N<sub>2</sub> at 0−5 °C. Cooling was removed and the mixture was stirred at 25 °C for 2 h, then diluted with water and the resulting suspension stirred for 15 min and filtered. The solid was dissolved in EtOAc, washed with 5% aqueous NaHCO<sub>3</sub>, dried (MgSO<sub>4</sub>) and filtered through a silica gel column. The filtrate was concentrated, and the resulting solid was triturated in hot EtOAc to give <b>10</b> (11 mg, 28%):  mp >260 °C dec; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 10.87 (s, 1 H, NH), 10.31 (s, 1 H, NH), 9·03 (s, 1 H), 9.00 (s, 1 H), 8.65 (s, 1 H), 8.17 (s, 1 H), 7.89 (d, <i>J</i> = 7.5 Hz, 1 H), 7.39−7.33 (m, 2 H), 6.99−6.90 (m, 1 H), 6.39 (dd, <i>J</i> = 15.4, 1.7 Hz, 1 H), 1.91 (dd, <i>J</i> = 7.0, 1.4 Hz, 3 H); MS (APCI) <i>m</i>/<i>z</i> (relative %) 381.8 (74), 382.8 (27), 383.8 (100), 384.8 (30), 385.9 (10). Anal. (C<sub>17</sub>H<sub>14</sub>BrN<sub>5</sub>O·0.25H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b>(2</b><b><i>E</i></b><b>)-</b><b><i>N</i></b><b>-[4-(3-Bromoanilino)-6-quinazolinyl]-2-butenamide (11).</b> Excess <i>trans</i>-crotonyl chloride was added to a solution of <b>39</b> (316 mg, 1.0 mmol) in THF (6 mL) stirred under N<sub>2</sub> at 0 °C. After 2.5 h the resulting yellow solid was collected by filtration and sonicated with EtOAc to give <b>11</b> (216 mg, 52%):  mp 279−281 °C; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 11.55 (br s, 1 H, NH), 10.78 (s, 1 H, NH), 9.17 (d, <i>J</i> = 1.9 Hz, 1 H, H-5), 8.97 (s, 1 H, H-2), 8.12 (dd, <i>J</i> = 9.1, 2.0 Hz, 1 H, H-7), 8.05 (t, <i>J</i> = 1.9 Hz, 1 H, H-2‘), 7.99 (d, <i>J</i> = 9.0 Hz, 1 H, H-8), 7.76 (dd, <i>J</i> = 8.1, 2.0 Hz, 1 H, H-6‘), 7.58 (dd, <i>J</i> = 8.6, 1.7 Hz, 1 H, H-4‘), 7.52 (t, <i>J</i> = 8.1 Hz, 1 H, H-5‘) 7.03−6.94 (m, 1 H, (CO)CH<img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>), 6.34 (dd, <i>J</i> = 15.1, 1.7 Hz, 1 H, CH<img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>CHCH<sub>3</sub>), 1.98 (dd, <i>J</i> = 6.8, 1.4 Hz, 3 H, CH<sub>3</sub>); MS (CI) 385 (89, <sup>81</sup>BrMH<sup>+</sup>), 384 (51, <sup>81</sup>BrM<sup>+</sup>), 383 (100, <sup>79</sup>BrMH<sup>+</sup>), 382 (37, <sup>79</sup>BrM<sup>+</sup>). Anal. (C<sub>18</sub>H<sub>15</sub>N<sub>4</sub>BrO·HCl) C, H, N. </div><div class="NLM_p"><b>(2</b><b><i>Z</i></b><b>)-</b><b><i>N</i></b><b>-[4-(3-Bromoanilino)-6-pyrido[3,4-</b><b><i>d</i></b><b>]pyrimidin-6-yl]-3-chloro-2-propenamide (12).</b> A stirred solution of <b>38</b> (128 mg, 0.4 mmol) and <i>cis</i>-3-chloroacrylic acid (172 mg, 1.6 mmol) in pyridine (2 mL) under N<sub>2</sub> was treated at −20 °C with EDCI·HCl (392 mg, 1.5 mmol). After 4.5 h at −20 °C, additional <i>cis</i>-3-chloroacrylic acid (57 mg) and EDCI·HCl (130 mg) were added, and the temperature was brought to −10 °C. After a total reaction time of 7 h, the viscous mixture was diluted with DMF and the resulting solution was poured into EtOAc/water (1:1). The aqueous phase was further extracted with EtOAc (2×), and the combined organic phases were washed with brine (2×), dried (MgSO<sub>4</sub>) and filtered through a column of flash silica gel. The filtrate was concentrated to a <a name="jm004400300435" id="jm004400300435"></a> solid that was dissolved in warm EtOAc and chromatographed on flash silica gel, eluting with EtOAc. The appropriate fractions were pooled and evaporated. The product was triturated in EtOAc/<i>tert</i>-butyl methyl ether (1:1), dried at 0.1 mm/25 °C and recrystallized from EtOAc to give <b>12</b> (30 mg, 18%):  mp 165−175 °C dec; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 11.09 (s, 1 H, NH), 10.38 (s, 1 H, NH), 9·04 (s, 1 H), 9.00 (s, 1 H), 8.66 (s, 1 H), 8.16 (t, <i>J</i> = 1.9 Hz, 1 H), 7.88 (dt, <i>J</i> = 7.7, 1.7 Hz, 1 H), 7.40−7.33 (m, 2 H), 7.07 (d, <i>J</i> = 8.0 Hz, 1 H), 6.77 (d, <i>J</i> = 8.0 Hz, 1 H); MS (APCI) <i>m</i>/<i>z</i> (relative %) 365.8 (29), 366.8 (36), 367.8 (35), 368.8 (35), 401.8 (82), 402.8 (18), 403.8 (100), 404.8 (20), 405.8 (29). Anal. (C<sub>16</sub>H<sub>11</sub>BrClN<sub>5</sub>O·0.25C<sub>4</sub>H<sub>8</sub>O<sub>2</sub>) C, H, N. </div><div class="NLM_p"><b>(2</b><b><i>E</i></b><b>)-</b><b><i>N</i></b><b>-[4-(3-Bromoanilino)-6-quinazolinyl]-4,4,4-trifluoro-2-butenamide (13).</b> A stirred solution of <b>39</b> (158 mg, 0.5 mmol) and 4,4,4-trifluorobut-2-enoic acid (153 mg, 1.1 mmol) in THF/DMF (4:1, 2.5 mL) was treated with EDCI·HCl (192 mg, 1.0 mmol) under N<sub>2</sub> at 0 °C. After 1 h the mixture was diluted with water (10 mL), and the resulting precipitate was collected, washed with water (2 × 5 mL) and ether (10 mL) and air-dried. The solid was suspended in EtOAc (10 mL), refluxed briefly, and sonicated for 10 min, then collected by filtration, washed with EtOAc (5 mL) and dried in a vacuum oven at 75 °C for 1.5 h to give <b>13</b> as the hydrochloride salt (76 mg, 33%):  mp 273−278 °C; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 11.09 (br s, 1 H, NH), 10.43 (s, 1 H, NH), 8.90 (s, 1 H, H-2), 8.70 (s, 1 H, H-5), 8.11 (s, 1 H, H-2‘), 7.97 (dd, <i>J</i> = 2.5, 9.2 Hz, 1 H, H-7), 7.87 (d, <i>J</i> = 9.0 Hz, 1 H, H-8), 7.81 (d, <i>J</i> = 6.9 Hz, 1 H, H-6‘), 7.41−7.33 (m, 2 H, H-5‘,H-4‘), 7,11 (d, <i>J</i> = 16.4 Hz, 1 H, CH<img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>CHCF<sub>3</sub>), 7.03 (dq, <i>J</i><sub>d</sub> = 16.4 Hz, <i>J</i><sub>q</sub> = 6.4 Hz, 1 H, CH<img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>CHCF<sub>3</sub>); MS (CI) 439 (78 <sup>81</sup>BrM<sup>+</sup>), 437 (100 <sup>79</sup>BrM<sup>+</sup>). Anal. (C<sub>18</sub>H<sub>13</sub>BrF<sub>3</sub>N<sub>4</sub>O·0.5HCl) C, H, N. </div><div class="NLM_p"><b>(2</b><b><i>E</i></b><b>)-</b><b><i>N</i></b><b>-[4-(3-Bromoanilino)pyrido[3,4-</b><b><i>d</i></b><b>]pyrimidin-6-yl]-2,4-pentadienamide</b><b>(14).</b> A stirred solution of <b>38</b> (160 mg, 0.5 mmol), 80% <i>trans</i>-2,4-pentadienoic acid (245 mg, 2 mmol), and pyridine (0.5 mL) in THF/DMA (2:1, 3 mL) under N<sub>2</sub> was cooled to 0−5 °C and treated with one portion of EDCI·HCl (490 mg, 2.5 mmol). Cooling was removed, and the viscous mixture was stirred at 25 °C for 23 h, then charged with additional <i>trans</i>-2,4-pentadienoic acid (125 mg), EDCI·HCl (240 mg) and THF/DMA (2:1, 2 mL). After a further 19 h the mixture was diluted with water and EtOAc. The biphasic mixture was warmed, then filtered through Celite, and the filter pad washed well with water and hot EtOAc. The filtrate was extracted with EtOAc (3×) and the combined organic phases were washed with brine, dried (MgSO<sub>4</sub>) and concentrated. The resulting solid was dissolved in hot EtOAc and chromatographed on silica gel, eluting with EtOAc. The product was triturated in warm EtOAc to give <b>14</b> (27 mg, 13%):  mp 210−215 °C; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 11.04 (s, 1 H, NH), 10.34 (s, 1 H, NH), 9.04 (s, 1 H), 9.02 (s, 1 H), 8.66 (s, 1 H), 8.17 (t, <i>J</i> = 1.9 Hz, 1 H), 7.89 (dt, <i>J</i> = 7.7, 1.7 Hz, 1 H), 7.40−7.27 (m, 3 H), 6.60 (dt, <i>J</i> = 16.9, 10.6 Hz, 1 H), 6.53 (d, <i>J</i> = 15.2 Hz, 1 H), 5.75 (d, <i>J</i> = 16.9 Hz, 1 H), 5.56 (d, <i>J</i> = 11.1 Hz, 1 H); MS (APCI) <i>m</i>/<i>z</i> (relative %) 395.9 (89), 396.9 (20), 397.9 (100), 398.9 (20). Anal. (C<sub>18</sub>H<sub>14</sub>BrN<sub>5</sub>O) C, H. </div><div class="NLM_p"><b><i>N</i></b><b>-[4-(3-Bromoanilino)-6-quinazolinyl]-2,3-butadienamide (15).</b> EDCI·HCl (384 mg, 2.0 mmol) was added to a stirred solution of <b>39</b> (316 mg, 1.0 mmol), and 2,3-butadienoic acid (173 mg, 2.06 mmol) in DMF (5 mL) stirred under N<sub>2</sub> at 0 °C. After 1.5 h the reaction was quenched with 0.1 M HCl (10 mL), and the resulting precipitate was collected and washed successively with water and Me<sub>2</sub>CO, then dissolved into Me<sub>2</sub>CO with the addition of Et<sub>3</sub>N. The solution was filtered through a short column of silica gel in Me<sub>2</sub>CO/CH<sub>2</sub>Cl<sub>2</sub> (1:1) to give <b>15</b> (247 mg, 56%):  mp 268−270 °C; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 10.39 (s, 1 H, NH), 9.93 (s, 1 H, NH), 8.76 (d, <i>J</i> = 2.2 Hz, 1 H, H-5), 8.58 (s, 1 H, H-2), 8.18 (s, 1 H, H-2‘), 7.87 (dt, <i>J</i> = 9.0, 1.9 Hz, 2 H, H-7,8), 7.79 (d, <i>J</i> = 8.8 Hz, 1 H, H-6‘), 7.34 (t, <i>J</i> = 7.9 Hz, 1 H, H-5‘), 7.29 (d, <i>J</i> = 8.3 Hz, 1 H, H-4‘), 6.07 (t, <i>J</i> = 6.5 Hz, 1 H, C<i>H</i><img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>C<img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>CH<sub>2</sub>), 5.49 (d, <i>J</i> = 6.6 Hz, 2 H, <img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>C<img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>CH<sub>2</sub>); MS (APCI) 382.8 (88, <sup>81</sup>BrMH<sup>+</sup>), 381.8 (19, <sup>81</sup>BrM<sup>+</sup>), 380.7 (100, <sup>79</sup>BrMH<sup>+</sup>). Anal. (C<sub>18</sub>H<sub>13</sub>BrN<sub>4</sub>O·0.8C<sub>3</sub>H<sub>6</sub>O·0.5H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b>(2</b><b><i>E</i></b><b>)-</b><b><i>N</i></b><b>-[4-(3-Bromoanilino)pyrido[3,4-</b><b><i>d</i></b><b>]pyrimidin-6-yl]-3-phenyl-2-propenamide</b><b>(16).</b><i>trans</i>-Cinnamic acid (60 mg, 0.4 mmol) was added to a stirred solution of <b>38</b> (32 mg, 0.1 mmol) in pyridine (0.4 mL). EDCI·HCl (98 mg, 0.5 mmol) was added and the mixture was stirred under N<sub>2</sub> at 25 °C for 2 h. The mixture was diluted with water, and the solids were collected and dissolved in EtOAc. The solution was washed with 5% aqueous NaHCO<sub>3</sub>, dried (MgSO<sub>4</sub>) and filtered through silica gel. The residue from removal of solvent was triturated with hot EtOAc to give <b>16</b> (23 mg, 51%):  mp 253−256 °C; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 11.07 (s, 1 H, NH), 10.36 (s, 1 H, NH), 9.06 (s, 1 H), 9.02 (s, 1 H), 8.67 (s, 1 H), 8.19 (s, 1 H), 7.90 (d, <i>J</i> = 7.7 Hz, 1 H), 7.72−7.65 (m, 3 H), 7.51−7.34 (m, 5 H), 7.14 (d, <i>J</i> = 15.7 Hz, 1 H). Anal. (C<sub>22</sub>H<sub>16</sub>N<sub>5</sub>OBr·0.25H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b>(2</b><b><i>E</i></b><b>)-</b><b><i>N</i></b><b>-[4-(3-Bromoanilino)-6-quinazolinyl]-4-oxo-2-pentenamide</b><b>(17).</b><i>N</i>-Ethyldiisopropylamine (0.26 mL, 1.5 mmol) and <b>39</b> (0.23 g, 0.75 mmol) were added to a stirred solution of (<i>E</i>)-4-oxopent-2-enoic acid (171 mg, 1.5 mmol) and EDCI·HCl (288 mg, 1.5 mmol) in THF/DMF (3:1, 4 mL) under N<sub>2</sub> at 25 °C. The ice bath was then removed, and the reaction mixture was stirred at 25 °C for 4 h, when further <i>N</i>-ethyldiisopropylamine (0.13 mL, 0.75 mmol), (<i>E</i>)-4-oxopent-2-enoic acid (86 mg, 0.75 mmol) and EDCI·HC1 (144 mg, 0.75 mmol) were added. The reaction mixture was stirred for a further 14 h at 25 °C, then added dropwise to stirred cold water (100 mL). The solid was collected, dissolved in MeOH (50 mL) and evaporated onto silica gel (3 g). Flash chromatography on silica gel, eluting with 10% MeOH/CH<sub>2</sub>Cl<sub>2</sub> (1:9), gave <b>17</b> (0.14 g, 45%):  mp 230 °C dec; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 10.91 (s, 1 H, NH), 9.99 (s, 1 H, NH), 8.87 (d, <i>J</i> = 1.9 Hz, 1 H, H-5), 8.60 (s, 1 H, H-2), 8.17 (t, <i>J</i> = 1.9 Hz, 1 H, H-2‘), 7.85 (m, 3 H, H-7,8,6‘), 7.37 (m, 2 H, H-5‘,4‘), 7.15 (d, <i>J</i> = 15.7 Hz, 1 H, pentenyl H-3), 6.99 (d, <i>J</i> = 15.7 Hz, 1 H, pentenyl H-2), 2.40 (s, 3 H, CH<sub>3</sub>); MS (APCI) 412.7 (100, <sup>81</sup>BrMH<sup>+</sup>), 410.8 (98, <sup>79</sup>BrMH<sup>+</sup>). Anal. (C<sub>19</sub>H<sub>15</sub>BrN<sub>4</sub>O<sub>2</sub>) C, H, N. </div><div class="NLM_p"><b>(2</b><b><i>E</i></b><b>)-4-{[4-(3-Bromoanilino)-6-quinazolinyl]amino}-4-oxo-2-butenoic Acid (18).</b> Maleic anhydride (0.266 g, 2.7 mmol) was added to a solution of <b>39</b> (0.78 g, 2.5 mmol) in DMF (8 mL), and the mixture was heated with stirring in a 70 °C oil bath for 2.5 h. The resulting suspension was cooled to room temperature and then diluted with water. The solid was collected, washed sequentially with a mixture of toluene/DMF (1:1), water, and IPA. The solid was dried under high vacuum at 60 °C for 16 h to give <b>18 </b>(0.87 g, 86%):  mp 224−225 °C dec; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 13.00 (br s, 1 H, COOH), 10.85 (br s, 1 H, NH), 9.96 (br s, 1 H, NH), 8.73 (d, <i>J</i> = 1.8 Hz, 1 H, H-5), 8.54 (s, 1 H, H-2), 8.11 (br s, 1 H, (CH<sub>3</sub>)<sub>2</sub>NC<i>H</i>O), 7.91−7.75 (m, 4 H), 7.32−7.24 (m, 2 H), 6.46 (d, <i>J</i> = 12.0 Hz, 1 H, C<i>H</i><img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>CH), 6.35 (d, <i>J</i> = 12.0 Hz, 1 H, CH<img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>C<i>H</i>), 2.84 (s, 3 H, (C<i>H</i><sub>3</sub>)<sub>2</sub>NCHO), 2.68 (s, 3 H, (C<i>H</i><sub>3</sub>)<sub>2</sub>NCHO); MS (APCI) 412.8 (100, <sup>81</sup>BrM<sup>+</sup>), 410.8 (96, <sup>79</sup>BrM<sup>+</sup>), 413.8 (26, <sup>81</sup>BrMH<sup>+</sup>), 411.8 (24, <sup>79</sup>BrMH<sup>+</sup>). Anal. (C<sub>18</sub>H<sub>13</sub>BrN<sub>4</sub>O<sub>3</sub>·DMF) C, H, N. </div><div class="NLM_p"><b>Ethyl (2</b><b><i>E</i></b><b>)-4-{[4-(3-Bromoanilino)-6-quinazolinyl]amino}-4-oxo-2-butenoate (19).</b><i>N</i>-Ethyldiisopropylamine (0.26 mL, 1.5 mmol) and <b>39 </b>(0.23 g, 0.75 mmol) were added to a solution of (<i>E</i>)-4-ethoxy-4-oxobut-2-enoic acid (216 mg, 1.5 mmol) and EDCI·HC1 (288 mg, 1.5 mmol) in THF/DMF (3:1, 4 mL) stirred under N<sub>2</sub> at 25 °C. The ice bath was removed, and the reaction mixture was stirred at 25 °C for 4 h, when further <i>N</i>-ethyldiisopropylamine (0.13 mL, 0.75 mmol), (<i>E</i>)-4-ethoxy-4-oxobut-2-enoic acid (108 mg, 0.75 mmol), and EDCI·HC1 (144 mg, 0.75 mmol) were added. After stirring a further 14 h at 25 °C, the reaction mixture was added dropwise to stirred cold water (100 mL). The solid was collected, dissolved in MeOH (50 mL), and dried onto silica gel (3 g) and flash chromatographed on silica gel, eluting with MeOH/CH<sub>2</sub>C1<sub>2</sub> (1:9). Concentration of pure fractions under reduced pressure gave <b>19</b> (0.19 g, 58%):  mp >255 °C; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 10.93 (s, 1 H, NH), 9.99 (s, 1 H, NH), 8.89 (d, <i>J</i> = 1.9 Hz, 1 H, H-5), 8.60 (s, 1 H, H-2), 8.16 (t, <i>J</i> = 1.9 Hz, 1 H, H-2‘), 7.85 (m, 3 H, H-7,8,6‘), 7.33 (m, 3 H, H-5‘,4‘, pentenyl H-3), 6.79 (d, <i>J</i> = 15.4 Hz, 1H, pentenyl H-2), 4.24 (q, <i>J</i> = 7.1 Hz, 2 H, CH<sub>2</sub>), 1.29 (t, <i>J</i> = 7.1 Hz, 3 H, CH<sub>3</sub>); MS (APCI) 442.8 (99, <sup>81</sup>BrMH<sup>+</sup>), 440.8 (100, <sup>79</sup>BrMH<sup>+</sup>). Anal. (C<sub>20</sub>H<sub>17</sub>BrN<sub>4</sub>O<sub>3</sub>) C, H, N. </div><div class="NLM_p"><a name="jm004400300436" id="jm004400300436"></a><b>Ethyl (2</b><b><i>E</i></b><b>)-4-{[4-(3-Bromoanilino)pyrido[3,4-</b><b><i>d</i></b><b>]pyrimidin-6-yl]amino}-4-oxo-2-butenoate </b><b>(20).</b> Reaction of <b>38</b> (32 mg, 0.1 mmol) with fumaric acid monoethyl ester (58 mg, 0.4 mmol) and EDCI·HCl (98 mg, 0.5 mmol) in pyridine (0.5 mL) was carried out as described above. After 5 h, the solution was poured into water, which formed a precipitate. The suspension was sonicated, then the solid was collected, washed well with water, and dried to give <b>20</b> (90 mg, 89%):  mp >230 °C dec; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 11.44 (s, 1 H, NH), 10.37 (s, 1 H, NH), 9.07 (s, 1 H, H-2), 9.05 (s, 1 H, H-8), 8.68 (s, 1 H, H-5), 8.17 (d, <i>J</i> = 2.0 Hz, 1 H, H-2‘), 7.89 (dt, <i>J</i> = 7.5, 1.9, 1.7 Hz, 1 H, H-4‘), 7.48 (d, <i>J</i> = 15.4 Hz, 1 H, fumarate H), 7.40−7.34 (m, 2 H, H-5‘,6‘), 6.83 (d, <i>J</i> = 15.4 Hz, 1 H, fumarate H), 4.24 (q, <i>J</i> = 7.0 Hz, 2 H, CH<sub>2</sub>), 1.28 (t, <i>J</i> = 7.0 Hz, 3 H, CH<sub>3</sub>). Anal. (C<sub>19</sub>H<sub>16</sub>BrN<sub>5</sub>O<sub>3</sub>·0.25H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b><i>N</i></b><b>-[4-(3-Bromoanilino)pyrido[3,4-</b><b><i>d</i></b><b>]pyrimidin-6-yl]-</b><b><i>N</i></b><b>-[2-(dimethylamino)ethyl]acrylamide </b><b>(21):  Example of Method of Scheme 2.</b> EDCI·HCl (980 mg, 5 mmol) was added to a stirred solution of <i>N</i><sup>4</sup>-(3-bromophenyl)-<i>N</i><sup>6</sup>-[2-(dimethylamino)ethyl]pyrido[3,4-<i>d</i>]pyrimidine-4,6-diamine<sup><a onclick="showRef(event, 'jm000372ib00019'); return false;" href="javascript:void(0);" class="ref jm000372ib00019">19</a></sup> (<b>40</b>) (387 mg, 1 mmol) and redistilled acrylic acid (0.25 mL, 3.6 mmol) in pyridine (5 mL) under N<sub>2</sub> cooled to 0−5 °C. After 30 min cooling was removed, and the solution was stirred for an additional 45 min, then diluted with 1% aqueous NaHCO<sub>3</sub>. The mixture was extracted with EtOAc (4×), and the combined extracts were washed with brine, dried (MgSO<sub>4</sub>), and concentrated to give <b>21</b> (122 mg, 28%):  mp (EtOAc, 5 °C) >160 °C dec; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 10.16 (s, 1 H, NH), 9.15 (s, 1 H), 8.80 (s, 1 H), 8.43 (s, 1 H), 8.22 (s, 1 H), 7.93 (d, <i>J</i> = 7.7 Hz, 1 H), 7.42−7.35 (m, 2 H), 6.29−6.22 (m, 2 H), 5.66 (dd, <i>J</i> = 9.0, 3.5 Hz, 1 H), 4.05 (t, <i>J</i> = 7.1 Hz, 2 H) 2.42 (t, <i>J</i> = 7.1 Hz, 2 H), 2.11 (s, 6 H); MS (APCI) <i>m</i>/<i>z</i> (relative %) 440.9 (99), 441.8 (23), 442.8 (100), 443.9 (24). Anal. (C<sub>20</sub>H<sub>21</sub>BrN<sub>6</sub>O) C, H, N. </div><div class="NLM_p"><b><i>N</i></b><b>-[4-(3-Bromoanilino)pyrido[3,4-</b><b><i>d</i></b><b>]pyrimidin-6-yl]-</b><b><i>N</i></b><b>-[3-(4-morpholinyl)propyl]acrylamide </b><b>(22):  Example of Method of Scheme 2.</b> To a stirred solution of <i>N</i><sup>4</sup>-(3-bromophenyl)-<i>N</i><sup>6</sup>-[3-(4-morpholinyl)propyl]pyrido[3,4-<i>d</i>]pyrimidine-4,6-diamine<sup>19</sup> (<b>41</b>) (400 mg, 0.90 mmol), DMAP (40 mg) and Et<sub>3</sub>N (excess, 2.0 mL) at 0 °C under N<sub>2</sub> was added acryloyl chloride (89 μL, 1.08 mmol). After 1 h stirring a further two portions of acid chloride (89 μL each) were added over the next 2 h and the procedure and workup above were followed to give, after column chromatography on silica gel eluting with MeOH/EtOAc (1:9) to MeOH/EtOAc (1:5), <b>22</b> (142 mg, 32%):  mp (CH<sub>2</sub>Cl<sub>2</sub>/hexane) 178−180 °C; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 10.15 (s, 1 H, NH), 9.15 (s, 1 H), 8.80 (s, 1 H), 8.47 (s, 1 H), 8.21 (br s, 1 H, H-2‘), 7.92 (br d, <i>J</i> = 7.6 Hz, 1 H, H-6‘), 7.41 (t, <i>J</i> = 8.0 Hz, 1 H, H-5‘), 7.37 (dt, <i>J</i> = 8.1, 1.6, 1.6 Hz, 1 H, H-4‘), 6.25 (m, 2 H, CH<sub>2</sub>C<i>H</i>CO, C<i>H</i><sub>2</sub>CHCO), 5.66 (m, 1 H, C<i>H</i><sub>2</sub>CHCO), 3.98 (t, <i>J</i> = 7.5 Hz, 2 H, CH<sub>2</sub>NRCO), 3.46 (t, <i>J</i> = 4.5 Hz, 4 H, morph. CH<sub>2</sub>), 2.29 (t, <i>J</i> = 7.1 Hz, 2 H, C<i>H</i><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>NRCO), 2.24 (br s, 4 H, morph. CH<sub>2</sub>), 1.73 (quintet, <i>J</i> = 7.2 Hz, 2 H, CH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>). Anal. (C<sub>23</sub>H<sub>25</sub>BrN<sub>6</sub>O<sub>2</sub>·H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b><i>N</i></b><b>-[4-(3-Bromoanilino)-6-quinazolinyl]-</b><b><i>N</i></b><b>-[3-(4-morpholinyl)propyl]acrylamide (23):  </b><b>Example of Method of Scheme 3. </b>A stirred solution of <b>4</b><sup>14</sup> (1.78 g, 4.82 mmol), morpholine (excess, 4.0 mL) and <i>p</i>-toluenesulfonic acid (catalytic) in THF (50 mL) was heated at 50 °C for 4 h before being concentrated under reduced pressure, diluted with water and extracted with EtOAc. The combined organic extracts were washed with brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, concentrated under reduced pressure and chromatographed on silica gel eluting with MeOH/CH<sub>2</sub>Cl<sub>2</sub>/EtOAc (15:40:45) to give <i>N</i>-[4-(3-bromoanilino)-6-quinazolinyl]-3-(4-morpholinyl)propanamide (<b>42</b>) (1.86 g, 78%):  mp (EtOAc) 184−186 °C; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 10.37 (s, 1 H, NH), 9.91 (s, 1 H, NH), 8.72 (d, <i>J</i> = 1.9 Hz, 1 H, H-5), 8.58 (s, 1 H, H-2), 8.17 (t, <i>J</i> = 2.1 Hz, 1 H, H-2‘), 7.86 (m, 2 H, H-7, 6‘), 7.78 (d, <i>J</i> = 8.9 Hz, 1 H, H-8), 7.35 (t, <i>J</i> = 8.0 Hz, 1 H, H-5‘), 7.29 (dt, <i>J</i> = 1.2, 1.2, 8.0 Hz, 1 H, H-4‘), 3.40 (t, <i>J</i> = 4.6 Hz, 4 H, morph. CH<sub>2</sub>), 2.69 (t, <i>J</i> = 6.6 Hz, 2 H, NCH<sub>2</sub>C<i>H</i><sub>2</sub>CONH), 2.58 (t, <i>J</i> = 6.6 Hz, 2 H, NC<i>H</i><sub>2</sub>CH<sub>2</sub>CONH), 2.44 (br s, 4 H, morph. CH<sub>2</sub>). Anal. (C<sub>21</sub>H<sub>22</sub>BrN<sub>5</sub>O<sub>2</sub>) C, H, N. </div><div class="NLM_p">To a stirred solution of <b>42</b> (0.85 g, 1.86 mmol) in THF (30 mL) under N<sub>2</sub> at 0 °C was added BH<sub>3</sub>·DMS (372 μL of a 10M solution, 2 mol equiv) dropwise. The resulting solution was allowed to warm to room temperature and then stirred for 2 h, before being quenched by the cautious addition of 1 N HCl (40 mL). The reaction mixture was then stirred at 50 °C for 2 h, basified by the addition of saturated Na<sub>2</sub>CO<sub>3</sub> and extracted with EtOAc. The combined organic extracts were washed with brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, concentrated under reduced pressure and chromatographed on silica gel eluting with MeOH/CH<sub>2</sub>Cl<sub>2</sub>/EtOAc (3:8:8) to give <i>N</i><sup>4</sup>-(3-bromophenyl)-<i>N</i><sup>6</sup>-[3-(4-morpholinyl)propyl]-4,6-quinazolinediamine (<b>43</b>) (130 mg, 16%) as a yellow glass (ca. 90% pure by NMR). This was used without further purification:  <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 9.40 (s, 1 H, NH), 8.37 (s, 1 H, H-2), 8.17 (t, <i>J</i> = 1.9 Hz, 1 H, H-2‘), 7.91 (br d, <i>J</i> = 8.2 Hz, 1 H, H-6‘), 7.54 (d, <i>J</i> = 9.0 Hz, 1 H, H-8), 7.34 (t, <i>J</i> = 8.0 Hz, 1 H, H-5‘), 7.27 (m, 2H, H-4‘, 7), 7.16 (d, <i>J</i> = 2.2 Hz, 1 H, H-5), 6.25 (t, <i>J</i> = 5.1 Hz, 1 H, CH<sub>2</sub>N<i>H</i>), 3.59 (t, <i>J</i> = 4.5 Hz, 4 H, morph. CH<sub>2</sub>), 3.22 (q, <i>J</i> = 6.0 Hz, 1 H, C<i>H</i><sub>2</sub>NH), 2.45 (t, <i>J</i> = 6.9 Hz, 2 H, C<i>H</i><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>NH), 2.39 (br s, 4 H, morph. CH<sub>2</sub>), 1.82 (quintet, <i>J</i> = 7.0 Hz, 2 H, CH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>). </div><div class="NLM_p">A stirred solution of <b>43</b> (133 mg, 0.30 mmol) in DMF (5.0 mL) under N<sub>2</sub> was treated sequentially with acrylic acid (83 μL, 1.20 mmol), Et<sub>3</sub>N (excess, 0.5 mL), and EDCI·HCl (115 mg, 0.6 mmol). Standard workup as above, followed by chromatography on silica gel, eluting with EtOAc:CH<sub>2</sub>Cl<sub>2</sub> (1:1) to MeOH/CH<sub>2</sub>Cl<sub>2</sub>/EtOAc (3:7:10), gave <b>23</b> (39 mg, 26%):  mp (CH<sub>2</sub>Cl<sub>2</sub>/hexane) 171−175 °C; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 9.86 (s, 1 H, NH), 8.70 (s, 1 H, H-2), 8.52 (d, <i>J</i> = 2.0 Hz, 1 H, H-5), 8.20 (t, <i>J</i> = 1.9 Hz, 1 H, H-2‘), 7.91 (partially obscured br d, <i>J</i> = 8.6 Hz, 1 H, H-6‘), 7.89 (d, <i>J</i> = 8.9 Hz, 1 H, H-8), 7.79 (dd, <i>J</i> = 8.8, 2.1 Hz, 1 H, H-7), 7.38 (t, <i>J</i> = 7.9 Hz, 1 H, H-5‘), 7.33 (dt, <i>J</i> = 8.4, 1.7, 1.7 Hz, 1 H, H-4‘), 6.22 (dd, <i>J</i> = 16.7, 2.3 Hz, 1 H, C<i>H</i><sub>2</sub>CHCO), 6.05 (br s, 1 H, CH<sub>2</sub>C<i>H</i>CO), 5.61 (br d, <i>J</i> = 8.8 Hz, 1 H, C<i>H</i><sub>2</sub>CHCO), 3.87 (t, <i>J</i> = 7.4 Hz, 2 H, CH<sub>2</sub>NRCO), 3.49 (t, <i>J</i> = 4.5 Hz, 4 H, morph. CH<sub>2</sub>), 2.28 (partially obscured t, <i>J</i> = 7.1 Hz, 2 H, C<i>H</i><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>NRCO), 2.27 (br s, 4 H, morph. CH<sub>2</sub>), 1.69 (quintet, <i>J</i> = 7.3 Hz, 2 H, CH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>); HRMS (DEI) (M<sup>+</sup>) calcd for C<sub>24</sub>H<sub>26</sub>Br<sup>81</sup>N<sub>5</sub>O<sub>2</sub> 497.1249, found 497.1250. </div><div class="NLM_p"><b>3-(Dimethylamino)propyl </b><b>(2</b><b><i>E</i></b><b>)-4-{[4-(3-Bromoanilino)-6-quinazolinyl]amino}-4-oxo-2-butenoate (24):  Example of </b><b>Method of Scheme 4. </b>A solution of <b>39 </b>(158 mg, 0.5 mmol) in THF (10 mL) was added dropwise over 15 min to a solution of fumaryl chloride (382 mg, 2.5 mmol) in THF (10 mL) stirred under N<sub>2</sub> at 0 °C. After 1 h at 0 °C the suspension was allowed to settle, and the supernatant of crude acid chloride <b>44</b> was decanted. Fresh THF (5 mL) was added, and the suspension was stirred at 0 °C while a solution of 3-(<i>N</i>,<i>N</i>-dimethylamino)propan-l-ol (1.18 mL, 10 mmol) in THF (5 mL) was added dropwise. The suspension was stirred at 25 °C for 1 h, the solvent was evaporated under reduced pressure, and the residue was triturated with cold water. The solid was collected, dissolved in a minimum volume of DMF, and absorbed onto silica gel (2 g) and dried. Flash chromatography on silica gel, eluting with CH<sub>2</sub>Cl<sub>2</sub>/MeOH (2:1) gave a product that was dissolved in AcOH/water (3:2, 2.5 mL), passed through a 0.45-μm filter, and purified by HPLC on a Vidac C<sub>18</sub> 218TP1022 reverse-phase HPLC column. Elution with 10% to 50% gradient of 0.1% TFA in water/0.l % TFA in CH<sub>3</sub>CN over 60 min gave <b>24</b> as the tris trifluoroacetate salt (51 mg, 12%):  mp 60 °C; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 11.14 (s, 1 H, NH), 10.85 (br s, 1 H, NH), 9.57 (br s, 1 H, NH), 9.01 (d, <i>J</i> = 1.7 Hz, 1 H, H-5), 8.79 (s, 1 H, H-2), 8.07 (s, 1H, H-2‘), 8.02 (dd, <i>J</i> = 2.1, 9.0 Hz, 1H, H-7), 7.89 (d, <i>J</i> = 8.9 Hz, 1H, H-8), 7.78 (d, <i>J</i> = 6.5 Hz, 1 H, H-6‘), 7.43 (m, 2 H, H-4‘,5‘), 7.34 (d, <i>J</i> = 15.4 Hz, 1 H, butenyl H-3), 6.84 (d, <i>J</i> = 15.4 Hz, 1 H, butenyl H-2), 4.26 (t, <i>J</i> = 6.2 Hz, 2 H, OCH<sub>2</sub>), 3.19 (m, 2 H, CH<sub>2</sub>N), 2.81 (d, <i>J</i> = 4.6 Hz, 6 H, CH<sub>3</sub>), 2.05 (m, 2 H, CH<sub>2</sub>); MS (APCI) 499.8 (100, <sup>81</sup>BrMH<sup>+</sup>), 497.9 (97, <sup>79</sup>BrMH<sup>+</sup>). Anal. (C<sub>23</sub>H<sub>24</sub>BrN<sub>5</sub>O<sub>3</sub>·3CF<sub>3</sub>CO<sub>2</sub>H) C, H, N. </div><div class="NLM_p"><b>(2</b><b><i>E</i></b><b>)-</b><b><i>N</i></b><b><sup>1</sup></b><sup></sup><b>-[4-(3-Bromoanilino)-6-quinazolinyl]-</b><b><i>N</i></b><b><sup>4</sup></b><sup></sup><b>-[3-(dimethylamino)propyl]-2-butenediami</b><b>de (25).</b> A solution of <b>39</b> (158 mg, 0.5 mmol) in THF (10 mL) was added dropwise <a name="jm004400300437" id="jm004400300437"></a> over 15 min to a solution of fumaryl chloride (382 mg, 2.5 mmol) in THF (10 mL) stirred under N<sub>2</sub> at 0 °C. After 1 h at 0 °C, the suspension was allowed to settle, and the supernatant was decanted. Fresh THF (5 mL) was added and the suspension was stirred at 0 °C while a solution of <i>N</i><sup>1</sup>,<i>N</i><sup>1</sup>-dimethyl-1,3-propanediamine (1.26 mL, 10 mmol) in THF (5 mL) was added dropwise. The suspension was stirred at 25 °C for 1 h, the solvent was stripped under reduced pressure, and the residue was triturated with cold water. The solid was collected, dissolved in boiling MeOH (25 mL), filtered, and evaporated under reduced pressure. The residue was dissolved in AcOH/water (3:2, 2.5 mL) and purified by HPLC on a Vidac C<sub>18</sub> 218TP1022 reverse-phase HPLC column. Elution with a 10% to 50% gradient of 0.1% TFA in water/0.l% TFA in CH<sub>3</sub>CN over 60 min gave <b>25</b> as the tris trifluoroacetate salt (154 mg, 37%):  mp 40 °C; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 11.02 (s, 1 H, NH), 9.50 (br s, 1 H, NH) 9.02 (d, <i>J</i> = 1.7 Hz, 1 H, H-5), 8.82 (s, 1 H, H-2), 8.74 (t, <i>J</i> = 5.7 Hz, 1 H, NH), 8.05 (s, 1 H, H-2‘), 8.02 (dd, <i>J</i> = 2.1, 9.0 Hz, 1 H, H-7), 7.89 (d, <i>J</i> = 8.9 Hz, 1 H, H-8), 7.76 (d, <i>J</i> = 7.2 Hz, H-6‘), 7.45 (m, 2 H, H-4‘,5‘), 7.17 (d, <i>J</i> = 14.9 Hz, 1 H, butenyl H-3), 7.05 (d, <i>J</i> = 15.2 Hz, 1 H, butenyl H-2), 3.03 (m, 2 H, NCH<sub>2</sub>), 3.08 (m, 2 H, CH<sub>2</sub>N), 2.79 (d, <i>J</i> = 4.8 Hz, 6 H, CH<sub>3</sub>), 1.83 (m, 2 H, CH<sub>2</sub>); MS (APCI) 498.8 (100, <sup>81</sup>BrMH<sup>+</sup>), 496.9 (97, <sup>79</sup>BrMH<sup>+</sup>). Anal. (C<sub>23</sub>H<sub>25</sub>BrN<sub>6</sub>O<sub>2</sub>·3CF<sub>3</sub>CO<sub>2</sub>H) C, H, N. </div><div class="NLM_p"><b>(2</b><b><i>E</i></b><b>)-</b><b><i>N</i></b><b><sup>1</sup></b><sup></sup><b>-[4-(3-Bromoanilino)pyrido[3,4-</b><b><i>d</i></b><b>]pyrimidin-6-yl]-</b><b><i>N</i></b><b><sup>4</sup></b><sup></sup><b>-[3-(4-morpholinyl)propyl]-2-b</b><b>utenediamide (28):  Example of Method of Scheme 5.</b><sup><a onclick="showRef(event, 'jm000372ib00020'); return false;" href="javascript:void(0);" class="ref jm000372ib00020">20</a></sup> A solution of (<i>E</i>)-but-2-enedioic acid monoethyl ester (<b>45</b>) (5.77 g 40.0 mmol) in THF (40 mL) was treated with oxalyl chloride (7.0 mL, 80.0 mmol), followed by two drops of DMF. The solution was stirred at room temperature for 1 h, then concentrated. The resulting residue was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (50 mL) and added dropwise during 20 min to a solution of 3-morpholin-4-ylpropylamine (6.43 mL, 44.0 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (200 mL) in a dry ice/acetone bath. At the end of the addition the reaction was allowed to come to room temperature, then poured into of 5% aqueous NaHCO<sub>3</sub> (500 mL). The layers were separated, and the aqueous layer was extracted with CH<sub>2</sub>Cl<sub>2</sub>, and the combined organic extracts were dried (MgSO<sub>4</sub>) and concentrated. Flash chromatography over silica gel, eluting with MeOH/CH<sub>2</sub>Cl<sub>2</sub> (1:5) gave ethyl (2<i>E</i>)-4-{[3-(4-morpholinyl)propyl]amino}-4-oxo-2-butenoate (<b>46a</b>) (8.44 g, 78%) as an oil:  <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 8.53 (t, <i>J</i> = 5.5 Hz, 1 H, NH), 7.76 (d, <i>J</i> = 15.4 Hz, 1 H, olefinic), 6.55 (d, <i>J</i> = 15.4 Hz, 1 H, olefinic), 4.20 (q, 2 H, <i>J</i> = 7.0 Hz, C<i>H</i><sub>2</sub>CH<sub>3</sub>), 3.56 (t, <i>J</i> = 4.7 Hz, 4 H, morph. CH<sub>2</sub>), 3.18 (q, 2 H, C<i>H</i><sub>2</sub>NH, coalesces to t on D<sub>2</sub>O wash), 2.32 (br s, 4 H, morph. CH<sub>2</sub>), 2.28 (t, <i>J</i> = 7.2 Hz, 2 H, morpholino-C<i>H</i><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>), 1.59 (quintet, <i>J</i> = 7.0 Hz, 2 H, CH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>), 1.24 (t, <i>J</i> = 7.1 Hz, 3 H, CH<sub>3</sub>); MS (APCI) M + 1 calcd 271.2, found 271.1. </div><div class="NLM_p">A solution of <b>46a</b> (0.50 g, 1.8 mmol) and Et<sub>3</sub>N (0.50 mL, 3.6 mmol) in water (10 mL) was stirred at room temperature overnight, concentrated, and coevaporated with EtOH to give crude (2<i>E</i>)-4-{[3-(4-morpholinyl)propyl]amino}-4-oxo-2-butenoic acid (<b>47a</b>) as a gum (containing Et<sub>3</sub>N):  <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 8.41 (t, <i>J</i> = 5.3 Hz, 1 H, NH), 6.81 (d, <i>J</i> = 15.7 Hz, 1 H, olefinic), 6.49 (d, <i>J</i> = 15.4 Hz, 1 H, olefinic), 3.56 (t, <i>J</i> = 4.6 Hz, 4 H, morph. CH<sub>2</sub>), 3.16 (dd, <i>J</i> = 12.8, 7.0 Hz, 2 H, C<i>H</i><i><sub>2</sub></i>NH, coalesces to t on D<sub>2</sub>O wash), 2.32 (br s, 4 H, morph. CH<sub>2</sub>), 2.27 (t, <i>J</i> = 7.1 Hz, 2 H, morpholino-C<i>H</i><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>), 1.59 (quintet, <i>J</i> = 7.0 Hz, 2 H, CH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>); MS (APCI) M + 1 calcd 243.1, found 243.2. </div><div class="NLM_p">A mixture of <b>47a</b> (assumed 1.8 mmol) and amine <b>38</b> (0.10 g, 0.32 mmol) in pyridine (2 mL) was treated with EDCI·HCl (0.34 g, 1.8 mmol), and the solution was stirred at room temperature overnight. The reaction was then poured into water, and the resulting solid was purified by flash chromatography over silica gel, eluting with MeOH/CH<sub>2</sub>Cl<sub>2</sub> (1:4) to give <b>28</b> (54 mg, 30.0%):  mp 237−240 °C dec; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 11.3 (s, 1 H, NH), 10.4 (s, 1 H, NH), 9.05 (s, 1 H), 9.02 (s, 1 H), 8.67 (s, 1 H), 8.58 (t, <i>J</i> = 5.5 Hz, 1 H, CH<sub>2</sub>N<i>H</i>), 8.17 (d, <i>J</i> = 1.7 Hz, 1 H), 7.89 (d, <i>J</i> = 6.5 Hz, 1 H), 7.36 (m, 2 H), 7.27 (d, <i>J</i> = 15.2 Hz, 1 H, olefinic), 7.08 (d, <i>J</i> = 15.2 Hz, 1 H, olefinic), 3.57 (t, <i>J</i> = 4.6 Hz, 4 H, morph. CH<sub>2</sub>), 3.21 (dd, <i>J</i> = 12.7, 6.6 Hz, 2 H, C<i>H</i><i><sub>2</sub></i>NH, coalesces to t with D<sub>2</sub>O), 2.34 (br s, 4 H, morph. CH<sub>2</sub>), 2.31 (t, <i>J</i> = 7.2 Hz, 2 H, morpholino-C<i>H</i><i><sub>2</sub></i>CH<sub>2</sub>CH<sub>2</sub>), 1.63 (quintet, <i>J</i> = 7 Hz, 2 H, CH<sub>2</sub>C<i>H</i><i><sub>2</sub></i>CH<sub>2</sub>); MS (APCI) M + 1 calcd 540.1, found 540.2. Anal. (C<sub>24</sub>H<sub>26</sub>BrN<sub>7</sub>O<sub>3</sub>·1.5H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b>(2</b><b><i>E</i></b><b>)-</b><b><i>N</i></b><b><sup>1</sup></b><sup></sup><b>-[4-(3-Bromoanilino)pyrido[3,4-</b><b><i>d</i></b><b>]pyrimidin-6-yl]-</b><b><i>N</i></b><b><sup>4</sup></b><sup></sup><b>-[3-(dimethylamino)propyl]-2-</b><b>butenediamide (26).</b> Similar reaction of <b>45</b> (5.75 g, 40 mmol), oxalyl chloride (7 mL) and DMF (3 drops) gave the crude acid chloride. This was diluted with anhydrous Et<sub>2</sub>O (200 mL) and the solution was cooled to −78 °C with mechanical stirring. The rapidly stirring solution was then treated dropwise with a solution of 3-dimethylaminopropylamine (5.54 mL, 44 mmol) in Et<sub>2</sub>O (60 mL). After addition was completed, the bath was removed and the thick suspension was allowed to slowly warm to room temperature over 1−2 h. The solid was collected and washed well with ether. It was then dissolved in water (orange solution), and the pH was adjusted to ca. 10.5 with sodium carbonate. The aqueous phase was extracted with EtOAc (4×), then the combined extracts were washed with brine, dried, and filtered through a pad of flash silica gel. The filtrate was concentrated to leave crude ethyl (2<i>E</i>)-4-{[3-(dimethylamino)propyl]amino}-4-oxo-2-butenoate (<b>46b</b>) (2.75 g, 30%; low yield was likely due to incomplete extraction due to water solubility), sufficiently pure by NMR to use in the next reaction:  <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 7.94 (br s, 1 H, NH), 6.80 (d, <i>J</i> = 15.6 Hz, 1 H, olefinic), 6.73 (d, <i>J</i> = 15.6 Hz, 1 H, olefinic), 4.20 (q, <i>J</i> = 7.1 Hz, 2 H, C<i>H</i><sub>2</sub>CH<sub>3</sub>), 3.42 (q, <i>J</i> = 5.8 Hz, 2 H, C<i>H</i><sub>2</sub>NH), 2.43 (t, <i>J</i> = 5.8 Hz, 2 H, Me<sub>2</sub>NC<i>H</i><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>), 2.24 (s, 6 H, N(CH<sub>3</sub>)<sub>2</sub>), 1.68 (quintet, <i>J</i> = 5.8 Hz, 2 H, CH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>), 1.27 (t, <i>J</i> = 7.1 Hz, 3 H, CH<sub>3</sub>). </div><div class="NLM_p">A solution of <b>46b</b> (2.43 g, 10.6 mmol) in deionized water (40 mL) was heated at reflux for 4 h. The water was stripped off and the residue was coevaporated with MeOH. The oil was dissolved in ca. 20 mL of MeOH, then treated with excess 2-propanolic HCl. The resultant solution was concentrated, the resulting solid was triturated in EtOH, washed with EtOH and dried to give (2<i>E</i>)-4-{[3-(dimethylamino)propyl]amino}-4-oxo-2-butenoic acid (<b>47b</b>) as the HCl salt (1.13 g):  mp 148−152 °C; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 8.77 (t, <i>J</i> = 5.8 Hz, 1 H, NH), 6.92 (d, <i>J</i> = 15.7 Hz, 1 H, olefinic), 6.53 (d, <i>J</i> = 15.7 Hz, 1 H, olefinic), 3.23 (q, <i>J</i> = 6.5 Hz, 2 H, C<i>H</i><i><sub>2</sub></i>NH, coalesces to t on D<sub>2</sub>O wash), 3.03 (m, 2 H, Me<sub>2</sub>NC<i>H</i><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>), 2.72 (s, 6 H, N(CH<sub>3</sub>)<sub>2</sub>), 1.84 (quintet, <i>J</i> = 7.0 Hz, 2 H, CH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>). Anal. (C<sub>9</sub>H<sub>16</sub>N<sub>2</sub>O<sub>3</sub>·HCl) C, H, N. Concentration of the filtrate gave a second crop (573 mg; total yield 1.7 g (68%)). </div><div class="NLM_p">A suspension of <b>38</b> (64 mg, 0.2 mmol) and <b>47b</b> HCl salt (190 mg, 0.8 mmol) in pyridine (1 mL) was mixed by warming, then cooled in an ice bath and treated with EDCI·HCl (196 mg). The resulting suspension was stirred under nitrogen at 0−5 °C for 2.5 h, then diluted with DMF (2 mL). The solution was added to a 1:1 mixture of water/EtOAc, and shaken until phase separation. The aqueous phase was further extracted with EtOAc (3×) and the combined extracts were discarded. The aqueous layer was made basic with 5% aqueous NaHCO<sub>3</sub>, and then extracted with EtOAc (5×) using small amounts of MeOH each time if necessary to bring about phase separation. The EtOAc extracts were combined and washed with brine, dried (MgSO<sub>4</sub>), and concentrated to leave a residue. This was sonicated in 2-propanol to give <b>26</b> (67 mg, 66%):  mp 235−38 °C; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 11.3 (s, 1 H, NH), 10.4 (s, 1 H, NH), 9.05 (s, 1 H), 9.02 (s, 1 H), 8.67 (s, 1 H), 8.57 (t, <i>J</i> = 5.5 Hz, 1 H, CH<sub>2</sub>N<i>H</i>), 8.17 (br s, 1 H), 7.88 (d, <i>J</i> = 7.5 Hz, 1 H), 7.36 (m, 2 H), 7.27 (d, <i>J</i> = 15.2 Hz, 1 H, olefinic), 7.07 (d, <i>J</i> = 15.2 Hz, 1 H, olefinic), 3.20 (q, <i>J</i> = 7.0 Hz, 2 H, C<i>H</i><i><sub>2</sub></i>NH, coalesces to t with D<sub>2</sub>O), 2.23 (t, <i>J</i> = 7.0 Hz, 2 H, Me<sub>2</sub>NC<i>H</i><i><sub>2</sub></i>CH<sub>2</sub>CH<sub>2</sub>), 2.13 (s, 6 H, N(CH<sub>3</sub>)<sub>2</sub>), 1.59 (quintet, <i>J</i> = 7.0 Hz, 2 H, CH<sub>2</sub>C<i>H</i><i><sub>2</sub></i>CH<sub>2</sub>). Anal. (C<sub>22</sub>H<sub>24</sub>BrN<sub>7</sub>O<sub>2</sub>·0.5H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b>(2</b><b><i>E</i></b><b>)-</b><b><i>N</i></b><b><sup>1</sup></b><sup></sup><b>-[4-(3-Bromoanilino)pyrido[3,4-</b><b><i>d</i></b><b>]pyrimidin-6-yl]-</b><b><i>N</i></b><b><sup>4</sup></b><sup></sup><b>-[3-(diethylamino)propyl]-2-bu</b><b>tenediamide (27).</b> Similar reaction of the acid chloride of <b>45</b> (from 5.75 g of <b>45</b>) with 3-diethylaminopropylamine (7.0 mL, 44.4 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (200 mL) gave ethyl (2<i>E</i>)-4-{[3-(diethylamino)propyl]amino}-4-oxo-2-butenoate (<b>46c</b>) (4.07 g, 37%) as an oil:  <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.47 (br s, 1 H, NH), 6.84 (d, <i>J</i> = 15.4 Hz, 1 H, <a name="jm004400300438" id="jm004400300438"></a> olefinic), 6.77 (d, <i>J</i> = 15.4 Hz, 1 H, olefinic), 4.24 (q, <i>J</i> = 7.0 Hz, 2 H, OC<i>H</i><sub>2</sub>CH<sub>3</sub>), 3.48 (q, <i>J</i> = 5.5 Hz, 2 H, C<i>H</i><sub>2</sub>NH), 2.63 (m, 6 H, Et<sub>2</sub>NC<i>H</i><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>, N(C<i>H</i><sub>2</sub>CH<sub>3</sub>)<sub>2</sub>), 1.75 (quintet, <i>J</i> = 5.5 Hz, 2 H, CH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>), 1.31 (t, <i>J</i> = 7.0 Hz, 3 H, OCH<sub>2</sub>C<i>H</i><sub>3</sub>), 1.10 (t, <i>J</i> = 7.1 Hz, 6 H, N(CH<sub>2</sub>C<i>H</i><sub>3</sub>)<sub>2</sub>). Anal. (C<sub>13</sub>H<sub>24</sub>N<sub>2</sub>O<sub>3</sub>·H<sub>2</sub>O) C, H, N. </div><div class="NLM_p">A solution of <b>46c</b> (4.05 g, 14.86 mmol) and LiOH monohydrate (1.27 g, 30.1 mmol) in MeOH:H<sub>2</sub>O (100 mL) was stirred at room temperature for 2 h. The mixture was evaporated to a semisolid, then diluted with warm MeOH and filtered through a pad of flash silica gel, washing well with MeOH. The eluate was concentrated to a solid that was triturated in Et<sub>2</sub>O to give (2<i>E</i>)-4-{[3-(dimethylamino)propyl]amino}-4-oxo-2-butenoic acid (<b>47c</b>) as the lithium salt (3 g). This salt (2.55 g, 10 mmol) was dissolved in water and the pH was adjusted to 4 with dilute aqueous HCl. This solution was loaded onto a column packed with 10 g dry weight of Dowex 50W x 8 resin (H<sup>+</sup> form; 200−400 mesh; 5.2 mol equiv/g), and the column was eluted successively with 50 mL each of water, 0.1 M aqueous NH<sub>3</sub>, 0.2 M aqueous NH<sub>3</sub>, and 100 mL 0.3 M aqueous NH<sub>3</sub>. Product fractions were pooled and concentrated to ca. 100 mL of solution that was then lyophilized and further dried at 5 mm/60 °C/5 h to provide the free acid (1.82 g) as a glassy solid that was used directly in the next reaction:  <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 8.46 (t, <i>J</i> = 5.3 Hz, 1 H, NH), 6.74 (d, <i>J</i> = 15.4 Hz, 1 H, olefinic), 6.48 (d, <i>J</i> = 15.4 Hz, 1 H, olefinic), 3.16 (q, <i>J</i> = 5.8 Hz, 2 H, C<i>H</i><i><sub>2</sub></i>NH, coalesces to t on D<sub>2</sub>O wash), 2.69 (m, 6 H, Et<sub>2</sub>NC<i>H</i><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>, N(C<i>H</i><sub>2</sub>CH<sub>3</sub>)<sub>2</sub>), 1.66 (quintet, <i>J</i> = 7.0 Hz, 2 H, CH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>), 1.04 (t, <i>J</i> = 7.2 Hz, 6 H, N(CH<sub>2</sub>C<i>H</i><sub>3</sub>)<sub>2</sub>). </div><div class="NLM_p">Reaction of <b>38</b> (32 mg, 1 mmol), <b>47c</b> (97 mg, 0.4 mmol), EDCI·HCl (98 mg) and pyridine (0.5 mL) was carried out as described above. After 1.25 h further EDCI·HCl (45 mg) was added, and the mixture was stirred at room temperature for an additional 17 h. Workup as above, followed by trituration in 2-propanol, gave <b>27</b> (10.5 mg, 20%):  mp 227−232 °C; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 11.3 (s, 1 H, NH), 10.4 (s, 1 H, NH), 9.05 (s, 1 H), 9.02 (s, 1 H), 8.67 (s, 1 H), 8.56 (t, <i>J</i> = 5.5 Hz, 1 H, CH<sub>2</sub>N<i>H</i>), 8.17 (br s, 1 H), 7.88 (d, <i>J</i> = 7.5 Hz, 1 H), 7.37 (m, 2 H), 7.27 (d, <i>J</i> = 15.2 Hz, 1 H, olefinic), 7.08 (d, <i>J</i> = 15.2 Hz, 1 H, olefinic), 3.20 (q, <i>J</i> = 6.0 Hz, 2 H, C<i>H</i><i><sub>2</sub></i>NH, coalesces to t with D<sub>2</sub>O), 2.44 (m, 6 H, Et<sub>2</sub>NC<i>H</i><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>, N(C<i>H</i><sub>2</sub>CH<sub>3</sub>)<sub>2</sub>), 1.57 (quintet, <i>J</i> = 7.0 Hz, 2 H, CH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>), 0.94 (t, <i>J</i> = 7.2 Hz, 6 H, N(CH<sub>2</sub>C<i>H</i><sub>3</sub>)<sub>2</sub>). Anal. (C<sub>24</sub>H<sub>28</sub>BrN<sub>7</sub>O<sub>2</sub>) C, H. </div><div class="NLM_p"><b>(2</b><b><i>E</i></b><b>)-</b><b><i>N</i></b><b><sup>1</sup></b><sup></sup><b>-[4-(3-Bromoanilino)pyrido[3,4-</b><b><i>d</i></b><b>]pyrimidin-6-yl]-</b><b><i>N</i></b><b><sup>4</sup></b><sup></sup><b>-[3-(1</b><b><i>H</i></b><b>-imidazol-1-yl)propyl]-</b><b>2-butenediamide (29).</b> Similar reaction of the acid chloride of <b>45</b> (from 5.77 g of <b>45</b>) with a solution of 3-imidazol-1-ylpropylamine (5.25 mL, 44.0 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (200 mL) in a dry ice/acetone bath, followed by flash chromatography of the residue on silica gel, eluting with MeOH/CH<sub>2</sub>Cl<sub>2</sub> (1:2), gave ethyl (2<i>E</i>)-4-{[3-(imidazol-1-yl)propyl]amino}-4-oxo-2-butenoate (<b>46d</b>) (5.21 g, 52%), which solidified on standing:  <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 8.60 (t, <i>J</i> = 5.4 Hz, 1 H, NH), 7.62 (s, 1 H, imidazole H), 7.18 (t, <i>J</i> = 1.2 Hz, 1 H, imidazole H), 6.99 (d, <i>J</i> = 15.7 Hz, 1 H, olefinic), 6.89 (s, 1 H, imidazole H), 6.57 (d, <i>J</i> = 15.7 Hz, 1 H, olefinic), 4.19 (q, <i>J</i> = 7.1 Hz, 2 H, C<i>H</i><sub>2</sub>CH<sub>3</sub>), 3.98 (t, <i>J</i> = 7.0 Hz, 2 H, CH<sub>2</sub>N), 3.11 (q, <i>J</i> = 6.8 Hz, 2 H, C<i>H</i><sub>2</sub>NH, coalesces to t with D<sub>2</sub>O), 1.88 (quintet, <i>J</i> = 6.9 Hz, 2 H, CH<sub>2</sub>C<i>H</i><i><sub>2</sub></i>CH<sub>2</sub>), 1.24 (t, <i>J</i> = 7.0 Hz, 3 H, CH<sub>3</sub>); MS (APCI) M + 1 calcd 252.1, found 252.1. Anal. (C<sub>12</sub>H<sub>17</sub>N<sub>3</sub>O<sub>3</sub>) C, H, N. </div><div class="NLM_p">A solution of <b>46d</b> (1.27 g, 5.05 mmol) and Et<sub>3</sub>N (1.42 mL, 10.2 mmol) in deionized water (25.5 mL) was heated at 60 °C for 30 min. The water was evaporated and residue was coevaporated with MeOH. The residue was crystallized from MeOH/2-propanol (1:1) to give (2<i>E</i>)-4-{[3-(imidazol-1-yl)propyl]amino}-4-oxo-2-butenoic acid (<b>47d</b>) (190 mg, 17%):  mp 170−174 °C; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 8.55 (t, <i>J</i> = 5.5 Hz, 1 H, NH), 7.64 (s, 1 H, imidazole H), 7.19 (t, <i>J</i> = 1.2 Hz, 1 H, imidazole H), 6.90 (d, <i>J</i> = 15.4 Hz, 1 H, olefinic), 6.89 (s, 1 H, imidazole H), 6.52 (d, <i>J</i> = 15.4 Hz, 1 H, olefinic), 3.98 (t, <i>J</i> = 7.0 Hz, 2 H, CH<sub>2</sub>N), 3.11 (q, <i>J</i> = 6.8 Hz, 2 H, C<i>H</i><sub>2</sub>NH, coalesces to t with D<sub>2</sub>O), 1.88 (quintet, <i>J</i> = 6.8 Hz, 2 H, CH<sub>2</sub>C<i>H</i><i><sub>2</sub></i>CH<sub>2</sub>). Anal. (C<sub>10</sub>H<sub>13</sub>N<sub>3</sub>O<sub>3</sub>) C, H, N. Further processing of the filtrate afforded 420 mg (37%) of additional product (total yield 610 mg (54%)). </div><div class="NLM_p">Reaction of <b>47d</b> (156 mg, 0.7 mmol) and <b>38</b> (64 mg, 0.2 mmol) with EDCI·HCL (196 mg) in pyridine (1 mL) was carried out as described above. After 2 h the dark orange solution was diluted with DMF (2 mL) and poured into 2.5% aqueous NaHCO<sub>3</sub>. The mixture was extracted with EtOAc (5×), and the combined EtOAc extracts were washed with brine, dried (MgSO<sub>4</sub>), and concentrated to a residue that was triturated in hot 2-propanol. After storage at room temperature for 30 min, the solid was collected to give <b>29</b> (13.5 mg, 13%):  mp 244−248 °C; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 11.3 (s, 1 H, NH), 10.4 (s, 1 H, NH), 9.06 (s, 1 H), 9.02 (s, 1 H), 8.67 (s, 1 H), 8.64 (t, <i>J</i> = 5.8 Hz, 1 H, NH), 8.17 (d, <i>J</i> = 1.7 Hz, 1 H), 7.88 (dt, <i>J</i> = 7.5, 1.9, 1.9 Hz, 1 H), 7.65 (s, 1 H, imidazole H), 7.37 (m, 2 H), 7.29 (d, <i>J</i> = 14.9 Hz, 1 H, olefinic), 7.20 (t, <i>J</i> = 1.2 Hz, 1 H, imidazole H), 7.08 (d, <i>J</i> = 14.9 Hz, 1 H, olefinic), 6.90 (t, <i>J</i> = 1.2 Hz, 1 H, imidazole H), 4.01 (t, <i>J</i> = 7.0 Hz, 2 H, CH<sub>2</sub>N), 3.14 (q, <i>J</i> = 6.8 Hz, 2 H, C<i>H</i><sub>2</sub>NH, coalesces to t with D<sub>2</sub>O), 1.91 (quintet, <i>J</i> = 7.0 Hz, 2 H, CH<sub>2</sub>C<i>H</i><i><sub>2</sub></i>CH<sub>2</sub>). Anal. (C<sub>23</sub>H<sub>21</sub>BrN<sub>8</sub>O<sub>2</sub>·0.75H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b>(2</b><b><i>E</i></b><b>)-</b><b><i>N</i></b><b><sup>1</sup></b><sup></sup><b>-[4-(3-Chloro-4-fluoroanilino)pyrido[3,4-</b><b><i>d</i></b><b>]pyrimidin-6-yl]-</b><b><i>N</i></b><b><sup>4</sup></b><sup></sup><b>-[3-(4-morpholinyl)pr</b><b>opyl]-2-butenediamide (31).</b> 6-Amino-4-(3-chloro-4-fluoroanilino)pyrido[3,4-<i>d</i>]pyrimidine<sup>14</sup> (<b>48</b>) (1.3 g, 4.5 mmol) and <b>47a</b> (4.36 g, 18 mmol) in dry pyridine (22.5 mL) were dissolved by gentle heating, then the solution was cooled in an ice bath under N<sub>2</sub> and treated with pulverized EDCI·HCl (4.31 g, 22.5 mmol). The reaction was stirred at 0−5 °C for 4 h, then poured onto a mixture of EtOAc/5% aqueous NaHCO<sub>3</sub>. The precipitated solid was collected, washed with water, then dissolved in hot MeOH. The solution was treated with limited conc HCl and set aside to crystallize, giving <b>31</b> (1.34 g, 51%) as a partial HCl salt:  mp 232−235 °C; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 11.3 (s, 1 H, NH), 10.5 (br s, ∼1 H, R<sub>2</sub>N<sup>+</sup>H), 10.4 (s, 1 H, NH), 9.06 (s, 1 H), 9.01 (s, 1 H), 8.79 (br s, 1 H, CH<sub>2</sub>N<i>H</i>), 8.66 (s, 1 H), 8.14 (dd, <i>J</i> = 2.7 Hz, <i>J</i><i><sub>H</sub></i><i><sub>-</sub></i><i><sub>F</sub></i> = 7.0 Hz, 1 H), 7.83 (m, 1 H), 7.48 (dd, <i>J</i> = 9.0 Hz, <i>J</i><i><sub>H</sub></i><i><sub>-</sub></i><i><sub>F</sub></i> = 9.0 Hz, 1 H), 7.30 (d, <i>J</i> = 15.2 Hz, 1 H, olefinic), 7.20 (d, <i>J</i> = 15.2 Hz, 1 H, olefinic), 3.8 (br s, 4 H, morph. CH<sub>2</sub>), 3.25 (q, <i>J</i> = 6.6 Hz, 2 H, C<i>H</i><i><sub>2</sub></i>NH, coalesces to t with D<sub>2</sub>O), 3.0 (br s, 6 H, morph. CH<sub>2</sub>, NC<i>H</i><i><sub>2</sub></i>CH<sub>2</sub>CH<sub>2</sub>), 1.85 (br s, 2 H, CH<sub>2</sub>C<i>H</i><i><sub>2</sub></i>CH<sub>2</sub>). Anal. (C<sub>24</sub>H<sub>25</sub>ClFN<sub>7</sub>O<sub>3</sub>·HCl·2H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b>(2</b><b><i>E</i></b><b>)-</b><b><i>N</i></b><b><sup>1</sup></b><sup></sup><b>-[4-(3-Bromoanilino)pyrido[3,4-</b><b><i>d</i></b><b>]pyrimidin-6-yl]-</b><b><i>N</i></b><b><sup>4</sup></b><sup></sup><b>-[3-(dimethylamino)propyl]-</b><b><i>N</i></b><b><sup>1</sup></b><sup></sup><b>-methyl-2-butenediamide (30). </b>Reaction of <b>37</b> (132 mg, 0.4 mmol) and <b>47b</b> (380 mg, 1.6 mmol) with EDCI·HCl (392 mg) in pyridine (2 mL) as above gave a crude product that was extracted with EtOAc (2×) to remove organic impurities. The combined EtOAc extracts were washed with water, then all aqueous phases were combined and adjusted to pH 9 with 2% aqueous NaOH. The resulting precipitate was collected, washed well with water, and then triturated in 2-propanol at 0 °C for 30 min to give <b>30</b> (64 mg, 31%):  mp 228−230 °C; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 10.1 (s, 1 H, NH), 9.15 (s, 1 H), 8.81 (s, 1 H), 8.47 (s, 1 H), 8.43 (t, <i>J</i> = 5.5 Hz, 1 H, CH<sub>2</sub>N<i>H</i>), 8.20 (s, 1 H), 7.90 (d, <i>J</i> = 7.2 Hz, 1 H), 7.39 (m, 2 H), 6.95 (d, <i>J</i> = 14.9 Hz, 1 H, olefinic), 6.72 (d, <i>J</i> = 14.9 Hz, 1 H, olefinic), 3.47 (s, 3 H, CONCH<sub>3</sub>), 3.09 (q, <i>J</i> = 6.0 Hz, 2 H, C<i>H</i><i><sub>2</sub></i>NH, coalesces to t with D<sub>2</sub>O), 2.15 (t, <i>J</i> = 7.2 Hz, 2 H, Me<sub>2</sub>NC<i>H</i><i><sub>2</sub></i>CH<sub>2</sub>CH<sub>2</sub>), 2.06 (s, 6 H, N(CH<sub>3</sub>)<sub>2</sub>), 1.50 (quintet, <i>J</i> = 7.2 Hz, 2 H, CH<sub>2</sub>C<i>H</i><i><sub>2</sub></i>CH<sub>2</sub>). Anal. (C<sub>23</sub>H<sub>26</sub>BrN<sub>7</sub>O<sub>2</sub>·0.25H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b><i>N</i></b><b>-[4-(3-Bromoanilino)pyrido[3,4-</b><b><i>d</i></b><b>]pyrimidin-6-yl]ethylenesulfonamide (32):  Example of </b><b>Method of Scheme 1.</b> To a stirred solution of <b>38</b> (0.25 g, 0.82 mmol) in THF (20 mL) under nitrogen was added Et<sub>3</sub>N (230 μL), a catalytic amount of DMAP and chloroethanesulfonyl chloride (120 μL, 1.15 mmol) dropwise. The reaction was stirred at room temperature for 1 h and then diluted with saturated NaHCO<sub>3</sub> and extracted with EtOAc. The combined organic extracts were washed with brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, concentrated under reduced pressure and chromatographed on silica gel eluting with MeOH/CH<sub>2</sub>Cl<sub>2</sub>/EtOAc (2:48:50), then recrystalized from CH<sub>2</sub>Cl<sub>2</sub>/hexane to give <b>32</b> (53 mg, 16%):  mp 261−265 <a name="jm004400300439" id="jm004400300439"></a> °C; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 11.02 (s, 1 H, SO<sub>2</sub>NH), 10.25 (s, 1 H, NH), 9.02 (s, 1 H), 8.67 (s, 1 H), 8.15 (br s, 1 H, H-2‘), 8.00 (s, 1 H), 7.87 (dt, <i>J</i> = 7.2, 1.9, 1.9 Hz, 1 H, H-6‘), 7.40 (partially obsc. t, <i>J</i> = 7.9 Hz, 1 H, H-5‘), 7.37 (partially obsc. dt, <i>J</i> = 7.8, 1.9, 1.9 Hz, 1 H, H-4‘), 7.07 (dd, <i>J</i> = 16.5, 9.9 Hz, 1 H, CH<sub>2</sub>C<i>H</i>SO<sub>2</sub>), 6.30 (d, <i>J</i> = 16.5 Hz, 1 H, C<i>H</i><sub>2</sub>CHSO<sub>2</sub>), 6.09 (d, <i>J</i> = 9.9 Hz, 1 H, C<i>H</i><sub>2</sub>CHSO<sub>2</sub>). Anal. (C<sub>15</sub>H<sub>12</sub>BrN<sub>5</sub>O<sub>2</sub>S·0.25H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b><i>N</i></b><b>-[4-(3-Bromoanilino)-6-quinazolinyl]ethylenesulfonamide (33).</b> To a stirred solution of <b>39</b> (0.30 g, 0.95 mmol) in THF (20 mL) under nitrogen were added Et<sub>3</sub>N (3.5 mol equiv, 3.33 mmol, 245 μL), a catalytic amount of DMAP and chloroethanesulfonyl chloride (1.2 mol equiv, 1.14 mmol, 119 μL) dropwise. Workup as above followed by chromatography on silica gel eluting with MeOH/CH<sub>2</sub>Cl<sub>2</sub>/EtOAc (3:47:50) and crystallization from CH<sub>2</sub>Cl<sub>2</sub>/hexane gave <b>33</b> (210 mg, 54%):  mp 217 °C dec; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 10.31 (s, 1 H, SO<sub>2</sub>NH), 9.96 (s, 1 H, NH), 8.60 (s, 1 H, H-2), 8.20 (d, <i>J</i> = 2.0 Hz, 1 H, H-5), 8.14 (br s, 1 H, H-2‘), 7.85 (br d, <i>J</i> = 7.9 Hz, 1 H, H-6‘), 7.81 (d, <i>J</i> = 8.9 Hz, 1 H, H-8), 7.67 (dd, <i>J</i> = 8.9, 2.1 Hz, 1 H, H-7), 7.37 (t, <i>J</i> = 8.0 Hz, 1 H, H-5‘), 7.32 (br d, <i>J</i> = 8.1 Hz, 1 H, H-4‘), 6.90 (dd, <i>J</i> = 16.4, 9.8 Hz, 1 H, CH<sub>2</sub>C<i>H</i>SO<sub>2</sub>), 6.17 (d, <i>J</i> = 16.4 Hz, 1 H, C<i>H</i><sub>2</sub>CHSO<sub>2</sub>), 6.06 (d, <i>J</i> = 9.8 Hz, 1 H, C<i>H</i><sub>2</sub>CHSO<sub>2</sub>). Anal. (C<sub>16</sub>H<sub>13</sub>BrN<sub>4</sub>O<sub>2</sub>S) C, H, N. </div><div class="NLM_p"><b>2-{[4-(3-Bromoanilino)pyrido[3,4-</b><b><i>d</i></b><b>]pyrimidin-6-yl]sulfonyl}ethanol (36):  Example of </b><b>Method of Scheme 6.</b> A nitrogen-purged solution of 2-mercaptoethanol (1.75 mL, 25 mmol) and 4-(3-bromoanilino)-6-fluoropyrido[3,4-<i>d</i>]pyrimidine<sup>17</sup> (<b>49</b>) (1.6 g, 5 mmol) in DMSO (10 mL) was treated with anhydrous cesium carbonate (3.26 g, 10 mmol). The stirred solution was heated at 50 °C for 2 h, then poured into 2% aqueous HCl (180 mL). After stirring for 15 min, the solids were collected, washed well with water, and dissolved in DMF. The solution was poured into EtOAc/water (1:1) the resulting mixture was extracted with EtOAc (3×). The combined extracts were washed with brine, dried (MgSO<sub>4</sub>) and filtered through a column of silica gel. The filtrate was concentrated to a solid that was triturated in EtOAc to give 2-{[4-(3-bromoanilino)pyrido[3,4-<i>d</i>]pyrimidin-6-yl]sulfanyl}ethanol (<b>50</b>) (1.24 g, 66%):  mp 182−185 °C; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 10.03 (s, 1 H, NH), 9.10 (s, 1 H), 8.69 (s, 1 H), 8.35 (s, 1 H), 8.22 (t, <i>J</i> = 1.9 Hz, 1 H), 7.91 (dt, <i>J</i> = 7.7, 1.9 Hz, 1 H), 7.42−7.34 (m, 2 H), 5.04 (t, <i>J</i> = 5.5 Hz, 1 H, OH), 3.68 (dd, <i>J</i> = 6.8, 5.7 Hz, 2 H), 3.36 (t, <i>J</i> = 6.8 Hz, 2 H); MS (APCI) <i>m</i>/<i>z</i> (relative %) 374.8 (49), 375.8 (10), 376.9 (100), 377.8 (23), 378.9 (63), 379.8 (14). Anal. (C<sub>15</sub>H<sub>13</sub>BrN<sub>4</sub>OS) C, H, N. </div><div class="NLM_p">A stirred suspension <b>50</b> (755 mg, 2 mmol) in CHCl<sub>3</sub> (30 mL) at 0−5 °C was treated with MCPBA (1.27 g of 57−86%) and slowly warmed to 25 °C over 4 h. After 14.5 and 17.5 h further MCPBA (720 mg and 720 mg) was added. After 19.5 h total reaction time, the suspension was cooled to 0−5 °C, treated with DMSO (2 mL) and allowed to warm to 20 °C for 30 min. The mixture was then partitioned between EtOAc and 5% aqueous NaHCO<sub>3</sub>. The organic phase was washed with brine, dried (MgSO<sub>4</sub>), concentrated to small volume and flash chromatographed on silica gel, eluting with EtOAc to give <b>34</b> (540 mg, 66%):  mp (EtOAc) 210−212 °C; <sup>1</sup>H NMR (CF<sub>3</sub>CO<sub>2</sub>H) δ 10.96 (s, 1 H), 10.90 (s, 1 H),) 10.42 (s, 1 H), 9.47 (s, 1H), 9.16 (d, <i>J</i> = 8.2 Hz, 1 H), 9.05 (d, <i>J</i> = 8.2 Hz, 1 H), 8.83 (t, <i>J</i> = 8.0 Hz, 1 H), 5.81(t, <i>J</i> = 5.2 Hz, 2 H), 5.43 (t, <i>J</i> = 5.2 Hz, 2 H); MS (APCI) <i>m</i>/<i>z</i> (relative %) 378.7 (39), 380.7 (45), 408.7 (100), 409.7 (15), 410.7 (97), 411.7 (17). Anal. (C<sub>15</sub>H<sub>13</sub>BrN<sub>4</sub>O<sub>3</sub>S) C, H, N. </div><div class="NLM_p"><b><i>N</i></b><b>-(3-Bromophenyl)-6-(vinylsulfonyl)pyrido[3,4-</b><b><i>d</i></b><b>]pyrimidin-4-amine (35). </b>Methanesulfonyl chloride (9.3 μL, 0.12 mmol) was added dropwise to a stirred suspension of <b>34 </b>(41 mg, 0.1 mmol) and Et<sub>3</sub>N (31 μL, 0.22 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (0.5 mL) under N<sub>2</sub> at 0−5 °C. Additional charges of methanesulfonyl chloride (9.3 μL) were added after 45 min and 1.5 h, the latter with additional Et<sub>3</sub>N (50 μL). After a total of 2.5 h the cold solution was quenched with 5% aqueous NaHCO<sub>3</sub>, then extracted with EtOAc (2×). The combined organic extracts were dried (MgSO<sub>4</sub>) then filtered through a pad of flash silica gel to give <b>35</b> (17 mg, 44%):  mp (EtOAc) 214−217 °C; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 10.64 (s, 1 H, NH), 9.30 (s, 1 H), 9.25 (s, 1 H), 8.87 (s, 1 H), 8.16 (s, 1 H), 7.89−7.85 (m, 1 H), 7.39−7.33 (m, 2 H), 7.17 (dd, <i>J</i> = 10.0, 16.5 Hz, 1 H), 6.46 (d, <i>J</i> = 16.4 Hz, 1 H), 6.37 (d, <i>J</i> = 10.0 Hz, 1 H). Anal. (C<sub>15</sub>H<sub>11</sub>BrN<sub>4</sub>O<sub>2</sub>S·0.25H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b><i>N</i></b><b>-(3-Bromophenyl)-6-(vinylsulfinyl)pyrido[3,4-</b><b><i>d</i></b><b>]pyrimidin-4-amine (36):  Example of </b><b>Method of Scheme 6.</b> A suspension of <b>50</b> (226 mg, 0.6 mmol) and 3-phenyl-2-(phenylsulfonyl)oxaziridine (180 mg) in CHCl<sub>3</sub> (6 mL) was stirred at room temperature for 3 h. The mixture was diluted with <i>tert</i>-butyl methyl ether (6 mL) and the precipitate was collected to give 2-[4-(3-bromophenylamino)pyrido[3,4-<i>d</i>]pyrimidine-6-sulfinyl]ethanol (<b>51</b>) (210 mg, 89%):  mp 233−235 °C; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 10.6 (s, 1 H, NH), 9.25 (s, 1 H), 9.04 (s, 1 H), 8.86 (s, 1 H), 8.23 (d, <i>J</i> = 1.9 Hz, 1 H), 7.95 (dt, <i>J</i> = 2.2, 2.2, 7.2 Hz, 1 H), 7.39 (m, 2 H), 5.09 (dd, <i>J</i> = 5.1, 5.8 Hz, 1 H, OH), 3.87 (m, 1 H, HOC<i>H</i><sub>2</sub>CH<sub>2</sub>), 3.80 (m, 1 H, HOC<i>H</i><sub>2</sub>CH<sub>2</sub>), 3.32 (m, 1 H, HOCH<sub>2</sub>C<i>H</i><sub>2</sub>), 2.98 (dt, <i>J</i> = 4.3, 4.3, 13.3 Hz, 1 H, HOCH<sub>2</sub>C<i>H</i><sub>2</sub>), 1.91 (dd, <i>J</i> = 7.0, 1.4 Hz, 3 H). Anal. (C<sub>15</sub>H<sub>13</sub>BrN<sub>4</sub>O<sub>2</sub>S) C, H, N. </div><div class="NLM_p">Methanesulfonyl chloride (0.056 mL, 0.72 mmol) was added to an ice-cold suspension of <b>51</b> (117 mg, 0.3 mmol) and Hunig's base (0.3 mL, 1.7 mmol) in dichloroethane (3 mL). After 1 h, the mixture was brought to room temperature and maintained there for 30 min. DBU (316 mg, 2 mmol) was added, and the solution stirred for 30 min, then quenched with water. The mixture was extracted with dichloroethane (2×) and the combined extracts were washed with 2% aqueous HCl, dried (Mg<sub>2</sub>SO<sub>4</sub>), and filtered through a pad of flash silica gel, eluting with EtOAc. Concentration of the combined product eluates and trituration of the resulting solid with MeOH gave <b>36</b> (69 mg, 61%):  mp 213-214 °C; <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ 10.61 (s, 1 H, NH), 9.25 (s, 1 H), 9.00 (s, 1 H), 8.86 (s, 1 H), 8.22 (s, 1 H), 7.93 (d, <i>J</i> = 7.0 Hz, 1 H), 7.38 (m, 2 H), 7.12 (dd, <i>J</i> = 9.6, 16.4 Hz, 1 H), 6.16 (d, <i>J</i> = 16.4 Hz, 1 H), 6.06 (d, <i>J</i> = 9.6 Hz, 1 H). Anal. (C<sub>15</sub>H<sub>11</sub>BrN<sub>4</sub>OS) C, H, N. </div><div class="NLM_p"><b>Tyrosine Kinase Assays.</b> EGFR tyrosine kinase was purified as described previously.<sup><a onclick="showRef(event, 'jm000372ib00021'); return false;" href="javascript:void(0);" class="ref jm000372ib00021">21</a></sup> Enzyme assays for IC<sub>50[app]</sub> determinations were performed in 96-well filter plates (Millipore MADVN6550, Millipore, Bedford, MA). The total volume was 0.1 mL containing 20 mM Hepes, pH 7.4, 50 mM sodium vanadate, 40 mM magnesium chloride, 10 μM adenosine triphosphate (ATP) containing 0.5 mCi of [<sup>32</sup>P]ATP, 20 mg of polyglutamic acid/tyrosine (Sigma Chemical Co., St. Louis, MO), 10 ng of EGFR tyrosine kinase and appropriate dilutions of inhibitor. All components except the ATP are added to the well and the plate was incubated with shaking for 10 min at 25 °C. The reaction was started by adding [<sup>32</sup>P]ATP and the plate incubated at 25 °C for 10 min. The reaction was terminated by addition of 0.1 mL of 20% trichloroacetic acid (TCA). The plate was kept at 4 °C for at least 15 min to allow the substrate to precipitate. The wells was then washed 5 times with 0.2 mL of 10% TCA and <sup>32</sup>P incorporation determined with a Wallac beta plate counter (Wallac, Inc., Gaithersburg, PA). </div><div class="NLM_p"><b>Irreversibility Test Protocol.</b> A431 human epidermoid carcinoma cells were grown in 6-well plates to about 80% confluency and then incubated in serum-free media for 18 h. Duplicate sets of cells were treated with 2 mM of designated compound to be tested as an irreversible inhibitor for 2 h. One set of cells was then stimulated with 100 ng/mL of EGF for 5 min and extracts made as described under the Western blotting procedure. The other set of cells was washed free of the compound with warmed serum-free media, incubated for 2 h, washed again, incubated another 2 h, washed again, and then incubated a further 4 h. This set of cells was then stimulated with EGF and extracts made similar to the first set of cells. </div><div class="NLM_p last"><b>In Vivo Chemotherapy.</b> Evaluation of in vivo anticancer effectiveness was performed as described previously.<sup>15</sup> The A431 epidermoid, H125 non-small-cell lung, and MCF-7 breast xenografts were maintained by serial in vivo passage in and anticancer effectiveness evaluated in nude mice (Charles River Breeding Laboratories). Compounds <b>7 </b>and <b>31</b> were <a name="jm004400300440" id="jm004400300440"></a> administered as suspensions in 0.5% methylcellulose in water due to insufficient solubility at the desired dosage concentration. Both compounds were dosed orally in a fixed volume of 0.5 mL. Host body weight change data are reported as the maximum treatment-related weight loss in these studies. Calculation of tumor growth inhibition (% T/C) and tumor growth delay (T−C) was performed as described previously.<sup><a onclick="showRef(event, 'jm000372ib00022 jm000372ib00023 jm000372ib00024'); return false;" href="javascript:void(0);" class="ref jm000372ib00022 jm000372ib00023 jm000372ib00024">22-24</a></sup></div></div><div class="NLM_back"><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87664" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87664" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><ul></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jeff B. Smaill</span> - <span class="hlFld-Affiliation affiliation">Auckland Cancer Society Research Centre, Faculty of Medicine and Health Science, The University of Auckland, Private Bag 92019, Auckland, New Zealand, and Pfizer Global Research and Development, Ann Arbor Laboratories, 2800 Plymouth Road, Ann Arbor, Michigan 48106-1047 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">H. D. Hollis Showalter</span> - <span class="hlFld-Affiliation affiliation">Auckland Cancer Society Research Centre, Faculty of Medicine and Health Science, The University of Auckland, Private Bag 92019, Auckland, New Zealand, and Pfizer Global Research and Development, Ann Arbor Laboratories, 2800 Plymouth Road, Ann Arbor, Michigan 48106-1047 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hairong Zhou</span> - <span class="hlFld-Affiliation affiliation">Auckland Cancer Society Research Centre, Faculty of Medicine and Health Science, The University of Auckland, Private Bag 92019, Auckland, New Zealand, and Pfizer Global Research and Development, Ann Arbor Laboratories, 2800 Plymouth Road, Ann Arbor, Michigan 48106-1047 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alexander J. Bridges</span> - <span class="hlFld-Affiliation affiliation">Auckland Cancer Society Research Centre, Faculty of Medicine and Health Science, The University of Auckland, Private Bag 92019, Auckland, New Zealand, and Pfizer Global Research and Development, Ann Arbor Laboratories, 2800 Plymouth Road, Ann Arbor, Michigan 48106-1047 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dennis J. McNamara</span> - <span class="hlFld-Affiliation affiliation">Auckland Cancer Society Research Centre, Faculty of Medicine and Health Science, The University of Auckland, Private Bag 92019, Auckland, New Zealand, and Pfizer Global Research and Development, Ann Arbor Laboratories, 2800 Plymouth Road, Ann Arbor, Michigan 48106-1047 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David W. Fry</span> - <span class="hlFld-Affiliation affiliation">Auckland Cancer Society Research Centre, Faculty of Medicine and Health Science, The University of Auckland, Private Bag 92019, Auckland, New Zealand, and Pfizer Global Research and Development, Ann Arbor Laboratories, 2800 Plymouth Road, Ann Arbor, Michigan 48106-1047 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">James M. Nelson</span> - <span class="hlFld-Affiliation affiliation">Auckland Cancer Society Research Centre, Faculty of Medicine and Health Science, The University of Auckland, Private Bag 92019, Auckland, New Zealand, and Pfizer Global Research and Development, Ann Arbor Laboratories, 2800 Plymouth Road, Ann Arbor, Michigan 48106-1047 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Veronika Sherwood</span> - <span class="hlFld-Affiliation affiliation">Auckland Cancer Society Research Centre, Faculty of Medicine and Health Science, The University of Auckland, Private Bag 92019, Auckland, New Zealand, and Pfizer Global Research and Development, Ann Arbor Laboratories, 2800 Plymouth Road, Ann Arbor, Michigan 48106-1047 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Patrick W. Vincent</span> - <span class="hlFld-Affiliation affiliation">Auckland Cancer Society Research Centre, Faculty of Medicine and Health Science, The University of Auckland, Private Bag 92019, Auckland, New Zealand, and Pfizer Global Research and Development, Ann Arbor Laboratories, 2800 Plymouth Road, Ann Arbor, Michigan 48106-1047 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bill J. Roberts</span> - <span class="hlFld-Affiliation affiliation">Auckland Cancer Society Research Centre, Faculty of Medicine and Health Science, The University of Auckland, Private Bag 92019, Auckland, New Zealand, and Pfizer Global Research and Development, Ann Arbor Laboratories, 2800 Plymouth Road, Ann Arbor, Michigan 48106-1047 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">William L. Elliott</span> - <span class="hlFld-Affiliation affiliation">Auckland Cancer Society Research Centre, Faculty of Medicine and Health Science, The University of Auckland, Private Bag 92019, Auckland, New Zealand, and Pfizer Global Research and Development, Ann Arbor Laboratories, 2800 Plymouth Road, Ann Arbor, Michigan 48106-1047 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">William A. Denny</span> - <span class="hlFld-Affiliation affiliation">Auckland Cancer Society Research Centre, Faculty of Medicine and Health Science, The University of Auckland, Private Bag 92019, Auckland, New Zealand, and Pfizer Global Research and Development, Ann Arbor Laboratories, 2800 Plymouth Road, Ann Arbor, Michigan 48106-1047 </span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="testing" data-doi="10.1021/jm000372i" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38604" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38604" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was partially supported by the Auckland Division of the Cancer Society of New Zealand. </p></div><div class="refs-header-label"></div><p class="references-count">
            This article references 24 other publications.
        </p><ol id="references" class="useLabel"><li id="jm000372ib00001"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm000372ib00001'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="jm000372ib00001_1"><span><span class="NLM_string-ref">Dowsett, M.; Cooke, T.; Ellis, I.; Gullick, W. J.; Gusterson, B.; Mallon, E.; Walker, R. Assessment of HER2 status in breast cancer:  why, when and how? <i>Eur. J. Cancer</i><b>2000</b>, <i>36</i>, 170−176.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2000&pages=176&author=M.+Dowsett&author=T.+Cooke&author=I.+Ellis&author=W.+J.+Gullick&author=B.+Gusterson&author=E.+Mallon&author=R+Walker&title=Assessment+of+HER2+status+in+breast+cancer%3A%E2%80%89+why%2C+when+and+how"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm000372ib00001_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDowsett%26aufirst%3DM.%26atitle%3DAssessment%2520of%2520HER2%2520status%2520in%2520breast%2520cancer%253A%25E2%2580%2589%2520why%252C%2520when%2520and%2520how%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D2000%26volume%3D36%26spage%3D176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm000372ib00002"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm000372ib00002'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="jm000372ib00002_1"><span><span class="NLM_string-ref">Kim, H.; Muller, W. J. The role of the epidermal growth factor receptor family in mammary tumorigenesis and metastasis. <i>  Exp. Cell Res.</i><b>1999</b>, <i>253</i>, 78−87.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=253&publication_year=1999&pages=87&author=H.+Kim&author=W.+J+Muller&title=The+role+of+the+epidermal+growth+factor+receptor+family+in+mammary+tumorigenesis+and+metastasis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm000372ib00002_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DH.%26atitle%3DThe%2520role%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%2520family%2520in%2520mammary%2520tumorigenesis%2520and%2520metastasis%26jtitle%3DExp.%2520Cell%2520Res.%26date%3D1999%26volume%3D253%26spage%3D87" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm000372ib00003"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm000372ib00003'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="jm000372ib00003_1"><span><span class="NLM_string-ref">Fry, D. W. Inhibition of the epidermal growth factor receptor family of tyrosine kinases as an approach to cancer chemotherapy:  Progression from reversible to irreversible inhibitors. <i>  Pharmacol. Ther</i>. <b>1999</b>, <i>82</i>, 207−218.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=1999&pages=218&author=D.+W+Fry&title=Inhibition+of+the+epidermal+growth+factor+receptor+family+of+tyrosine+kinases+as+an+approach+to+cancer+chemotherapy%3A%E2%80%89+Progression+from+reversible+to+irreversible+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm000372ib00003_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFry%26aufirst%3DD.%2BW%26atitle%3DInhibition%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%2520family%2520of%2520tyrosine%2520kinases%2520as%2520an%2520approach%2520to%2520cancer%2520chemotherapy%253A%25E2%2580%2589%2520Progression%2520from%2520reversible%2520to%2520irreversible%2520inhibitors%26jtitle%3DPharmacol.%2520Ther.%26date%3D1999%26volume%3D82%26spage%3D218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm000372ib00004"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm000372ib00004'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="jm000372ib00004_1"><span><span class="NLM_string-ref">Traxler, P.; Green, J.; Mett, H.; Sequin, U.; Furet, P. Use of a pharmacophore model for the design of EGFR tyrosine kinase inhibitors:  isoflavones and 3-phenyl-4(1H)-quinolones. <i>  J. Med. Chem</i>. <b>1999</b>, <i>42</i>, 1018−1026.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=1026&author=P.+Traxler&author=J.+Green&author=H.+Mett&author=U.+Sequin&author=P+Furet&title=Use+of+a+pharmacophore+model+for+the+design+of+EGFR+tyrosine+kinase+inhibitors%3A%E2%80%89+isoflavones+and+3-phenyl-4%281H%29-quinolones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm000372ib00004_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTraxler%26aufirst%3DP.%26atitle%3DUse%2520of%2520a%2520pharmacophore%2520model%2520for%2520the%2520design%2520of%2520EGFR%2520tyrosine%2520kinase%2520inhibitors%253A%25E2%2580%2589%2520isoflavones%2520and%25203-phenyl-4%25281H%2529-quinolones%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D1026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm000372ib00005"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm000372ib00005'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="jm000372ib00005_1"><span><span class="NLM_string-ref">Woodburn, J. R. The epidermal growth factor receptor and its inhibition in cancer therapy. <i>  Pharmacol. Ther</i>. <b>1999</b>, <i>82</i>, 241−250.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=1999&pages=250&author=J.+R+Woodburn&title=The+epidermal+growth+factor+receptor+and+its+inhibition+in+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm000372ib00005_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWoodburn%26aufirst%3DJ.%2BR%26atitle%3DThe%2520epidermal%2520growth%2520factor%2520receptor%2520and%2520its%2520inhibition%2520in%2520cancer%2520therapy%26jtitle%3DPharmacol.%2520Ther.%26date%3D1999%26volume%3D82%26spage%3D250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm000372ib00006"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm000372ib00006'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="jm000372ib00006_1"><span><span class="NLM_string-ref">Palmer, B. D.; Trumpp-Kallmeyer, S.; Fry, D. W.; Nelson, J. M.; Showalter, H. D. H.; Denny, W. A. Tyrosine Kinase Inhibitors. 11. Soluble analogues of pyrrolo- and pyrazinoquinazolines as EGFR inhibitors:  synthesis, biological evaluation and modelling of the mode of binding. <i>  J. Med. Chem</i>. <b>1997</b>, <i>40,</i> 1519−1529.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=1529&author=B.+D.+Palmer&author=S.+Trumpp-Kallmeyer&author=D.+W.+Fry&author=J.+M.+Nelson&author=H.+D.+H.+Showalter&author=W.+A+Denny&title=Tyrosine+Kinase+Inhibitors.+11.+Soluble+analogues+of+pyrrolo-+and+pyrazinoquinazolines+as+EGFR+inhibitors%3A%E2%80%89+synthesis%2C+biological+evaluation+and+modelling+of+the+mode+of+binding"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm000372ib00006_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPalmer%26aufirst%3DB.%2BD.%26atitle%3DTyrosine%2520Kinase%2520Inhibitors.%252011.%2520Soluble%2520analogues%2520of%2520pyrrolo-%2520and%2520pyrazinoquinazolines%2520as%2520EGFR%2520inhibitors%253A%25E2%2580%2589%2520synthesis%252C%2520biological%2520evaluation%2520and%2520modelling%2520of%2520the%2520mode%2520of%2520binding%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D1529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm000372ib00007"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm000372ib00007'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="jm000372ib00007_1"><span><span class="NLM_string-ref">Shewchuk, L.; Hassell, A.; Wisely, B.; Rocque, W.; Holmes, W.; Veal, J.; Kuyper, L F. Binding mode of the 4-anilinoquinazoline class of protein kinase inhibitor:  X-ray crystallographic studies of 4-anilinoquinazolines bound to cyclin-dependent kinase 2 and p38 kinase.<i> J. Med. Chem</i>. <b>2000</b>, <i>43</i>, 133−138.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=138&author=L.+Shewchuk&author=A.+Hassell&author=B.+Wisely&author=W.+Rocque&author=W.+Holmes&author=J.+Veal&author=L+F+Kuyper&title=Binding+mode+of+the+4-anilinoquinazoline+class+of+protein+kinase+inhibitor%3A%E2%80%89+X-ray+crystallographic+studies+of+4-anilinoquinazolines+bound+to+cyclin-dependent+kinase+2+and+p38+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm000372ib00007_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShewchuk%26aufirst%3DL.%26atitle%3DBinding%2520mode%2520of%2520the%25204-anilinoquinazoline%2520class%2520of%2520protein%2520kinase%2520inhibitor%253A%25E2%2580%2589%2520X-ray%2520crystallographic%2520studies%2520of%25204-anilinoquinazolines%2520bound%2520to%2520cyclin-dependent%2520kinase%25202%2520and%2520p38%2520kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm000372ib00008"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm000372ib00008'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="jm000372ib00008_1"><span><span class="NLM_string-ref">Pollack, V. A.; Savage, D. M.; Baker, D. A.; Tsaparikos, K. E.; Sloan, D. E.; Moyer, J. D.; Barbacci, E. G.; Pustilnik, L. R.; Smolarek, T. A.; Davis, J. A.; Vaidya, M. P.; Arnold, L. D.; Doty, J. L.; Iwata, K. K.; Morin, M. J. Inhibition of epidermal growth factor receptor-associated tyrosine phosphorylation in human carcinomas with CP-358,774:  Dynamics of receptor inhibition in situ and antitumor effects in athymic mice. <i>  J. </i><i>Pharmacol. Exp. Ther</i>. <b>1999</b>, <i>291</i>, 739−748.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=291&publication_year=1999&pages=748&author=V.+A.+Pollack&author=D.+M.+Savage&author=D.+A.+Baker&author=K.+E.+Tsaparikos&author=D.+E.+Sloan&author=J.+D.+Moyer&author=E.+G.+Barbacci&author=L.+R.+Pustilnik&author=T.+A.+Smolarek&author=J.+A.+Davis&author=M.+P.+Vaidya&author=L.+D.+Arnold&author=J.+L.+Doty&author=K.+K.+Iwata&author=M.+J+Morin&title=Inhibition+of+epidermal+growth+factor+receptor-associated+tyrosine+phosphorylation+in+human+carcinomas+with+CP-358%2C774%3A%E2%80%89+Dynamics+of+receptor+inhibition+in+situ+and+antitumor+effects+in+athymic+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm000372ib00008_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPollack%26aufirst%3DV.%2BA.%26atitle%3DInhibition%2520of%2520epidermal%2520growth%2520factor%2520receptor-associated%2520tyrosine%2520phosphorylation%2520in%2520human%2520carcinomas%2520with%2520CP-358%252C774%253A%25E2%2580%2589%2520Dynamics%2520of%2520receptor%2520inhibition%2520in%2520situ%2520and%2520antitumor%2520effects%2520in%2520athymic%2520mice%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1999%26volume%3D291%26spage%3D748" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm000372ib00009"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm000372ib00009'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="jm000372ib00009_1"><span><span class="NLM_string-ref">Baselga, J.; Herbst, R.; LoRusso, P.; Rischin, D.; Ranson, M.; Plummer, R.; Raymond, E.; Maddox, A.; Kaye, S. B.; Kieback, D. G.; Harris, A.; Ochs, J. Continuous administration of ZD1839 (Iressa), a novel oral epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI), in patients with five selected tumor types:  evidence of activity and good tolerability. <i>  Proc. </i><i>Am.</i><i> Soc. Clin. Oncol</i>. <b>2000</b>, <i>19</i>, 177a (abstract 686).</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Baselga%2C+J.%3B+Herbst%2C+R.%3B+LoRusso%2C+P.%3B+Rischin%2C+D.%3B+Ranson%2C+M.%3B+Plummer%2C+R.%3B+Raymond%2C+E.%3B+Maddox%2C+A.%3B+Kaye%2C+S.+B.%3B+Kieback%2C+D.+G.%3B+Harris%2C+A.%3B+Ochs%2C+J.+Continuous+administration+of+ZD1839+%28Iressa%29%2C+a+novel+oral+epidermal+growth+factor+receptor+tyrosine+kinase+inhibitor+%28EGFR-TKI%29%2C+in+patients+with+five+selected+tumor+types%3A%E2%80%89+evidence+of+activity+and+good+tolerability.+Proc.+Am.+Soc.+Clin.+Oncol.+2000%2C+19%2C+177a+%28abstract+686%29.+Baselga%2C+J.%3B+Herbst%2C+R.%3B+LoRusso%2C+P.%3B+Rischin%2C+D.%3B+Ranson%2C+M.%3B+Plummer%2C+R.%3B+Raymond%2C+E.%3B+Maddox%2C+A.%3B+Kaye%2C+S.+B.%3B+Kieback%2C+D.+G.%3B+Harris%2C+A.%3B+Ochs%2C+J.+Continuous+administration+of+ZD1839+%28Iressa%29%2C+a+novel+oral+epidermal+growth+factor+receptor+tyrosine+kinase+inhibitor+%28EGFR-TKI%29%2C+in+patients+with+five+selected+tumor+types%3A%E2%80%89+evidence+of+activity+and+good+tolerability.+Proc.+Am.+Soc.+Clin.+Oncol.+2000%2C+19%2C+177a+%28abstract+686%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm000372ib00009_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dother%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm000372ib00010"><div class="reference"><div class="NLM_citation" id="jm000372ib00010_1"><span><span class="NLM_string-ref">Bridges, A. J. The rationale and strategy used to develop a series of highly potent, irreversible, inhibitors of the epidermal growth factor receptor family of tyrosine kinases. <i>  Curr. Med. Chem</i>. <b>1999</b>, <i>6</i>, 825−843.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1999&pages=843&author=A.+J+Bridges&title=The+rationale+and+strategy+used+to+develop+a+series+of+highly+potent%2C+irreversible%2C+inhibitors+of+the+epidermal+growth+factor+receptor+family+of+tyrosine+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm000372ib00010_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBridges%26aufirst%3DA.%2BJ%26atitle%3DThe%2520rationale%2520and%2520strategy%2520used%2520to%2520develop%2520a%2520series%2520of%2520highly%2520potent%252C%2520irreversible%252C%2520inhibitors%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%2520family%2520of%2520tyrosine%2520kinases%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D1999%26volume%3D6%26spage%3D843" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm000372ib00011"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm000372ib00011'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="jm000372ib00011_1"><span><span class="NLM_string-ref">Vincent, P. W.; Bridges, A. J.; Dykes, D. J.; Fry, D. W.; Leopold, W. R.; Patmore, S. J.; Roberts, B. J.; Rose, S.; Sherwood, V.; Zhou, H. R.; Elliott, W. L. Anticancer efficacy of the irreversible EGFr tyrosine kinase inhibitor PD 0169414 against human tumor xenografts. <i>  Cancer Chemother. </i><i>Pharmacol</i>. <b>2000</b>, <i>45</i>, 231−238.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2000&pages=238&author=P.+W.+Vincent&author=A.+J.+Bridges&author=D.+J.+Dykes&author=D.+W.+Fry&author=W.+R.+Leopold&author=S.+J.+Patmore&author=B.+J.+Roberts&author=S.+Rose&author=V.+Sherwood&author=H.+R.+Zhou&author=W.+L+Elliott&title=Anticancer+efficacy+of+the+irreversible+EGFr+tyrosine+kinase+inhibitor+PD+0169414+against+human+tumor+xenografts"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm000372ib00011_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVincent%26aufirst%3DP.%2BW.%26atitle%3DAnticancer%2520efficacy%2520of%2520the%2520irreversible%2520EGFr%2520tyrosine%2520kinase%2520inhibitor%2520PD%25200169414%2520against%2520human%2520tumor%2520xenografts%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2000%26volume%3D45%26spage%3D238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm000372ib00012"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm000372ib00012'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="jm000372ib00012_1"><span><span class="NLM_string-ref">Wissner, A.; Johnson, B. D.; Floyd, M. B.; Kitchen, D. B. 4-Aminoquinazolines as EGFR inhibitors. U.S. Patent 5,760,041, June 2, 1998. Discafani, C. M.; Carroll, M. L.; Floyd, M. B.; Hollander, I. J.; Husain, Z.; Johnson, B. D.; Kitchen, D.; May, M. K.; Malo, M. S.; Minnick, A. A.; Nilakantan, R.; Shen, R.; Wang, Y.-F.; Wissner, A.; Greenberger, L. M. Irreversible inhibition of epidermal growth factor receptor tyrosine kinase with in vivo activity by N-[4-[(3-bromophenyl)amino]-6-quinazolinyl]-2-butynamide (CL-378,785). <i>  Biochem. Pharmacol</i>. <b>1999</b>, <i>57</i>, 917−925.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1998&author=A.+Wissner&author=B.+D.+Johnson&author=M.+B.+Floyd&author=D.+B.+Kitchen&title=June+2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm000372ib00012_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DWissner%26aufirst%3DA.%26atitle%3D4-Aminoquinazolines%2520as%2520EGFR%2520inhibitors.%2520U.S.%2520Patent%25205%252C760%252C041%26btitle%3DJune%25202%26date%3D1998%26pub%3DPharmacol" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm000372ib00013"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm000372ib00013'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="jm000372ib00013_1"><span><span class="NLM_string-ref">Fry, D. W.; Bridges, A. J.; Denny, W. A.; Doherty. A.; Gries, K. D.; Hicks, J. L.; Hook, K. E.; Keller, P. R.; Leopold, W. R.; Loo, J. A.; McNamara, D, J.; Nelson, J. M.; Sherwood, V.; Smaill, J. B.; Trumpp-Kallmeyer, S.; Dobrusin, E. M. Specific, irreversible inactivation of the epidermal growth factor receptor and erbB2, by a new class of tyrosine kinase inhibitor. <i>  Proc. </i><i>Natl. Acad. Sci. U.S.A.</i><b>1998</b>, <i>95</i>, 12022−12027.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1998&pages=12027&author=D.+W.+Fry&author=A.+J.+Bridges&author=W.+A.+Denny&author=A.+Doherty&author=K.+D.+Gries&author=J.+L.+Hicks&author=K.+E.+Hook&author=P.+R.+Keller&author=W.+R.+Leopold&author=J.+A.+Loo&author=D%2C+J+McNamara&author=J.+M.+Nelson&author=V.+Sherwood&author=J.+B.+Smaill&author=S.+Trumpp-Kallmeyer&author=E.+M+Dobrusin&title=Specific%2C+irreversible+inactivation+of+the+epidermal+growth+factor+receptor+and+erbB2%2C+by+a+new+class+of+tyrosine+kinase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm000372ib00013_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFry%26aufirst%3DD.%2BW.%26atitle%3DSpecific%252C%2520irreversible%2520inactivation%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%2520and%2520erbB2%252C%2520by%2520a%2520new%2520class%2520of%2520tyrosine%2520kinase%2520inhibitor%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1998%26volume%3D95%26spage%3D12027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm000372ib00014"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm000372ib00014'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="jm000372ib00014_1"><span><span class="NLM_string-ref">Smaill, J. B.; Palmer, B. D.; Rewcastle, G. W.; Denny, W. A.; McNamara, D. J.; Dobrusin, E. M.; Bridges, A. J.; Zhou, H. R.; Showalter, H. D. H.; Winters, R. T.; Leopold, W. R.; Fry, D. W.; Nelson, J. M.; Slintak, V.; Elliot, W. L.; Roberts, B. J.; Vincent, P. W.; Patmore, S. J. Tyrosine kinase inhibitors. 15. 4-(phenylamino)quinazoline and 4-(phenylamino)pyrido[<i>d</i>]pyrimidine acrylamides as irreversible inhibitors of the ATP binding site of the epidermal growth factor receptor. <i>  J. Med. </i><i>Chem</i>. <b>1999</b>, <i>42</i>, 1803−1815.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=1815&author=J.+B.+Smaill&author=B.+D.+Palmer&author=G.+W.+Rewcastle&author=W.+A.+Denny&author=D.+J.+McNamara&author=E.+M.+Dobrusin&author=A.+J.+Bridges&author=H.+R.+Zhou&author=H.+D.+H.+Showalter&author=R.+T.+Winters&author=W.+R.+Leopold&author=D.+W.+Fry&author=J.+M.+Nelson&author=V.+Slintak&author=W.+L.+Elliot&author=B.+J.+Roberts&author=P.+W.+Vincent&author=S.+J+Patmore&title=Tyrosine+kinase+inhibitors.+15.+4-%28phenylamino%29quinazoline+and+4-%28phenylamino%29pyrido%5Bd%5Dpyrimidine+acrylamides+as+irreversible+inhibitors+of+the+ATP+binding+site+of+the+epidermal+growth+factor+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm000372ib00014_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSmaill%26aufirst%3DJ.%2BB.%26atitle%3DTyrosine%2520kinase%2520inhibitors.%252015.%25204-%2528phenylamino%2529quinazoline%2520and%25204-%2528phenylamino%2529pyrido%255Bd%255Dpyrimidine%2520acrylamides%2520as%2520irreversible%2520inhibitors%2520of%2520the%2520ATP%2520binding%2520site%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D1815" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm000372ib00015"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm000372ib00015'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="jm000372ib00015_1"><span><span class="NLM_string-ref">Smaill, J. B.; Rewcastle, G. W.; Bridges, A. J.; Zhou, H.; Showalter, H. D. H.; Fry, D. W.; Nelson, J. M.; Sherwood, V.; Elliott, W. L.; Vincent, P. W.; DeJohn, D.; Loo, J. A.; Gries, K. D.; Chan, O. H.; Reyner, E.L.; Lipka, E.; and Denny, W. A. Tyrosine kinase inhibitors. 17. Irreversible inhibitors of the epidermal growth factor receptor:  4-(phenylamino)quinazoline- and 4-(phenylamino)pyrido[3,2-<i>d</i>]pyrimidine-6-acrylamides bearing additional solubilizing functions. <i>  J. Med. Chem</i>. <b>2000</b>, <i>43</i>, 1380−1397.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=1397&author=J.+B.+Smaill&author=G.+W.+Rewcastle&author=A.+J.+Bridges&author=H.+Zhou&author=H.+D.+H.+Showalter&author=D.+W.+Fry&author=J.+M.+Nelson&author=V.+Sherwood&author=W.+L.+Elliott&author=P.+W.+Vincent&author=D.+DeJohn&author=J.+A.+Loo&author=K.+D.+Gries&author=O.+H.+Chan&author=E.L.+Reyner&author=E.+Lipka&author=W.+A.+Denny&title=Tyrosine+kinase+inhibitors.+17.+Irreversible+inhibitors+of+the+epidermal+growth+factor+receptor%3A%E2%80%89+4-%28phenylamino%29quinazoline-+and+4-%28phenylamino%29pyrido%5B3%2C2-d%5Dpyrimidine-6-acrylamides+bearing+additional+solubilizing+functions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm000372ib00015_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSmaill%26aufirst%3DJ.%2BB.%26atitle%3DTyrosine%2520kinase%2520inhibitors.%252017.%2520Irreversible%2520inhibitors%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%253A%25E2%2580%2589%25204-%2528phenylamino%2529quinazoline-%2520and%25204-%2528phenylamino%2529pyrido%255B3%252C2-d%255Dpyrimidine-6-acrylamides%2520bearing%2520additional%2520solubilizing%2520functions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D1397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm000372ib00016"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm000372ib00016'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="jm000372ib00016_1"><span><span class="NLM_string-ref">Medina, L.; Gomez, L.; Cerna, C.; Kraker, A.; Yochmowitz, M.; Weitman, S. Investigation of the effects of the tyrosine kinase (TK) inhibitor CI-1033 (PD 0183805) against human tumor specimens taken directly from patients. <i>  Proc. </i><i>Am.</i><i> Assoc. Cancer Res</i>. <b>2000</b>, <i>41</i>, 483 (abstract 3078).</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2000&pages=483&author=L.+Medina&author=L.+Gomez&author=C.+Cerna&author=A.+Kraker&author=M.+Yochmowitz&author=S+Weitman&title=Investigation+of+the+effects+of+the+tyrosine+kinase+%28TK%29+inhibitor+CI-1033+%28PD+0183805%29+against+human+tumor+specimens+taken+directly+from+patients"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm000372ib00016_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMedina%26aufirst%3DL.%26atitle%3DInvestigation%2520of%2520the%2520effects%2520of%2520the%2520tyrosine%2520kinase%2520%2528TK%2529%2520inhibitor%2520CI-1033%2520%2528PD%25200183805%2529%2520against%2520human%2520tumor%2520specimens%2520taken%2520directly%2520from%2520patients%26jtitle%3DProc.%2520Am.%2520Assoc.%2520Cancer%2520Res.%26date%3D2000%26volume%3D41%26spage%3D483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm000372ib00017"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm000372ib00017'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="jm000372ib00017_1"><span><span class="NLM_string-ref">Rewcastle, G. W.; Palmer, B. D.; Thompson, A. M.; Bridges, A. J.; Cody, D. A.; Zhou, H.; Fry, D. J.; McMichael, A.; Denny, W. A. Tyrosine kinase inhibitors. 10. Isomeric 4-[(3-bromophenyl)amino]-pyrido[<i>d</i>]-pyrimidines are potent ATP binding site inhibitors of the tyrosine kinase function of the epidermal growth factor receptor. <i>  J. Med. Chem</i>. <b>1996</b>, <i>39</i>, 1823−1835.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=1835&author=G.+W.+Rewcastle&author=B.+D.+Palmer&author=A.+M.+Thompson&author=A.+J.+Bridges&author=D.+A.+Cody&author=H.+Zhou&author=D.+J.+Fry&author=A.+McMichael&author=W.+A+Denny&title=Tyrosine+kinase+inhibitors.+10.+Isomeric+4-%5B%283-bromophenyl%29amino%5D-pyrido%5Bd%5D-pyrimidines+are+potent+ATP+binding+site+inhibitors+of+the+tyrosine+kinase+function+of+the+epidermal+growth+factor+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm000372ib00017_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRewcastle%26aufirst%3DG.%2BW.%26atitle%3DTyrosine%2520kinase%2520inhibitors.%252010.%2520Isomeric%25204-%255B%25283-bromophenyl%2529amino%255D-pyrido%255Bd%255D-pyrimidines%2520are%2520potent%2520ATP%2520binding%2520site%2520inhibitors%2520of%2520the%2520tyrosine%2520kinase%2520function%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1996%26volume%3D39%26spage%3D1835" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm000372ib00018"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm000372ib00018'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="jm000372ib00018_1"><span><span class="NLM_string-ref">Rewcastle, G. W.; Denny, W. A.; Zhou, H.; Cody, D. R.; McMichael, A.; Fry, D. W.; Bridges, A.J. Tyrosine kinase inhibitors. 5. Synthesis and structure−activity relationships for 4-(phenylmethyl)amino- and 4-phenylaminoquinazolines as potent adenosine 5‘-triphosphate binding site inhibitors of the tyrosine kinase domain of epidermal growth factor receptor. <i>  J. Med. Chem</i>. <b>1995</b>, <i>38</i>, 3482−3487.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1995&pages=3487&author=G.+W.+Rewcastle&author=W.+A.+Denny&author=H.+Zhou&author=D.+R.+Cody&author=A.+McMichael&author=D.+W.+Fry&author=A.J+Bridges&title=Tyrosine+kinase+inhibitors.+5.+Synthesis+and+structure%E2%88%92activity+relationships+for+4-%28phenylmethyl%29amino-+and+4-phenylaminoquinazolines+as+potent+adenosine+5%E2%80%98-triphosphate+binding+site+inhibitors+of+the+tyrosine+kinase+domain+of+epidermal+growth+factor+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm000372ib00018_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRewcastle%26aufirst%3DG.%2BW.%26atitle%3DTyrosine%2520kinase%2520inhibitors.%25205.%2520Synthesis%2520and%2520structure%25E2%2588%2592activity%2520relationships%2520for%25204-%2528phenylmethyl%2529amino-%2520and%25204-phenylaminoquinazolines%2520as%2520potent%2520adenosine%25205%25E2%2580%2598-triphosphate%2520binding%2520site%2520inhibitors%2520of%2520the%2520tyrosine%2520kinase%2520domain%2520of%2520epidermal%2520growth%2520factor%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1995%26volume%3D38%26spage%3D3487" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm000372ib00019"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm000372ib00019'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="jm000372ib00019_1"><span><span class="NLM_string-ref">Rewcastle, G. W.; Murray, D. K.; Elliott, W. L.; Fry, D. W.; Howard, C. T.; Nelson, J. M.; Roberts, B. J.; Vincent, P. W.; Showalter, H. D. H.; Winters, R. T.; Denny, W. A. Tyrosine kinase inhibitors. 14. Structure−activity relationships for methylamino-substituted derivatives of 4-[(3-bromophenyl)amino]-6-(methylamino)pyrido[3,4-<i>d</i>]pyrimidine (PD 158780), a potent and specific inhibitor of the tyrosine kinase activity of receptors for the EGF family of growth factors. <i>  J. Med. Chem</i>. <b>1998</b>, <i>41</i>, 742−751.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=751&author=G.+W.+Rewcastle&author=D.+K.+Murray&author=W.+L.+Elliott&author=D.+W.+Fry&author=C.+T.+Howard&author=J.+M.+Nelson&author=B.+J.+Roberts&author=P.+W.+Vincent&author=H.+D.+H.+Showalter&author=R.+T.+Winters&author=W.+A+Denny&title=Tyrosine+kinase+inhibitors.+14.+Structure%E2%88%92activity+relationships+for+methylamino-substituted+derivatives+of+4-%5B%283-bromophenyl%29amino%5D-6-%28methylamino%29pyrido%5B3%2C4-d%5Dpyrimidine+%28PD+158780%29%2C+a+potent+and+specific+inhibitor+of+the+tyrosine+kinase+activity+of+receptors+for+the+EGF+family+of+growth+factors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm000372ib00019_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRewcastle%26aufirst%3DG.%2BW.%26atitle%3DTyrosine%2520kinase%2520inhibitors.%252014.%2520Structure%25E2%2588%2592activity%2520relationships%2520for%2520methylamino-substituted%2520derivatives%2520of%25204-%255B%25283-bromophenyl%2529amino%255D-6-%2528methylamino%2529pyrido%255B3%252C4-d%255Dpyrimidine%2520%2528PD%2520158780%2529%252C%2520a%2520potent%2520and%2520specific%2520inhibitor%2520of%2520the%2520tyrosine%2520kinase%2520activity%2520of%2520receptors%2520for%2520the%2520EGF%2520family%2520of%2520growth%2520factors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D751" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm000372ib00020"><div class="reference"><div class="NLM_citation" id="jm000372ib00020_1"><span><span class="NLM_string-ref">Horne, S.; Taylor, N.; Collins, S.; Rodrigo, R. Rapid syntheses of some indole alkaloids of the Calabar bean. <i>  J. Chem. Soc.</i><i>,</i><i> Perkin Trans</i><i>I</i><b>1991</b>, 3047−3051.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3047&publication_year=1991&pages=3051&author=S.+Horne&author=N.+Taylor&author=S.+Collins&author=R+Rodrigo&title=Rapid+syntheses+of+some+indole+alkaloids+of+the+Calabar+bean"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm000372ib00020_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHorne%26aufirst%3DS.%26atitle%3DRapid%2520syntheses%2520of%2520some%2520indole%2520alkaloids%2520of%2520the%2520Calabar%2520bean%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Perkin%2520Trans%2520I%26date%3D1991%26volume%3D3047%26spage%3D3051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm000372ib00021"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm000372ib00021'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="jm000372ib00021_1"><span><span class="NLM_string-ref">Thompson, A. M.; Murray, D. K.; Elliott, W. L.; Fry, D. W.; Nelson, J. A.; Showalter, H. D. H.; Roberts, B. J.; Vincent, P. W.; Denny, W. A. Tyrosine kinase inhibitors. 13. Structure−activity relationships for soluble 7-substituted 4-[(3-bromophenyl)amino]-pyrido[4,3-<i>d</i>]pyrimidines designed as inhibitors of the tyrosine kinase activity of the epidermal growth factor receptor. <i>  J. Med. Chem</i>. <b>1997</b>, <i>40</i>, 3915−3925.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=3925&author=A.+M.+Thompson&author=D.+K.+Murray&author=W.+L.+Elliott&author=D.+W.+Fry&author=J.+A.+Nelson&author=H.+D.+H.+Showalter&author=B.+J.+Roberts&author=P.+W.+Vincent&author=W.+A+Denny&title=Tyrosine+kinase+inhibitors.+13.+Structure%E2%88%92activity+relationships+for+soluble+7-substituted+4-%5B%283-bromophenyl%29amino%5D-pyrido%5B4%2C3-d%5Dpyrimidines+designed+as+inhibitors+of+the+tyrosine+kinase+activity+of+the+epidermal+growth+factor+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm000372ib00021_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DA.%2BM.%26atitle%3DTyrosine%2520kinase%2520inhibitors.%252013.%2520Structure%25E2%2588%2592activity%2520relationships%2520for%2520soluble%25207-substituted%25204-%255B%25283-bromophenyl%2529amino%255D-pyrido%255B4%252C3-d%255Dpyrimidines%2520designed%2520as%2520inhibitors%2520of%2520the%2520tyrosine%2520kinase%2520activity%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D3925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm000372ib00022"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm000372ib00022'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="jm000372ib00022_1"><span><span class="NLM_string-ref">Leopold, W. R.; Nelson, J. M.; Plowman, J.; Jackson, R. C. Anthrapyrazoles, a new class of intercalating agents with high-level, broad spectrum activity against murine tumors. <i>  Cancer Res</i>. <b>1985</b>, <i>45</i>, 5532−5539.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1985&pages=5539&author=W.+R.+Leopold&author=J.+M.+Nelson&author=J.+Plowman&author=R.+C+Jackson&title=Anthrapyrazoles%2C+a+new+class+of+intercalating+agents+with+high-level%2C+broad+spectrum+activity+against+murine+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm000372ib00022_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeopold%26aufirst%3DW.%2BR.%26atitle%3DAnthrapyrazoles%252C%2520a%2520new%2520class%2520of%2520intercalating%2520agents%2520with%2520high-level%252C%2520broad%2520spectrum%2520activity%2520against%2520murine%2520tumors%26jtitle%3DCancer%2520Res.%26date%3D1985%26volume%3D45%26spage%3D5539" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm000372ib00023"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm000372ib00023'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="jm000372ib00023_1"><span><span class="NLM_string-ref">Elliott, W. L.; Howard, C. T.; Dykes, D. J.; Leopold, W. R. Sequence and schedule-dependent synergy of trimetrexate in combination with 5-fluorouracil in vitro and in mice. <i>  Cancer Res</i>. <b>1989</b>, <i>49</i>, 5586−5590.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1989&pages=5590&author=W.+L.+Elliott&author=C.+T.+Howard&author=D.+J.+Dykes&author=W.+R+Leopold&title=Sequence+and+schedule-dependent+synergy+of+trimetrexate+in+combination+with+5-fluorouracil+in+vitro+and+in+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm000372ib00023_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DElliott%26aufirst%3DW.%2BL.%26atitle%3DSequence%2520and%2520schedule-dependent%2520synergy%2520of%2520trimetrexate%2520in%2520combination%2520with%25205-fluorouracil%2520in%2520vitro%2520and%2520in%2520mice%26jtitle%3DCancer%2520Res.%26date%3D1989%26volume%3D49%26spage%3D5590" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm000372ib00024"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm000372ib00024'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="jm000372ib00024_1"><span><span class="NLM_string-ref">Elliott, W. L.; Roberts, B. J.; Howard, C. T.; Leopold, W. R. Chemotherapy with [SP-4-3-(<i>R</i>)]-[1,1-cyclobutanedicarboxylato(2-)](2-methyl-1,4-butanediamine-N,N')platinum (CI-973, NK121) in combination with standard agents against murine tumors in vivo. <i>  Cancer Res</i>. <b>1994</b>, <i>54</i>, 4412−4418.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1994&pages=4418&author=W.+L.+Elliott&author=B.+J.+Roberts&author=C.+T.+Howard&author=W.+R.+Leopold&author=+Chemotherapy&author=+N%27&title=in+combination+with+standard+agents+against+murine+tumors+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm000372ib00024_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DElliott%26aufirst%3DW.%2BL.%26atitle%3Din%2520combination%2520with%2520standard%2520agents%2520against%2520murine%2520tumors%2520in%2520vivo%26jtitle%3DCancer%2520Res.%26date%3D1994%26volume%3D54%26spage%3D4418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'jm000372ib00001':['jm000372ib00001_1'],'jm000372ib00002':['jm000372ib00002_1'],'jm000372ib00003':['jm000372ib00003_1'],'jm000372ib00004':['jm000372ib00004_1'],'jm000372ib00005':['jm000372ib00005_1'],'jm000372ib00006':['jm000372ib00006_1'],'jm000372ib00007':['jm000372ib00007_1'],'jm000372ib00008':['jm000372ib00008_1'],'jm000372ib00009':['jm000372ib00009_1'],'jm000372ib00010':['jm000372ib00010_1'],'jm000372ib00011':['jm000372ib00011_1'],'jm000372ib00012':['jm000372ib00012_1'],'jm000372ib00013':['jm000372ib00013_1'],'jm000372ib00014':['jm000372ib00014_1'],'jm000372ib00015':['jm000372ib00015_1'],'jm000372ib00016':['jm000372ib00016_1'],'jm000372ib00017':['jm000372ib00017_1'],'jm000372ib00018':['jm000372ib00018_1'],'jm000372ib00019':['jm000372ib00019_1'],'jm000372ib00020':['jm000372ib00020_1'],'jm000372ib00021':['jm000372ib00021_1'],'jm000372ib00022':['jm000372ib00022_1'],'jm000372ib00023':['jm000372ib00023_1'],'jm000372ib00024':['jm000372ib00024_1']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 69 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hiroyuki  Kimura</span>, <span class="hlFld-ContribAuthor ">Haruka  Okuda</span>, <span class="hlFld-ContribAuthor ">Masumi  Ishiguro</span>, <span class="hlFld-ContribAuthor ">Kenji  Arimitsu</span>, <span class="hlFld-ContribAuthor ">Akira  Makino</span>, <span class="hlFld-ContribAuthor ">Ryuichi  Nishii</span>, <span class="hlFld-ContribAuthor ">Anna  Miyazaki</span>, <span class="hlFld-ContribAuthor ">Yusuke  Yagi</span>, <span class="hlFld-ContribAuthor ">Hiroyuki  Watanabe</span>, <span class="hlFld-ContribAuthor ">Ikuo  Kawasaki</span>, <span class="hlFld-ContribAuthor ">Masahiro  Ono</span>, and <span class="hlFld-ContribAuthor ">Hideo  Saji</span>  . </span><span class="cited-content_cbyCitation_article-title">18F-Labeled Pyrido[3,4-d]pyrimidine as an Effective Probe for Imaging of L858R Mutant Epidermal Growth Factor Receptor. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>8 </em>
                                    (4)
                                     , 418-422. <a href="https://doi.org/10.1021/acsmedchemlett.6b00520" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.6b00520</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.6b00520&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.6b00520%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3D18F-Labeled%252BPyrido%25255B3%25252C4-d%25255Dpyrimidine%252Bas%252Ban%252BEffective%252BProbe%252Bfor%252BImaging%252Bof%252BL858R%252BMutant%252BEpidermal%252BGrowth%252BFactor%252BReceptor%26aulast%3DKimura%26aufirst%3DHiroyuki%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D28122016%26date%3D20032017%26date%3D31032017%26date%3D13042017%26date%3D20032017%26volume%3D8%26issue%3D4%26spage%3D418%26epage%3D422" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jeff B.  Smaill</span>, <span class="hlFld-ContribAuthor ">Andrea J.  Gonzales</span>, <span class="hlFld-ContribAuthor ">Julie A.  Spicer</span>, <span class="hlFld-ContribAuthor ">Helen  Lee</span>, <span class="hlFld-ContribAuthor ">Jessica E.  Reed</span>, <span class="hlFld-ContribAuthor ">Karen  Sexton</span>, <span class="hlFld-ContribAuthor ">Irene W.  Althaus</span>, <span class="hlFld-ContribAuthor ">Tong  Zhu</span>, <span class="hlFld-ContribAuthor ">Shannon L.  Black</span>, <span class="hlFld-ContribAuthor ">Adrian  Blaser</span>, <span class="hlFld-ContribAuthor ">William A.  Denny</span>, <span class="hlFld-ContribAuthor ">Paul A.  Ellis</span>, <span class="hlFld-ContribAuthor ">Stephen  Fakhoury</span>, <span class="hlFld-ContribAuthor ">Patricia J.  Harvey</span>, <span class="hlFld-ContribAuthor ">Ken  Hook</span>, <span class="hlFld-ContribAuthor ">Florence O. J.  McCarthy</span>, <span class="hlFld-ContribAuthor ">Brian D.  Palmer</span>, <span class="hlFld-ContribAuthor ">Freddy  Rivault</span>, <span class="hlFld-ContribAuthor ">Kevin  Schlosser</span>, <span class="hlFld-ContribAuthor ">Teresa  Ellis</span>, <span class="hlFld-ContribAuthor ">Andrew M.  Thompson</span>, <span class="hlFld-ContribAuthor ">Erin  Trachet</span>, <span class="hlFld-ContribAuthor ">R. Thomas  Winters</span>, <span class="hlFld-ContribAuthor ">Haile  Tecle</span>, and <span class="hlFld-ContribAuthor ">Alexander  Bridges</span>  . </span><span class="cited-content_cbyCitation_article-title">Tyrosine Kinase Inhibitors. 20. Optimization of Substituted Quinazoline and Pyrido[3,4-d]pyrimidine Derivatives as Orally Active, Irreversible Inhibitors of the Epidermal Growth Factor Receptor Family. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (17)
                                     , 8103-8124. <a href="https://doi.org/10.1021/acs.jmedchem.6b00883" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00883</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00883&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00883%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTyrosine%252BKinase%252BInhibitors.%252B20.%252BOptimization%252Bof%252BSubstituted%252BQuinazoline%252Band%252BPyrido%25255B3%25252C4-d%25255Dpyrimidine%252BDerivatives%252Bas%252BOrally%252BActive%25252C%252BIrreversible%252BInhibitors%252Bof%252Bthe%252BEpidermal%252BGrowth%252BFactor%252BReceptor%252BFamily%26aulast%3DSmaill%26aufirst%3DJeff%2BB.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D15062016%26date%3D22082016%26date%3D08092016%26date%3D04082016%26volume%3D59%26issue%3D17%26spage%3D8103%26epage%3D8124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu  Zhou</span>, <span class="hlFld-ContribAuthor ">Jiang  Wang</span>, <span class="hlFld-ContribAuthor ">Zhanni  Gu</span>, <span class="hlFld-ContribAuthor ">Shuni  Wang</span>, <span class="hlFld-ContribAuthor ">Wei  Zhu</span>, <span class="hlFld-ContribAuthor ">José Luis  Aceña</span>, <span class="hlFld-ContribAuthor ">Vadim A.  Soloshonok</span>, <span class="hlFld-ContribAuthor ">Kunisuke  Izawa</span>, and <span class="hlFld-ContribAuthor ">Hong  Liu</span>  . </span><span class="cited-content_cbyCitation_article-title">Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2016,</strong> <em>116 </em>
                                    (2)
                                     , 422-518. <a href="https://doi.org/10.1021/acs.chemrev.5b00392" title="DOI URL">https://doi.org/10.1021/acs.chemrev.5b00392</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.5b00392&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.5b00392%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DNext%252BGeneration%252Bof%252BFluorine-Containing%252BPharmaceuticals%25252C%252BCompounds%252BCurrently%252Bin%252BPhase%252BII%2525E2%252580%252593III%252BClinical%252BTrials%252Bof%252BMajor%252BPharmaceutical%252BCompanies%25253A%252BNew%252BStructural%252BTrends%252Band%252BTherapeutic%252BAreas%26aulast%3DZhou%26aufirst%3DYu%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D06072015%26date%3D12012016%26date%3D27012016%26volume%3D116%26issue%3D2%26spage%3D422%26epage%3D518" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor "> Jessica E.    Reed </span><span class="hlFld-ContribAuthor "> Jeff B.    Smaill </span>. </span><span class="cited-content_cbyCitation_article-title">The Discovery of Dacomitinib, a Potent Irreversible EGFR Inhibitor. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 207-233. <a href="https://doi.org/10.1021/bk-2016-1239.ch008" title="DOI URL">https://doi.org/10.1021/bk-2016-1239.ch008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/bk-2016-1239.ch008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fbk-2016-1239.ch008%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BDiscovery%252Bof%252BDacomitinib%25252C%252Ba%252BPotent%252BIrreversible%252BEGFR%252BInhibitor%26aulast%3DReed%26aufirst%3DJessica%2BE.%26date%3D2016%26date%3D2016%26spage%3D207%26epage%3D233%26atitle%3DComprehensive%252BAccounts%252Bof%252BPharmaceutical%252BResearch%252Band%252BDevelopment%25253A%252BFrom%252BDiscovery%252Bto%252BLate-Stage%252BProcess%252BDevelopment%252BVolume%252B1%26aulast%3DAbdel-Magid%26aufirst%3DAhmed%2BF.%26date%3D2016%26date%3D2016%26volume%3D1239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei  Zhou</span>, <span class="hlFld-ContribAuthor ">Xiaofeng  Liu</span>, <span class="hlFld-ContribAuthor ">Zhengchao  Tu</span>, <span class="hlFld-ContribAuthor ">Lianwen  Zhang</span>, <span class="hlFld-ContribAuthor ">Xin  Ku</span>, <span class="hlFld-ContribAuthor ">Fang  Bai</span>, <span class="hlFld-ContribAuthor ">Zhenjiang  Zhao</span>, <span class="hlFld-ContribAuthor ">Yufang  Xu</span>, <span class="hlFld-ContribAuthor ">Ke  Ding</span>, and <span class="hlFld-ContribAuthor ">Honglin  Li</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Pteridin-7(8H)-one-Based Irreversible Inhibitors Targeting the Epidermal Growth Factor Receptor (EGFR) Kinase T790M/L858R Mutant. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (20)
                                     , 7821-7837. <a href="https://doi.org/10.1021/jm401045n" title="DOI URL">https://doi.org/10.1021/jm401045n</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm401045n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm401045n%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BPteridin-7%2525288H%252529-one-Based%252BIrreversible%252BInhibitors%252BTargeting%252Bthe%252BEpidermal%252BGrowth%252BFactor%252BReceptor%252B%252528EGFR%252529%252BKinase%252BT790M%25252FL858R%252BMutant%26aulast%3DZhou%26aufirst%3DWei%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D03042013%26date%3D09102013%26date%3D24102013%26date%3D22092013%26volume%3D56%26issue%3D20%26spage%3D7821%26epage%3D7837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jianwei  Wu</span>, <span class="hlFld-ContribAuthor ">Wenteng  Chen</span>, <span class="hlFld-ContribAuthor ">Guangxin  Xia</span>, <span class="hlFld-ContribAuthor ">Jing  Zhang</span>, <span class="hlFld-ContribAuthor ">Jiaan  Shao</span>, <span class="hlFld-ContribAuthor ">Biqin  Tan</span>, <span class="hlFld-ContribAuthor ">Chunchun  Zhang</span>, <span class="hlFld-ContribAuthor ">Wanwan  Yu</span>, <span class="hlFld-ContribAuthor ">Qinjie  Weng</span>, <span class="hlFld-ContribAuthor ">Haiyan  Liu</span>, <span class="hlFld-ContribAuthor ">Miao  Hu</span>, <span class="hlFld-ContribAuthor ">Hailin  Deng</span>, <span class="hlFld-ContribAuthor ">Yu  Hao</span>, <span class="hlFld-ContribAuthor ">Jingkang  Shen</span>, and <span class="hlFld-ContribAuthor ">Yongping  Yu</span>  . </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Biological Evaluation of Novel Conformationally Constrained Inhibitors Targeting EGFR. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>4 </em>
                                    (10)
                                     , 974-978. <a href="https://doi.org/10.1021/ml4002437" title="DOI URL">https://doi.org/10.1021/ml4002437</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml4002437&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml4002437%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BBiological%252BEvaluation%252Bof%252BNovel%252BConformationally%252BConstrained%252BInhibitors%252BTargeting%252BEGFR%26aulast%3DWu%26aufirst%3DJianwei%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D27062013%26date%3D06082013%26date%3D09082013%26date%3D10102013%26date%3D06082013%26volume%3D4%26issue%3D10%26spage%3D974%26epage%3D978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shaohua  Chang</span>, <span class="hlFld-ContribAuthor ">Lianwen  Zhang</span>, <span class="hlFld-ContribAuthor ">Shilin  Xu</span>, <span class="hlFld-ContribAuthor ">Jinfeng  Luo</span>, <span class="hlFld-ContribAuthor ">Xiaoyun  Lu</span>, <span class="hlFld-ContribAuthor ">Zhang  Zhang</span>, <span class="hlFld-ContribAuthor ">Tianfeng  Xu</span>, <span class="hlFld-ContribAuthor ">Yingxue  Liu</span>, <span class="hlFld-ContribAuthor ">Zhengchao  Tu</span>, <span class="hlFld-ContribAuthor ">Yong  Xu</span>, <span class="hlFld-ContribAuthor ">Xiaomei  Ren</span>, <span class="hlFld-ContribAuthor ">Meiyu  Geng</span>, <span class="hlFld-ContribAuthor ">Jian  Ding</span>, <span class="hlFld-ContribAuthor ">Duanqing  Pei</span>, and <span class="hlFld-ContribAuthor ">Ke  Ding</span>  . </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Biological Evaluation of Novel Conformationally Constrained Inhibitors Targeting Epidermal Growth Factor Receptor Threonine790 → Methionine790 Mutant. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (6)
                                     , 2711-2723. <a href="https://doi.org/10.1021/jm201591k" title="DOI URL">https://doi.org/10.1021/jm201591k</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm201591k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm201591k%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BBiological%252BEvaluation%252Bof%252BNovel%252BConformationally%252BConstrained%252BInhibitors%252BTargeting%252BEpidermal%252BGrowth%252BFactor%252BReceptor%252BThreonine790%252B%2525E2%252586%252592%252BMethionine790%252BMutant%26aulast%3DChang%26aufirst%3DShaohua%26date%3D2012%26date%3D2012%26date%3D2011%26date%3D25112011%26date%3D01032012%26date%3D22032012%26date%3D16022012%26volume%3D55%26issue%3D6%26spage%3D2711%26epage%3D2723" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Caterina  Carmi</span>, <span class="hlFld-ContribAuthor ">Elena  Galvani</span>, <span class="hlFld-ContribAuthor ">Federica  Vacondio</span>, <span class="hlFld-ContribAuthor ">Silvia  Rivara</span>, <span class="hlFld-ContribAuthor ">Alessio  Lodola</span>, <span class="hlFld-ContribAuthor ">Simonetta  Russo</span>, <span class="hlFld-ContribAuthor ">Stefania  Aiello</span>, <span class="hlFld-ContribAuthor ">Fabrizio  Bordi</span>, <span class="hlFld-ContribAuthor ">Gabriele  Costantino</span>, <span class="hlFld-ContribAuthor ">Andrea  Cavazzoni</span>, <span class="hlFld-ContribAuthor ">Roberta R.  Alfieri</span>, <span class="hlFld-ContribAuthor ">Andrea  Ardizzoni</span>, <span class="hlFld-ContribAuthor ">Pier Giorgio  Petronini</span>, and <span class="hlFld-ContribAuthor ">Marco  Mor</span>  . </span><span class="cited-content_cbyCitation_article-title">Irreversible Inhibition of Epidermal Growth Factor Receptor Activity by 3-Aminopropanamides. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (5)
                                     , 2251-2264. <a href="https://doi.org/10.1021/jm201507x" title="DOI URL">https://doi.org/10.1021/jm201507x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm201507x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm201507x%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIrreversible%252BInhibition%252Bof%252BEpidermal%252BGrowth%252BFactor%252BReceptor%252BActivity%252Bby%252B3-Aminopropanamides%26aulast%3DCarmi%26aufirst%3DCaterina%26date%3D2012%26date%3D2012%26date%3D2011%26date%3D08112011%26date%3D17022012%26date%3D08032012%26date%3D26012012%26volume%3D55%26issue%3D5%26spage%3D2251%26epage%3D2264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Caterina  Carmi</span>, <span class="hlFld-ContribAuthor ">Andrea  Cavazzoni</span>, <span class="hlFld-ContribAuthor ">Stefano  Vezzosi</span>, <span class="hlFld-ContribAuthor ">Fabrizio  Bordi</span>, <span class="hlFld-ContribAuthor ">Federica  Vacondio</span>, <span class="hlFld-ContribAuthor ">Claudia  Silva</span>, <span class="hlFld-ContribAuthor ">Silvia  Rivara</span>, <span class="hlFld-ContribAuthor ">Alessio  Lodola</span>, <span class="hlFld-ContribAuthor ">Roberta R.  Alfieri</span>, <span class="hlFld-ContribAuthor ">Silvia  La Monica</span>, <span class="hlFld-ContribAuthor ">Maricla  Galetti</span>, <span class="hlFld-ContribAuthor ">Andrea  Ardizzoni</span>, <span class="hlFld-ContribAuthor ">Pier Giorgio  Petronini</span> and <span class="hlFld-ContribAuthor ">Marco  Mor</span>  . </span><span class="cited-content_cbyCitation_article-title">Novel Irreversible Epidermal Growth Factor Receptor Inhibitors by Chemical Modulation of the Cysteine-Trap Portion. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2010,</strong> <em>53 </em>
                                    (5)
                                     , 2038-2050. <a href="https://doi.org/10.1021/jm901558p" title="DOI URL">https://doi.org/10.1021/jm901558p</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm901558p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm901558p%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252BIrreversible%252BEpidermal%252BGrowth%252BFactor%252BReceptor%252BInhibitors%252Bby%252BChemical%252BModulation%252Bof%252Bthe%252BCysteine-Trap%252BPortion%26aulast%3DCarmi%26aufirst%3DCaterina%26date%3D2010%26date%3D2010%26date%3D2009%26date%3D21102009%26date%3D12022010%26date%3D11032010%26volume%3D53%26issue%3D5%26spage%3D2038%26epage%3D2050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mi Young  Cha</span>, <span class="hlFld-ContribAuthor ">Kwang-Ok  Lee</span>, <span class="hlFld-ContribAuthor ">Jong Woo  Kim</span>, <span class="hlFld-ContribAuthor ">Chang Gon  Lee</span>, <span class="hlFld-ContribAuthor ">Ji Yeon  Song</span>, <span class="hlFld-ContribAuthor ">Young Hoon  Kim</span>, <span class="hlFld-ContribAuthor ">Gwan Sun  Lee</span>, <span class="hlFld-ContribAuthor ">Seung Bum  Park</span> and <span class="hlFld-ContribAuthor ">Maeng Sup  Kim</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of A Novel Her-1/Her-2 Dual Tyrosine Kinase Inhibitor for the Treatment of Her-1 Selective Inhibitor-Resistant Non-small Cell Lung Cancer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2009,</strong> <em>52 </em>
                                    (21)
                                     , 6880-6888. <a href="https://doi.org/10.1021/jm901146p" title="DOI URL">https://doi.org/10.1021/jm901146p</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm901146p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm901146p%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BA%252BNovel%252BHer-1%25252FHer-2%252BDual%252BTyrosine%252BKinase%252BInhibitor%252Bfor%252Bthe%252BTreatment%252Bof%252BHer-1%252BSelective%252BInhibitor-Resistant%252BNon-small%252BCell%252BLung%252BCancer%26aulast%3DCha%26aufirst%3DMi%2BYoung%26date%3D2009%26date%3D2009%26date%3D2009%26date%3D31072009%26date%3D15102009%26date%3D12112009%26volume%3D52%26issue%3D21%26spage%3D6880%26epage%3D6888" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Concettina  La Motta</span>, <span class="hlFld-ContribAuthor ">Stefania  Sartini</span>, <span class="hlFld-ContribAuthor ">Tiziano  Tuccinardi</span>, <span class="hlFld-ContribAuthor ">Erika  Nerini</span>, <span class="hlFld-ContribAuthor ">Federico  Da Settimo</span> and <span class="hlFld-ContribAuthor ">Adriano  Martinelli</span>. </span><span class="cited-content_cbyCitation_article-title">Computational Studies of Epidermal Growth Factor Receptor: Docking Reliability, Three-Dimensional Quantitative Structure−Activity Relationship Analysis, and Virtual Screening Studies. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2009,</strong> <em>52 </em>
                                    (4)
                                     , 964-975. <a href="https://doi.org/10.1021/jm800829v" title="DOI URL">https://doi.org/10.1021/jm800829v</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm800829v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm800829v%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DComputational%252BStudies%252Bof%252BEpidermal%252BGrowth%252BFactor%252BReceptor%25253A%252BDocking%252BReliability%25252C%252BThree-Dimensional%252BQuantitative%252BStructure%2525E2%252588%252592Activity%252BRelationship%252BAnalysis%25252C%252Band%252BVirtual%252BScreening%252BStudies%26aulast%3DLa%2BMotta%26aufirst%3DConcettina%26date%3D2009%26date%3D2009%26date%3D2008%26date%3D26%252002%25202009%26date%3D26%252001%25202009%26date%3D8%252007%25202008%26volume%3D52%26issue%3D4%26spage%3D964%26epage%3D975" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rambabu  Gundla</span>, <span class="hlFld-ContribAuthor ">Roza  Kazemi</span>, <span class="hlFld-ContribAuthor ">Ramadevi  Sanam</span>, <span class="hlFld-ContribAuthor ">Ravikumar  Muttineni</span>, <span class="hlFld-ContribAuthor ">Jagarlapudi A. R. P.  Sarma</span>, <span class="hlFld-ContribAuthor ">Raveendra  Dayam</span> and <span class="hlFld-ContribAuthor ">Nouri  Neamati</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Novel Small-Molecule Inhibitors of Human Epidermal Growth Factor Receptor-2: Combined Ligand and Target-Based Approach. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2008,</strong> <em>51 </em>
                                    (12)
                                     , 3367-3377. <a href="https://doi.org/10.1021/jm7013875" title="DOI URL">https://doi.org/10.1021/jm7013875</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm7013875&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm7013875%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BNovel%252BSmall-Molecule%252BInhibitors%252Bof%252BHuman%252BEpidermal%252BGrowth%252BFactor%252BReceptor-2%25253A%252BCombined%252BLigand%252Band%252BTarget-Based%252BApproach%26aulast%3DGundla%26aufirst%3DRambabu%26date%3D2008%26date%3D2008%26date%3D2007%26date%3D26%252006%25202008%26date%3D24%252005%25202008%26date%3D05%252011%25202007%26volume%3D51%26issue%3D12%26spage%3D3367%26epage%3D3377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Alka  Kurup,,   Rajni  Garg, and,   <span class="NLM_string-name hlFld-ContribAuthor">Corwin  Hansch</span>. </span><span class="cited-content_cbyCitation_article-title">Comparative QSAR Study of Tyrosine Kinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2001,</strong> <em>101 </em>
                                    (8)
                                     , 2573-2600. <a href="https://doi.org/10.1021/cr010154c" title="DOI URL">https://doi.org/10.1021/cr010154c</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cr010154c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcr010154c%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DComparative%252BQSAR%252BStudy%252Bof%252BTyrosine%252BKinase%252BInhibitors%26aulast%3DKurup%26aufirst%3DAlka%26date%3D2001%26date%3D2001%26date%3D2001%26date%3D19%252004%25202001%2520Received%2520April%252019%252C%25202001%26volume%3D101%26issue%3D8%26spage%3D2573%26epage%3D2600" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alan J.  Cameron</span>, <span class="hlFld-ContribAuthor ">Paul W. R.  Harris</span>, <span class="hlFld-ContribAuthor ">Margaret A.  Brimble</span>. </span><span class="cited-content_cbyCitation_article-title">On‐Resin Preparation of Allenamidyl Peptides: A Versatile Chemoselective Conjugation and Intramolecular Cyclisation Tool. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2020,</strong> <em>132 </em>
                                    (41)
                                     , 18210-18217. <a href="https://doi.org/10.1002/ange.202004656" title="DOI URL">https://doi.org/10.1002/ange.202004656</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.202004656&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.202004656%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DOn%2525E2%252580%252590Resin%252BPreparation%252Bof%252BAllenamidyl%252BPeptides%25253A%252BA%252BVersatile%252BChemoselective%252BConjugation%252Band%252BIntramolecular%252BCyclisation%252BTool%26aulast%3DCameron%26aufirst%3DAlan%2BJ.%26date%3D2020%26date%3D2020%26volume%3D132%26issue%3D41%26spage%3D18210%26epage%3D18217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alan J.  Cameron</span>, <span class="hlFld-ContribAuthor ">Paul W. R.  Harris</span>, <span class="hlFld-ContribAuthor ">Margaret A.  Brimble</span>. </span><span class="cited-content_cbyCitation_article-title">On‐Resin Preparation of Allenamidyl Peptides: A Versatile Chemoselective Conjugation and Intramolecular Cyclisation Tool. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2020,</strong> <em>59 </em>
                                    (41)
                                     , 18054-18061. <a href="https://doi.org/10.1002/anie.202004656" title="DOI URL">https://doi.org/10.1002/anie.202004656</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.202004656&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.202004656%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DOn%2525E2%252580%252590Resin%252BPreparation%252Bof%252BAllenamidyl%252BPeptides%25253A%252BA%252BVersatile%252BChemoselective%252BConjugation%252Band%252BIntramolecular%252BCyclisation%252BTool%26aulast%3DCameron%26aufirst%3DAlan%2BJ.%26date%3D2020%26date%3D2020%26volume%3D59%26issue%3D41%26spage%3D18054%26epage%3D18061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">N. A.  Seebacher</span>, <span class="hlFld-ContribAuthor ">A. E.  Stacy</span>, <span class="hlFld-ContribAuthor ">G. M.  Porter</span>, <span class="hlFld-ContribAuthor ">A. M.  Merlot</span>. </span><span class="cited-content_cbyCitation_article-title">Clinical development of targeted and immune based anti-cancer therapies. </span><span class="cited-content_cbyCitation_journal-name">Journal of Experimental & Clinical Cancer Research</span><span> <strong>2019,</strong> <em>38 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13046-019-1094-2" title="DOI URL">https://doi.org/10.1186/s13046-019-1094-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13046-019-1094-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13046-019-1094-2%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Experimental%2520%2526%2520Clinical%2520Cancer%2520Research%26atitle%3DClinical%252Bdevelopment%252Bof%252Btargeted%252Band%252Bimmune%252Bbased%252Banti-cancer%252Btherapies%26aulast%3DSeebacher%26aufirst%3DN.%2BA.%26date%3D2019%26date%3D2019%26volume%3D38%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohamed  Monier</span>, <span class="hlFld-ContribAuthor ">Doaa  Abdel-Latif</span>, <span class="hlFld-ContribAuthor ">Ahmed  El-Mekabaty</span>, <span class="hlFld-ContribAuthor ">Başak D.  Mert</span>, <span class="hlFld-ContribAuthor ">Khaled M.  Elattar</span>. </span><span class="cited-content_cbyCitation_article-title">Advances in the Chemistry of 6-6 Bicyclic Systems: Chemistry of Pyrido[3,4- d]pyrimidines. </span><span class="cited-content_cbyCitation_journal-name">Current Organic Synthesis</span><span> <strong>2019,</strong> <em>16 </em>
                                    (6)
                                     , 812-854. <a href="https://doi.org/10.2174/1570179416666190704113647" title="DOI URL">https://doi.org/10.2174/1570179416666190704113647</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1570179416666190704113647&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1570179416666190704113647%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Organic%2520Synthesis%26atitle%3DAdvances%252Bin%252Bthe%252BChemistry%252Bof%252B6-6%252BBicyclic%252BSystems%25253A%252BChemistry%252Bof%252BPyrido%25255B3%25252C4-%252Bd%25255Dpyrimidines%26aulast%3DMonier%26aufirst%3DMohamed%26date%3D2019%26volume%3D16%26issue%3D6%26spage%3D812%26epage%3D854" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yang  Li</span>, <span class="hlFld-ContribAuthor ">Jie  Xiao</span>, <span class="hlFld-ContribAuthor ">Qizhi  Zhang</span>, <span class="hlFld-ContribAuthor ">Wenmei  Yu</span>, <span class="hlFld-ContribAuthor ">Mengqin  Liu</span>, <span class="hlFld-ContribAuthor ">Yu  Guo</span>, <span class="hlFld-ContribAuthor ">Jun  He</span>, <span class="hlFld-ContribAuthor ">Yunmei  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">The association between anti-tumor potency and structure-activity of protein-kinases inhibitors based on quinazoline molecular skeleton. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2019,</strong> <em>27 </em>
                                    (3)
                                     , 568-577. <a href="https://doi.org/10.1016/j.bmc.2018.12.032" title="DOI URL">https://doi.org/10.1016/j.bmc.2018.12.032</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2018.12.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2018.12.032%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DThe%252Bassociation%252Bbetween%252Banti-tumor%252Bpotency%252Band%252Bstructure-activity%252Bof%252Bprotein-kinases%252Binhibitors%252Bbased%252Bon%252Bquinazoline%252Bmolecular%252Bskeleton%26aulast%3DLi%26aufirst%3DYang%26date%3D2019%26volume%3D27%26issue%3D3%26spage%3D568%26epage%3D577" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Poojali P.  Warekar</span>, <span class="hlFld-ContribAuthor ">Kirti T.  Patil</span>, <span class="hlFld-ContribAuthor ">Priyanka T.  Patil</span>, <span class="hlFld-ContribAuthor ">Aniket P.  Sarkate</span>, <span class="hlFld-ContribAuthor ">Kshipra S.  Karnik</span>, <span class="hlFld-ContribAuthor ">Santosh S.  Undare</span>, <span class="hlFld-ContribAuthor ">Govind B.  Kolekar</span>, <span class="hlFld-ContribAuthor ">Madhukar B.  Deshmukh</span>, <span class="hlFld-ContribAuthor ">Shivadatta  Prabhu</span>, <span class="hlFld-ContribAuthor ">Prashant. V.  Anbhule</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of some new piritrexim analogs as potential anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">Research on Chemical Intermediates</span><span> <strong>2018,</strong> <em>44 </em>
                                    (2)
                                     , 749-767. <a href="https://doi.org/10.1007/s11164-017-3132-z" title="DOI URL">https://doi.org/10.1007/s11164-017-3132-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11164-017-3132-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11164-017-3132-z%26sid%3Dliteratum%253Aachs%26jtitle%3DResearch%2520on%2520Chemical%2520Intermediates%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Bsome%252Bnew%252Bpiritrexim%252Banalogs%252Bas%252Bpotential%252Banticancer%252Bagents%26aulast%3DWarekar%26aufirst%3DPoojali%2BP.%26date%3D2018%26date%3D2017%26volume%3D44%26issue%3D2%26spage%3D749%26epage%3D767" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Weiwei  Han</span>, <span class="hlFld-ContribAuthor ">Yongli  Du</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Development of the Second and Third Generation Irreversible Epidermal Growth Factor Receptor Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Chemistry & Biodiversity</span><span> <strong>2017,</strong> <em>14 </em>
                                    (7)
                                     , e1600372. <a href="https://doi.org/10.1002/cbdv.201600372" title="DOI URL">https://doi.org/10.1002/cbdv.201600372</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cbdv.201600372&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcbdv.201600372%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%2526%2520Biodiversity%26atitle%3DRecent%252BDevelopment%252Bof%252Bthe%252BSecond%252Band%252BThird%252BGeneration%252BIrreversible%252BEpidermal%252BGrowth%252BFactor%252BReceptor%252BInhibitors%26aulast%3DHan%26aufirst%3DWeiwei%26date%3D2017%26date%3D2017%26volume%3D14%26issue%3D7%26spage%3De1600372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pankaj Kumar  Singh</span>, <span class="hlFld-ContribAuthor ">Om  Silakari</span>. </span><span class="cited-content_cbyCitation_article-title">Novel EGFR (T790M)-cMET dual inhibitors: putative therapeutic agents for non-small-cell lung cancer. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2017,</strong> <em>9 </em>
                                    (5)
                                     , 469-483. <a href="https://doi.org/10.4155/fmc-2016-0234" title="DOI URL">https://doi.org/10.4155/fmc-2016-0234</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2016-0234&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2016-0234%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DNovel%252BEGFR%252B%252528T790M%252529-cMET%252Bdual%252Binhibitors%25253A%252Bputative%252Btherapeutic%252Bagents%252Bfor%252Bnon-small-cell%252Blung%252Bcancer%26aulast%3DSingh%26aufirst%3DPankaj%2BKumar%26date%3D2017%26volume%3D9%26issue%3D5%26spage%3D469%26epage%3D483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">P. K.  Singh</span>, <span class="hlFld-ContribAuthor ">O.  Silakari</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular dynamics and pharmacophore modelling studies of different subtype (ALK and EGFR (T790M)) inhibitors in NSCLC. </span><span class="cited-content_cbyCitation_journal-name">SAR and QSAR in Environmental Research</span><span> <strong>2017,</strong> <em>28 </em>
                                    (3)
                                     , 221-233. <a href="https://doi.org/10.1080/1062936X.2017.1300189" title="DOI URL">https://doi.org/10.1080/1062936X.2017.1300189</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/1062936X.2017.1300189&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F1062936X.2017.1300189%26sid%3Dliteratum%253Aachs%26jtitle%3DSAR%2520and%2520QSAR%2520in%2520Environmental%2520Research%26atitle%3DMolecular%252Bdynamics%252Band%252Bpharmacophore%252Bmodelling%252Bstudies%252Bof%252Bdifferent%252Bsubtype%252B%252528ALK%252Band%252BEGFR%252B%252528T790M%252529%252529%252Binhibitors%252Bin%252BNSCLC%26aulast%3DSingh%26aufirst%3DP.%2BK.%26date%3D2017%26date%3D2017%26volume%3D28%26issue%3D3%26spage%3D221%26epage%3D233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jing  Yang</span>, <span class="hlFld-ContribAuthor ">Zhengchao  Tu</span>, <span class="hlFld-ContribAuthor ">Xin  Xu</span>, <span class="hlFld-ContribAuthor ">Jinfeng  Luo</span>, <span class="hlFld-ContribAuthor ">Xing  Yan</span>, <span class="hlFld-ContribAuthor ">Chongzhao  Ran</span>, <span class="hlFld-ContribAuthor ">Xinliang  Mao</span>, <span class="hlFld-ContribAuthor ">Ke  Ding</span>, <span class="hlFld-ContribAuthor ">Chunhua  Qiao</span>. </span><span class="cited-content_cbyCitation_article-title">Novel conjugates of endoperoxide and 4-anilinoquinazoline as potential anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (6)
                                     , 1341-1345. <a href="https://doi.org/10.1016/j.bmcl.2017.02.023" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.02.023</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.02.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.02.023%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DNovel%252Bconjugates%252Bof%252Bendoperoxide%252Band%252B4-anilinoquinazoline%252Bas%252Bpotential%252Banticancer%252Bagents%26aulast%3DYang%26aufirst%3DJing%26date%3D2017%26volume%3D27%26issue%3D6%26spage%3D1341%26epage%3D1345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dhrubajyoti  Gogoi</span>, <span class="hlFld-ContribAuthor ">Vishwa Jyoti  Baruah</span>, <span class="hlFld-ContribAuthor ">Amrita Kashyap  Chaliha</span>, <span class="hlFld-ContribAuthor ">Bibhuti Bhushan  Kakoti</span>, <span class="hlFld-ContribAuthor ">Diganta  Sarma</span>, <span class="hlFld-ContribAuthor ">Alak Kumar  Buragohain</span>. </span><span class="cited-content_cbyCitation_article-title">3D pharmacophore-based virtual screening, docking and density functional theory approach towards the discovery of novel human epidermal growth factor receptor-2 (HER2) inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Theoretical Biology</span><span> <strong>2016,</strong> <em>411 </em>, 68-80. <a href="https://doi.org/10.1016/j.jtbi.2016.09.016" title="DOI URL">https://doi.org/10.1016/j.jtbi.2016.09.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jtbi.2016.09.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jtbi.2016.09.016%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Theoretical%2520Biology%26atitle%3D3D%252Bpharmacophore-based%252Bvirtual%252Bscreening%25252C%252Bdocking%252Band%252Bdensity%252Bfunctional%252Btheory%252Bapproach%252Btowards%252Bthe%252Bdiscovery%252Bof%252Bnovel%252Bhuman%252Bepidermal%252Bgrowth%252Bfactor%252Breceptor-2%252B%252528HER2%252529%252Binhibitors%26aulast%3DGogoi%26aufirst%3DDhrubajyoti%26date%3D2016%26volume%3D411%26spage%3D68%26epage%3D80" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jie  Hu</span>, <span class="hlFld-ContribAuthor ">Yali  Zhang</span>, <span class="hlFld-ContribAuthor ">Lili  Dong</span>, <span class="hlFld-ContribAuthor ">Zhe  Wang</span>, <span class="hlFld-ContribAuthor ">Lingfeng  Chen</span>, <span class="hlFld-ContribAuthor ">Dandan  Liang</span>, <span class="hlFld-ContribAuthor ">Dengjian  Shi</span>, <span class="hlFld-ContribAuthor ">Xiaoou  Shan</span>, <span class="hlFld-ContribAuthor ">Guang  Liang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Biological Evaluation of Novel Quinazoline Derivatives as Anti-inflammatory Agents against Lipopolysaccharide-induced Acute Lung Injury in Rats. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2015,</strong> <em>85 </em>
                                    (6)
                                     , 672-684. <a href="https://doi.org/10.1111/cbdd.12454" title="DOI URL">https://doi.org/10.1111/cbdd.12454</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.12454&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.12454%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BBiological%252BEvaluation%252Bof%252BNovel%252BQuinazoline%252BDerivatives%252Bas%252BAnti-inflammatory%252BAgents%252Bagainst%252BLipopolysaccharide-induced%252BAcute%252BLung%252BInjury%252Bin%252BRats%26aulast%3DHu%26aufirst%3DJie%26date%3D2015%26date%3D2014%26volume%3D85%26issue%3D6%26spage%3D672%26epage%3D684" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Richard  Schroeder</span>, <span class="hlFld-ContribAuthor ">Cheryl  Stevens</span>, <span class="hlFld-ContribAuthor ">Jayalakshmi  Sridhar</span>. </span><span class="cited-content_cbyCitation_article-title">Small Molecule Tyrosine Kinase Inhibitors of ErbB2/HER2/Neu in the Treatment of Aggressive Breast Cancer. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2014,</strong> <em>19 </em>
                                    (9)
                                     , 15196-15212. <a href="https://doi.org/10.3390/molecules190915196" title="DOI URL">https://doi.org/10.3390/molecules190915196</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules190915196&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules190915196%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DSmall%252BMolecule%252BTyrosine%252BKinase%252BInhibitors%252Bof%252BErbB2%25252FHER2%25252FNeu%252Bin%252Bthe%252BTreatment%252Bof%252BAggressive%252BBreast%252BCancer%26aulast%3DSchroeder%26aufirst%3DRichard%26date%3D2014%26date%3D2014%26volume%3D19%26issue%3D9%26spage%3D15196%26epage%3D15212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiu L.  Yang</span>, <span class="hlFld-ContribAuthor ">Tian C.  Wang</span>, <span class="hlFld-ContribAuthor ">Sen  Lin</span>, <span class="hlFld-ContribAuthor ">Hou X.  Fan</span>. </span><span class="cited-content_cbyCitation_article-title">Irreversible Inhibitors of the Epidermal Growth Factor Receptor: Thienopyrimidine Core with α,β-Unsaturated Amide Side Chain. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2014,</strong> <em>347 </em>
                                    (8)
                                     , 552-558. <a href="https://doi.org/10.1002/ardp.201400098" title="DOI URL">https://doi.org/10.1002/ardp.201400098</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.201400098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.201400098%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3DIrreversible%252BInhibitors%252Bof%252Bthe%252BEpidermal%252BGrowth%252BFactor%252BReceptor%25253A%252BThienopyrimidine%252BCore%252Bwith%252B%2525CE%2525B1%25252C%2525CE%2525B2-Unsaturated%252BAmide%252BSide%252BChain%26aulast%3DYang%26aufirst%3DXiu%2BL.%26date%3D2014%26date%3D2014%26volume%3D347%26issue%3D8%26spage%3D552%26epage%3D558" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ranjan  Behera</span>, <span class="hlFld-ContribAuthor ">Sarah M.  Thomas</span>, <span class="hlFld-ContribAuthor ">Kojo  Mensa-Wilmot</span>. </span><span class="cited-content_cbyCitation_article-title">New Chemical Scaffolds for Human African Trypanosomiasis Lead Discovery from a Screen of Tyrosine Kinase Inhibitor Drugs. </span><span class="cited-content_cbyCitation_journal-name">Antimicrobial Agents and Chemotherapy</span><span> <strong>2014,</strong> <em>58 </em>
                                    (4)
                                     , 2202-2210. <a href="https://doi.org/10.1128/AAC.01691-13" title="DOI URL">https://doi.org/10.1128/AAC.01691-13</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/AAC.01691-13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FAAC.01691-13%26sid%3Dliteratum%253Aachs%26jtitle%3DAntimicrobial%2520Agents%2520and%2520Chemotherapy%26atitle%3DNew%252BChemical%252BScaffolds%252Bfor%252BHuman%252BAfrican%252BTrypanosomiasis%252BLead%252BDiscovery%252Bfrom%252Ba%252BScreen%252Bof%252BTyrosine%252BKinase%252BInhibitor%252BDrugs%26aulast%3DBehera%26aufirst%3DRanjan%26date%3D2014%26date%3D2014%26volume%3D58%26issue%3D4%26spage%3D2202%26epage%3D2210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Feng  Zhao</span>, <span class="hlFld-ContribAuthor ">Zhaohu  Lin</span>, <span class="hlFld-ContribAuthor ">Feng  Wang</span>, <span class="hlFld-ContribAuthor ">Weili  Zhao</span>, <span class="hlFld-ContribAuthor ">Xiaochun  Dong</span>. </span><span class="cited-content_cbyCitation_article-title">Four-membered heterocycles-containing 4-anilino-quinazoline derivatives as epidermal growth factor receptor (EGFR) kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (19)
                                     , 5385-5388. <a href="https://doi.org/10.1016/j.bmcl.2013.07.049" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.07.049</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.07.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.07.049%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DFour-membered%252Bheterocycles-containing%252B4-anilino-quinazoline%252Bderivatives%252Bas%252Bepidermal%252Bgrowth%252Bfactor%252Breceptor%252B%252528EGFR%252529%252Bkinase%252Binhibitors%26aulast%3DZhao%26aufirst%3DFeng%26date%3D2013%26volume%3D23%26issue%3D19%26spage%3D5385%26epage%3D5388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ronald J.  Hill</span>, <span class="hlFld-ContribAuthor ">Yan  Lou</span>, <span class="hlFld-ContribAuthor ">Seng-Lai  Tan</span>. </span><span class="cited-content_cbyCitation_article-title">B-Cell Antigen Receptor Signaling in Chronic Lymphocytic Leukemia: Therapeutic Targets and Translational Opportunities. </span><span class="cited-content_cbyCitation_journal-name">International Reviews of Immunology</span><span> <strong>2013,</strong> <em>32 </em>
                                    (4)
                                     , 377-396. <a href="https://doi.org/10.3109/08830185.2013.818141" title="DOI URL">https://doi.org/10.3109/08830185.2013.818141</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3109/08830185.2013.818141&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3109%2F08830185.2013.818141%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Reviews%2520of%2520Immunology%26atitle%3DB-Cell%252BAntigen%252BReceptor%252BSignaling%252Bin%252BChronic%252BLymphocytic%252BLeukemia%25253A%252BTherapeutic%252BTargets%252Band%252BTranslational%252BOpportunities%26aulast%3DHill%26aufirst%3DRonald%2BJ.%26date%3D2013%26date%3D2013%26volume%3D32%26issue%3D4%26spage%3D377%26epage%3D396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Samar  Mowafy</span>, <span class="hlFld-ContribAuthor ">Nahla A.  Farag</span>, <span class="hlFld-ContribAuthor ">Khaled A.M.  Abouzid</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and in vitro anti-proliferative activity of 4,6-quinazolinediamines as potent EGFR-TK inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>61 </em>, 132-145. <a href="https://doi.org/10.1016/j.ejmech.2012.10.017" title="DOI URL">https://doi.org/10.1016/j.ejmech.2012.10.017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2012.10.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2012.10.017%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bin%2525C2%2525A0vitro%252Banti-proliferative%252Bactivity%252Bof%252B4%25252C6-quinazolinediamines%252Bas%252Bpotent%252BEGFR-TK%252Binhibitors%26aulast%3DMowafy%26aufirst%3DSamar%26date%3D2013%26volume%3D61%26spage%3D132%26epage%3D145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Samiksha  Katiyar</span>, <span class="hlFld-ContribAuthor ">Irina  Kufareva</span>, <span class="hlFld-ContribAuthor ">Ranjan  Behera</span>, <span class="hlFld-ContribAuthor ">Sarah M.  Thomas</span>, <span class="hlFld-ContribAuthor ">Yuko  Ogata</span>, <span class="hlFld-ContribAuthor ">Michael  Pollastri</span>, <span class="hlFld-ContribAuthor ">Ruben  Abagyan</span>, <span class="hlFld-ContribAuthor ">Kojo  Mensa-Wilmot</span>, . </span><span class="cited-content_cbyCitation_article-title">Lapatinib-Binding Protein Kinases in the African Trypanosome: Identification of Cellular Targets for Kinase-Directed Chemical Scaffolds. </span><span class="cited-content_cbyCitation_journal-name">PLoS ONE</span><span> <strong>2013,</strong> <em>8 </em>
                                    (2)
                                     , e56150. <a href="https://doi.org/10.1371/journal.pone.0056150" title="DOI URL">https://doi.org/10.1371/journal.pone.0056150</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0056150&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0056150%26sid%3Dliteratum%253Aachs%26jtitle%3DPLoS%2520ONE%26atitle%3DLapatinib-Binding%252BProtein%252BKinases%252Bin%252Bthe%252BAfrican%252BTrypanosome%25253A%252BIdentification%252Bof%252BCellular%252BTargets%252Bfor%252BKinase-Directed%252BChemical%252BScaffolds%26aulast%3DKatiyar%26aufirst%3DSamiksha%26date%3D2013%26date%3D2013%26volume%3D8%26issue%3D2%26spage%3De56150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jinsheng  Lin</span>, <span class="hlFld-ContribAuthor ">Wei  Shen</span>, <span class="hlFld-ContribAuthor ">Jingwei  Xue</span>, <span class="hlFld-ContribAuthor ">Juan  Sun</span>, <span class="hlFld-ContribAuthor ">Xue  Zhang</span>, <span class="hlFld-ContribAuthor ">Can  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Novel oxazolo[4,5-g]quinazolin-2(1H)-ones: Dual inhibitors of EGFR and Src protein tyrosine kinases. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>, 39-48. <a href="https://doi.org/10.1016/j.ejmech.2012.06.055" title="DOI URL">https://doi.org/10.1016/j.ejmech.2012.06.055</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2012.06.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2012.06.055%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252Boxazolo%25255B4%25252C5-g%25255Dquinazolin-2%2525281H%252529-ones%25253A%252BDual%252Binhibitors%252Bof%252BEGFR%252Band%252BSrc%252Bprotein%252Btyrosine%252Bkinases%26aulast%3DLin%26aufirst%3DJinsheng%26date%3D2012%26volume%3D55%26spage%3D39%26epage%3D48" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mi Young  Cha</span>, <span class="hlFld-ContribAuthor ">Kwang-Ok  Lee</span>, <span class="hlFld-ContribAuthor ">Mira  Kim</span>, <span class="hlFld-ContribAuthor ">Ji Yeon  Song</span>, <span class="hlFld-ContribAuthor ">Kyu Hang  Lee</span>, <span class="hlFld-ContribAuthor ">Jongmin  Park</span>, <span class="hlFld-ContribAuthor ">Yun Jung  Chae</span>, <span class="hlFld-ContribAuthor ">Young Hoon  Kim</span>, <span class="hlFld-ContribAuthor ">Kwee Hyun  Suh</span>, <span class="hlFld-ContribAuthor ">Gwan Sun  Lee</span>, <span class="hlFld-ContribAuthor ">Seung Bum  Park</span>, <span class="hlFld-ContribAuthor ">Maeng Sup  Kim</span>. </span><span class="cited-content_cbyCitation_article-title">Antitumor activity of HM781-36B, a highly effective pan-HER inhibitor in erlotinib-resistant NSCLC and other EGFR-dependent cancer models. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Cancer</span><span> <strong>2012,</strong> <em>130 </em>
                                    (10)
                                     , 2445-2454. <a href="https://doi.org/10.1002/ijc.26276" title="DOI URL">https://doi.org/10.1002/ijc.26276</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ijc.26276&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fijc.26276%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Cancer%26atitle%3DAntitumor%252Bactivity%252Bof%252BHM781-36B%25252C%252Ba%252Bhighly%252Beffective%252Bpan-HER%252Binhibitor%252Bin%252Berlotinib-resistant%252BNSCLC%252Band%252Bother%252BEGFR-dependent%252Bcancer%252Bmodels%26aulast%3DCha%26aufirst%3DMi%2BYoung%26date%3D2012%26date%3D2011%26volume%3D130%26issue%3D10%26spage%3D2445%26epage%3D2454" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Siyuan  Li</span>, <span class="hlFld-ContribAuthor ">Chunying  Guo</span>, <span class="hlFld-ContribAuthor ">Hongli  Zhao</span>, <span class="hlFld-ContribAuthor ">Yun  Tang</span>, <span class="hlFld-ContribAuthor ">Minbo  Lan</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of 4-[3-chloro-4-(3-fluorobenzyloxy)anilino]-6-(3-substituted-phenoxy)pyrimidines as dual EGFR/ErbB-2 kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2012,</strong> <em>20 </em>
                                    (2)
                                     , 877-885. <a href="https://doi.org/10.1016/j.bmc.2011.11.056" title="DOI URL">https://doi.org/10.1016/j.bmc.2011.11.056</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2011.11.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2011.11.056%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252B4-%25255B3-chloro-4-%2525283-fluorobenzyloxy%252529anilino%25255D-6-%2525283-substituted-phenoxy%252529pyrimidines%252Bas%252Bdual%252BEGFR%25252FErbB-2%252Bkinase%252Binhibitors%26aulast%3DLi%26aufirst%3DSiyuan%26date%3D2012%26volume%3D20%26issue%3D2%26spage%3D877%26epage%3D885" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Galyna G.  Berest</span>, <span class="hlFld-ContribAuthor ">Olexii Yu.  Voskoboynik</span>, <span class="hlFld-ContribAuthor ">Sergiy I.  Kovalenko</span>, <span class="hlFld-ContribAuthor ">Olexii M.  Antypenko</span>, <span class="hlFld-ContribAuthor ">Inna S.  Nosulenko</span>, <span class="hlFld-ContribAuthor ">Andrii M.  Katsev</span>, <span class="hlFld-ContribAuthor ">Olena S.  Shandrovskaya</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological activity of novel N-cycloalkyl-(cycloalkylaryl)-2-[(3-R-2-oxo-2H-[1,2,4]triazino[2,3-c]quinazoline-6-yl)thio]acetamides. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>46 </em>
                                    (12)
                                     , 6066-6074. <a href="https://doi.org/10.1016/j.ejmech.2011.10.022" title="DOI URL">https://doi.org/10.1016/j.ejmech.2011.10.022</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2011.10.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2011.10.022%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bactivity%252Bof%252Bnovel%252BN-cycloalkyl-%252528cycloalkylaryl%252529-2-%25255B%2525283-R-2-oxo-2H-%25255B1%25252C2%25252C4%25255Dtriazino%25255B2%25252C3-c%25255Dquinazoline-6-yl%252529thio%25255Dacetamides%26aulast%3DBerest%26aufirst%3DGalyna%2BG.%26date%3D2011%26volume%3D46%26issue%3D12%26spage%3D6066%26epage%3D6074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vita  Majce</span>, <span class="hlFld-ContribAuthor ">Marijan  Kočevar</span>, <span class="hlFld-ContribAuthor ">Slovenko  Polanc</span>. </span><span class="cited-content_cbyCitation_article-title">A rapid and simple amine-catalyzed microwave-assisted isomerization of maleamides into fumaramides. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2011,</strong> <em>52 </em>
                                    (26)
                                     , 3287-3290. <a href="https://doi.org/10.1016/j.tetlet.2011.04.066" title="DOI URL">https://doi.org/10.1016/j.tetlet.2011.04.066</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2011.04.066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2011.04.066%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DA%252Brapid%252Band%252Bsimple%252Bamine-catalyzed%252Bmicrowave-assisted%252Bisomerization%252Bof%252Bmaleamides%252Binto%252Bfumaramides%26aulast%3DMajce%26aufirst%3DVita%26date%3D2011%26volume%3D52%26issue%3D26%26spage%3D3287%26epage%3D3290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sabine  Klüter </span>, <span class="hlFld-ContribAuthor ">Jeffrey R.  Simard </span>, <span class="hlFld-ContribAuthor ">Haridas B.  Rode</span>, <span class="hlFld-ContribAuthor ">Christian  Grütter</span>, <span class="hlFld-ContribAuthor ">Vijaykumar  Pawar</span>, <span class="hlFld-ContribAuthor ">Hans C. A.  Raaijmakers</span>, <span class="hlFld-ContribAuthor ">Tjeerd A.  Barf</span>, <span class="hlFld-ContribAuthor ">Matthias  Rabiller</span>, <span class="hlFld-ContribAuthor ">Willem A. L.  van Otterlo </span>, <span class="hlFld-ContribAuthor ">Daniel  Rauh </span>. </span><span class="cited-content_cbyCitation_article-title">Characterization of Irreversible Kinase Inhibitors by Directly Detecting Covalent Bond Formation: A Tool for Dissecting Kinase Drug Resistance. </span><span class="cited-content_cbyCitation_journal-name">ChemBioChem</span><span> <strong>2010,</strong> <em>11 </em>
                                    (18)
                                     , 2557-2566. <a href="https://doi.org/10.1002/cbic.201000352" title="DOI URL">https://doi.org/10.1002/cbic.201000352</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cbic.201000352&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcbic.201000352%26sid%3Dliteratum%253Aachs%26jtitle%3DChemBioChem%26atitle%3DCharacterization%252Bof%252BIrreversible%252BKinase%252BInhibitors%252Bby%252BDirectly%252BDetecting%252BCovalent%252BBond%252BFormation%25253A%252BA%252BTool%252Bfor%252BDissecting%252BKinase%252BDrug%252BResistance%26aulast%3DKl%25C3%25BCter%25E2%2580%2589%26aufirst%3DSabine%26date%3D2010%26date%3D2010%26volume%3D11%26issue%3D18%26spage%3D2557%26epage%3D2566" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Haiyan  Sun</span>, <span class="hlFld-ContribAuthor ">Huichang  Bi</span>, <span class="hlFld-ContribAuthor ">Min  Huang</span>, <span class="hlFld-ContribAuthor ">Dong  Liu</span>, <span class="hlFld-ContribAuthor ">Zhenyu  Qin</span>. </span><span class="cited-content_cbyCitation_article-title">Absorption of CH330331, a novel 4-anilinoquinazoline inhibitor of epidermal growth factor receptor tyrosine kinase: comparative studies using in vitro, in situ and in vivo models. </span><span class="cited-content_cbyCitation_journal-name">Biopharmaceutics & Drug Disposition</span><span> <strong>2010,</strong> <em>31 </em>
                                    (8-9)
                                     , 486-494. <a href="https://doi.org/10.1002/bdd.729" title="DOI URL">https://doi.org/10.1002/bdd.729</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/bdd.729&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fbdd.729%26sid%3Dliteratum%253Aachs%26jtitle%3DBiopharmaceutics%2520%2526%2520Drug%2520Disposition%26atitle%3DAbsorption%252Bof%252BCH330331%25252C%252Ba%252Bnovel%252B4-anilinoquinazoline%252Binhibitor%252Bof%252Bepidermal%252Bgrowth%252Bfactor%252Breceptor%252Btyrosine%252Bkinase%25253A%252Bcomparative%252Bstudies%252Busing%252Bin%252Bvitro%25252C%252Bin%252Bsitu%252Band%252Bin%252Bvivo%252Bmodels%26aulast%3DSun%26aufirst%3DHaiyan%26date%3D2010%26date%3D2010%26volume%3D31%26issue%3D8-9%26spage%3D486%26epage%3D494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Farhan  Ahmad Pasha</span>, <span class="hlFld-ContribAuthor ">Muhammad  Muddassar</span>, <span class="hlFld-ContribAuthor ">Anil  Kumar Srivastava</span>, <span class="hlFld-ContribAuthor ">Seung  Joo Cho</span>. </span><span class="cited-content_cbyCitation_article-title">In silico QSAR studies of anilinoquinolines as EGFR inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Modeling</span><span> <strong>2010,</strong> <em>16 </em>
                                    (2)
                                     , 263-277. <a href="https://doi.org/10.1007/s00894-009-0534-x" title="DOI URL">https://doi.org/10.1007/s00894-009-0534-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00894-009-0534-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00894-009-0534-x%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Modeling%26atitle%3DIn%252Bsilico%252BQSAR%252Bstudies%252Bof%252Banilinoquinolines%252Bas%252BEGFR%252Binhibitors%26aulast%3DAhmad%2BPasha%26aufirst%3DFarhan%26date%3D2010%26date%3D2009%26volume%3D16%26issue%3D2%26spage%3D263%26epage%3D277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hyun Seung  Ban</span>, <span class="hlFld-ContribAuthor ">Yuko  Tanaka</span>, <span class="hlFld-ContribAuthor ">Wataru  Nabeyama</span>, <span class="hlFld-ContribAuthor ">Masako  Hatori</span>, <span class="hlFld-ContribAuthor ">Hiroyuki  Nakamura</span>. </span><span class="cited-content_cbyCitation_article-title">Enhancement of EGFR tyrosine kinase inhibition by C–C multiple bonds-containing anilinoquinazolines. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2010,</strong> <em>18 </em>
                                    (2)
                                     , 870-879. <a href="https://doi.org/10.1016/j.bmc.2009.11.035" title="DOI URL">https://doi.org/10.1016/j.bmc.2009.11.035</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2009.11.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2009.11.035%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DEnhancement%252Bof%252BEGFR%252Btyrosine%252Bkinase%252Binhibition%252Bby%252BC%2525E2%252580%252593C%252Bmultiple%252Bbonds-containing%252Banilinoquinazolines%26aulast%3DBan%26aufirst%3DHyun%2BSeung%26date%3D2010%26volume%3D18%26issue%3D2%26spage%3D870%26epage%3D879" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Egle  Avizienyte</span>, <span class="hlFld-ContribAuthor ">Richard A.  Ward</span>, <span class="hlFld-ContribAuthor ">Andrew P.  Garner</span>. </span><span class="cited-content_cbyCitation_article-title">Comparison of the EGFR resistance mutation profiles generated by EGFR-targeted tyrosine kinase inhibitors and the impact of drug combinations. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Journal</span><span> <strong>2008,</strong> <em>415 </em>
                                    (2)
                                     , 197-206. <a href="https://doi.org/10.1042/BJ20080728" title="DOI URL">https://doi.org/10.1042/BJ20080728</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1042/BJ20080728&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1042%2FBJ20080728%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Journal%26atitle%3DComparison%252Bof%252Bthe%252BEGFR%252Bresistance%252Bmutation%252Bprofiles%252Bgenerated%252Bby%252BEGFR-targeted%252Btyrosine%252Bkinase%252Binhibitors%252Band%252Bthe%252Bimpact%252Bof%252Bdrug%252Bcombinations%26aulast%3DAvizienyte%26aufirst%3DEgle%26date%3D2008%26date%3D2008%26volume%3D415%26issue%3D2%26spage%3D197%26epage%3D206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Giulio  Rastelli</span>, <span class="hlFld-ContribAuthor ">Robin  Rosenfeld</span>, <span class="hlFld-ContribAuthor ">Ralph  Reid</span>, <span class="hlFld-ContribAuthor ">Daniel V.  Santi</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular modeling and crystal structure of ERK2–hypothemycin complexes. </span><span class="cited-content_cbyCitation_journal-name">Journal of Structural Biology</span><span> <strong>2008,</strong> <em>164 </em>
                                    (1)
                                     , 18-23. <a href="https://doi.org/10.1016/j.jsb.2008.05.002" title="DOI URL">https://doi.org/10.1016/j.jsb.2008.05.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jsb.2008.05.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jsb.2008.05.002%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Structural%2520Biology%26atitle%3DMolecular%252Bmodeling%252Band%252Bcrystal%252Bstructure%252Bof%252BERK2%2525E2%252580%252593hypothemycin%252Bcomplexes%26aulast%3DRastelli%26aufirst%3DGiulio%26date%3D2008%26volume%3D164%26issue%3D1%26spage%3D18%26epage%3D23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hai-Feng  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Computational Study of the Binding Mode of Epidermal Growth Factor Receptor Kinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2008,</strong> <em>71 </em>
                                    (5)
                                     , 434-446. <a href="https://doi.org/10.1111/j.1747-0285.2008.00656.x" title="DOI URL">https://doi.org/10.1111/j.1747-0285.2008.00656.x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/j.1747-0285.2008.00656.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fj.1747-0285.2008.00656.x%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DComputational%252BStudy%252Bof%252Bthe%252BBinding%252BMode%252Bof%252BEpidermal%252BGrowth%252BFactor%252BReceptor%252BKinase%252BInhibitors%26aulast%3DChen%26aufirst%3DHai-Feng%26date%3D2008%26date%3D2008%26volume%3D71%26issue%3D5%26spage%3D434%26epage%3D446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Neelu  Kaila</span>, <span class="hlFld-ContribAuthor ">Neal  Green</span>, <span class="hlFld-ContribAuthor ">Huan-Qiu  Li</span>, <span class="hlFld-ContribAuthor ">Yonghan  Hu</span>, <span class="hlFld-ContribAuthor ">Kristin  Janz</span>, <span class="hlFld-ContribAuthor ">Lori Krim  Gavrin</span>, <span class="hlFld-ContribAuthor ">Jennifer  Thomason</span>, <span class="hlFld-ContribAuthor ">Steve  Tam</span>, <span class="hlFld-ContribAuthor ">Dennis  Powell</span>, <span class="hlFld-ContribAuthor ">John  Cuozzo</span>, <span class="hlFld-ContribAuthor ">J. Perry  Hall</span>, <span class="hlFld-ContribAuthor ">Jean-Baptiste  Telliez</span>, <span class="hlFld-ContribAuthor ">Sang  Hsu</span>, <span class="hlFld-ContribAuthor ">Cheryl  Nickerson-Nutter</span>, <span class="hlFld-ContribAuthor ">Qin  Wang</span>, <span class="hlFld-ContribAuthor ">Lih-Ling  Lin</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of a novel class of selective Tpl2 kinase inhibitors: 4-Alkylamino-[1,7]naphthyridine-3-carbonitriles. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2007,</strong> <em>15 </em>
                                    (19)
                                     , 6425-6442. <a href="https://doi.org/10.1016/j.bmc.2007.06.054" title="DOI URL">https://doi.org/10.1016/j.bmc.2007.06.054</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2007.06.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2007.06.054%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252Ba%252Bnovel%252Bclass%252Bof%252Bselective%252BTpl2%252Bkinase%252Binhibitors%25253A%252B4-Alkylamino-%25255B1%25252C7%25255Dnaphthyridine-3-carbonitriles%26aulast%3DKaila%26aufirst%3DNeelu%26date%3D2007%26volume%3D15%26issue%3D19%26spage%3D6425%26epage%3D6442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hai-Yan  Sun</span>, <span class="hlFld-ContribAuthor ">Su  Guan</span>, <span class="hlFld-ContribAuthor ">Hui-Chang  Bi</span>, <span class="hlFld-ContribAuthor ">Qi-Biao  Su</span>, <span class="hlFld-ContribAuthor ">Wen-Lin  Huang</span>, <span class="hlFld-ContribAuthor ">Balram  Chowbay</span>, <span class="hlFld-ContribAuthor ">Min  Huang</span>, <span class="hlFld-ContribAuthor ">Xiao  Chen</span>, <span class="hlFld-ContribAuthor ">Chun-Guang  Li</span>, <span class="hlFld-ContribAuthor ">Shu-Feng  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Determination of CH330331, a novel 4-anilinoquinazoline inhibitor of epidermal growth factor receptor tyrosine kinase, in human Caco-2 monolayers by high performance liquid chromatography with ultraviolet detection: Application to a trans-epithelial transport study. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chromatography B</span><span> <strong>2007,</strong> <em>854 </em>
                                    (1-2)
                                     , 320-327. <a href="https://doi.org/10.1016/j.jchromb.2007.03.052" title="DOI URL">https://doi.org/10.1016/j.jchromb.2007.03.052</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jchromb.2007.03.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jchromb.2007.03.052%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chromatography%2520B%26atitle%3DDetermination%252Bof%252BCH330331%25252C%252Ba%252Bnovel%252B4-anilinoquinazoline%252Binhibitor%252Bof%252Bepidermal%252Bgrowth%252Bfactor%252Breceptor%252Btyrosine%252Bkinase%25252C%252Bin%252Bhuman%252BCaco-2%252Bmonolayers%252Bby%252Bhigh%252Bperformance%252Bliquid%252Bchromatography%252Bwith%252Bultraviolet%252Bdetection%25253A%252BApplication%252Bto%252Ba%252Btrans-epithelial%252Btransport%252Bstudy%26aulast%3DSun%26aufirst%3DHai-Yan%26date%3D2007%26volume%3D854%26issue%3D1-2%26spage%3D320%26epage%3D327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Galith  Abourbeh</span>, <span class="hlFld-ContribAuthor ">Samar  Dissoki</span>, <span class="hlFld-ContribAuthor ">Orit  Jacobson</span>, <span class="hlFld-ContribAuthor ">Amir  Litchi</span>, <span class="hlFld-ContribAuthor ">Revital Ben  Daniel</span>, <span class="hlFld-ContribAuthor ">Desirediu  Laki</span>, <span class="hlFld-ContribAuthor ">Alexander  Levitzki</span>, <span class="hlFld-ContribAuthor ">Eyal  Mishani</span>. </span><span class="cited-content_cbyCitation_article-title">Evaluation of radiolabeled ML04, a putative irreversible inhibitor of epidermal growth factor receptor, as a bioprobe for PET imaging of EGFR-overexpressing tumors. </span><span class="cited-content_cbyCitation_journal-name">Nuclear Medicine and Biology</span><span> <strong>2007,</strong> <em>34 </em>
                                    (1)
                                     , 55-70. <a href="https://doi.org/10.1016/j.nucmedbio.2006.10.012" title="DOI URL">https://doi.org/10.1016/j.nucmedbio.2006.10.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.nucmedbio.2006.10.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.nucmedbio.2006.10.012%26sid%3Dliteratum%253Aachs%26jtitle%3DNuclear%2520Medicine%2520and%2520Biology%26atitle%3DEvaluation%252Bof%252Bradiolabeled%252BML04%25252C%252Ba%252Bputative%252Birreversible%252Binhibitor%252Bof%252Bepidermal%252Bgrowth%252Bfactor%252Breceptor%25252C%252Bas%252Ba%252Bbioprobe%252Bfor%252BPET%252Bimaging%252Bof%252BEGFR-overexpressing%252Btumors%26aulast%3DAbourbeh%26aufirst%3DGalith%26date%3D2007%26volume%3D34%26issue%3D1%26spage%3D55%26epage%3D70" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yonghan  Hu</span>, <span class="hlFld-ContribAuthor ">Neal  Green</span>, <span class="hlFld-ContribAuthor ">Lori K.  Gavrin</span>, <span class="hlFld-ContribAuthor ">Kristin  Janz</span>, <span class="hlFld-ContribAuthor ">Neelu  Kaila</span>, <span class="hlFld-ContribAuthor ">Huan-Qiu  Li</span>, <span class="hlFld-ContribAuthor ">Jennifer R.  Thomason</span>, <span class="hlFld-ContribAuthor ">John W.  Cuozzo</span>, <span class="hlFld-ContribAuthor ">J. Perry  Hall</span>, <span class="hlFld-ContribAuthor ">Sang  Hsu</span>, <span class="hlFld-ContribAuthor ">Cheryl  Nickerson-Nutter</span>, <span class="hlFld-ContribAuthor ">Jean-Baptiste  Telliez</span>, <span class="hlFld-ContribAuthor ">Lih-Ling  Lin</span>, <span class="hlFld-ContribAuthor ">Steve  Tam</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of Tpl2 kinase and TNFα production with quinoline-3-carbonitriles for the treatment of rheumatoid arthritis. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2006,</strong> <em>16 </em>
                                    (23)
                                     , 6067-6072. <a href="https://doi.org/10.1016/j.bmcl.2006.08.102" title="DOI URL">https://doi.org/10.1016/j.bmcl.2006.08.102</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2006.08.102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2006.08.102%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DInhibition%252Bof%252BTpl2%252Bkinase%252Band%252BTNF%2525CE%2525B1%252Bproduction%252Bwith%252Bquinoline-3-carbonitriles%252Bfor%252Bthe%252Btreatment%252Bof%252Brheumatoid%252Barthritis%26aulast%3DHu%26aufirst%3DYonghan%26date%3D2006%26volume%3D16%26issue%3D23%26spage%3D6067%26epage%3D6072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shantaram  Kamath</span>, <span class="hlFld-ContribAuthor ">John K.  Buolamwini</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting EGFR and HER-2 receptor tyrosine kinases for cancer drug discovery and development. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2006,</strong> <em>26 </em>
                                    (5)
                                     , 569-594. <a href="https://doi.org/10.1002/med.20070" title="DOI URL">https://doi.org/10.1002/med.20070</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.20070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.20070%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DTargeting%252BEGFR%252Band%252BHER-2%252Breceptor%252Btyrosine%252Bkinases%252Bfor%252Bcancer%252Bdrug%252Bdiscovery%252Band%252Bdevelopment%26aulast%3DKamath%26aufirst%3DShantaram%26date%3D2006%26date%3D2006%26volume%3D26%26issue%3D5%26spage%3D569%26epage%3D594" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A.  Pal</span>, <span class="hlFld-ContribAuthor ">A.  Glekas</span>, <span class="hlFld-ContribAuthor ">M.  Doubrovin</span>, <span class="hlFld-ContribAuthor ">J.  Balatoni</span>, <span class="hlFld-ContribAuthor ">T.  Beresten</span>, <span class="hlFld-ContribAuthor ">D.  Maxwell</span>, <span class="hlFld-ContribAuthor ">S.  Soghomonyan</span>, <span class="hlFld-ContribAuthor ">A.  Shavrin</span>, <span class="hlFld-ContribAuthor ">L.  Ageyeva</span>, <span class="hlFld-ContribAuthor ">R.  Finn</span>, <span class="hlFld-ContribAuthor ">S. M.  Larson</span>, <span class="hlFld-ContribAuthor ">W.  Bornmann</span>, <span class="hlFld-ContribAuthor ">J. G.  Gelovani</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular Imaging of EGFR Kinase Activity in Tumors with 124I-Labeled Small Molecular Tracer and Positron Emission Tomography. </span><span class="cited-content_cbyCitation_journal-name">Molecular Imaging and Biology</span><span> <strong>2006,</strong> <em>8 </em>
                                    (5)
                                     , 262-277. <a href="https://doi.org/10.1007/s11307-006-0049-0" title="DOI URL">https://doi.org/10.1007/s11307-006-0049-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11307-006-0049-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11307-006-0049-0%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Imaging%2520and%2520Biology%26atitle%3DMolecular%252BImaging%252Bof%252BEGFR%252BKinase%252BActivity%252Bin%252BTumors%252Bwith%252B124I-Labeled%252BSmall%252BMolecular%252BTracer%252Band%252BPositron%252BEmission%252BTomography%26aulast%3DPal%26aufirst%3DA.%26date%3D2006%26date%3D2006%26volume%3D8%26issue%3D5%26spage%3D262%26epage%3D277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexander  Levitzki</span>, <span class="hlFld-ContribAuthor ">Eyal  Mishani</span>. </span><span class="cited-content_cbyCitation_article-title">Tyrphostins and Other Tyrosine Kinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Annual Review of Biochemistry</span><span> <strong>2006,</strong> <em>75 </em>
                                    (1)
                                     , 93-109. <a href="https://doi.org/10.1146/annurev.biochem.75.103004.142657" title="DOI URL">https://doi.org/10.1146/annurev.biochem.75.103004.142657</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1146/annurev.biochem.75.103004.142657&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1146%2Fannurev.biochem.75.103004.142657%26sid%3Dliteratum%253Aachs%26jtitle%3DAnnual%2520Review%2520of%2520Biochemistry%26atitle%3DTyrphostins%252Band%252BOther%252BTyrosine%252BKinase%252BInhibitors%26aulast%3DLevitzki%26aufirst%3DAlexander%26date%3D2006%26volume%3D75%26issue%3D1%26spage%3D93%26epage%3D109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yeong-Shiau  Pu</span>, <span class="hlFld-ContribAuthor ">Min-Wei  Hsieh</span>, <span class="hlFld-ContribAuthor ">Chuang-Wei  Wang</span>, <span class="hlFld-ContribAuthor ">Guang-Yaw  Liu</span>, <span class="hlFld-ContribAuthor ">Chao-Yuan  Huang</span>, <span class="hlFld-ContribAuthor ">Chia-Chi  Lin</span>, <span class="hlFld-ContribAuthor ">Jing-Yi  Guan</span>, <span class="hlFld-ContribAuthor ">Shinne-Ren  Lin</span>, <span class="hlFld-ContribAuthor ">Tzyh-Chyuan  Hour</span>. </span><span class="cited-content_cbyCitation_article-title">Epidermal growth factor receptor inhibitor (PD168393) potentiates cytotoxic effects of paclitaxel against androgen-independent prostate cancer cells. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Pharmacology</span><span> <strong>2006,</strong> <em>71 </em>
                                    (6)
                                     , 751-760. <a href="https://doi.org/10.1016/j.bcp.2005.12.009" title="DOI URL">https://doi.org/10.1016/j.bcp.2005.12.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bcp.2005.12.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bcp.2005.12.009%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Pharmacology%26atitle%3DEpidermal%252Bgrowth%252Bfactor%252Breceptor%252Binhibitor%252B%252528PD168393%252529%252Bpotentiates%252Bcytotoxic%252Beffects%252Bof%252Bpaclitaxel%252Bagainst%252Bandrogen-independent%252Bprostate%252Bcancer%252Bcells%26aulast%3DPu%26aufirst%3DYeong-Shiau%26date%3D2006%26volume%3D71%26issue%3D6%26spage%3D751%26epage%3D760" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chukwuemeka  Isanbor</span>, <span class="hlFld-ContribAuthor ">David  O’Hagan</span>. </span><span class="cited-content_cbyCitation_article-title">Fluorine in medicinal chemistry: A review of anti-cancer agents. </span><span class="cited-content_cbyCitation_journal-name">Journal of Fluorine Chemistry</span><span> <strong>2006,</strong> <em>127 </em>
                                    (3)
                                     , 303-319. <a href="https://doi.org/10.1016/j.jfluchem.2006.01.011" title="DOI URL">https://doi.org/10.1016/j.jfluchem.2006.01.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jfluchem.2006.01.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jfluchem.2006.01.011%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Fluorine%2520Chemistry%26atitle%3DFluorine%252Bin%252Bmedicinal%252Bchemistry%25253A%252BA%252Breview%252Bof%252Banti-cancer%252Bagents%26aulast%3DIsanbor%26aufirst%3DChukwuemeka%26date%3D2006%26volume%3D127%26issue%3D3%26spage%3D303%26epage%3D319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sylvester R.  Klutchko</span>, <span class="hlFld-ContribAuthor ">Hairong  Zhou</span>, <span class="hlFld-ContribAuthor ">R. Thomas  Winters</span>, <span class="hlFld-ContribAuthor ">Tuan P.  Tran</span>, <span class="hlFld-ContribAuthor ">Alexander J.  Bridges</span>, <span class="hlFld-ContribAuthor ">Irene W.  Althaus</span>, <span class="hlFld-ContribAuthor ">Danielle M.  Amato</span>, <span class="hlFld-ContribAuthor ">William L.  Elliott</span>, <span class="hlFld-ContribAuthor ">Paul A.  Ellis</span>, <span class="hlFld-ContribAuthor ">Mary Ann  Meade</span>, <span class="hlFld-ContribAuthor ">Billy J.  Roberts</span>, <span class="hlFld-ContribAuthor ">David W.  Fry</span>, <span class="hlFld-ContribAuthor ">Andrea J.  Gonzales</span>, <span class="hlFld-ContribAuthor ">Patricia J.  Harvey</span>, <span class="hlFld-ContribAuthor ">James M.  Nelson</span>, <span class="hlFld-ContribAuthor ">Veronica  Sherwood</span>, <span class="hlFld-ContribAuthor ">Hyo-Kyung  Han</span>, <span class="hlFld-ContribAuthor ">Gerry  Pace</span>, <span class="hlFld-ContribAuthor ">Jeff B.  Smaill</span>, <span class="hlFld-ContribAuthor ">William A.  Denny</span>, <span class="hlFld-ContribAuthor ">H. D. Hollis  Showalter</span>. </span><span class="cited-content_cbyCitation_article-title">Tyrosine Kinase Inhibitors. 19. 6-Alkynamides of 4-Anilinoquinazolines and 4-Anilinopyrido[3,4-
              d
              ]pyrimidines as Irreversible Inhibitors of the erbB Family of Tyrosine Kinase Receptors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2006,</strong> <em>49 </em>
                                    (4)
                                     , 1475-1485. <a href="https://doi.org/10.1021/jm050936o" title="DOI URL">https://doi.org/10.1021/jm050936o</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm050936o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm050936o%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTyrosine%252BKinase%252BInhibitors.%252B19.%252B6-Alkynamides%252Bof%252B4-Anilinoquinazolines%252Band%252B4-Anilinopyrido%25255B3%25252C4-%252Bd%252B%25255Dpyrimidines%252Bas%252BIrreversible%252BInhibitors%252Bof%252Bthe%252BerbB%252BFamily%252Bof%252BTyrosine%252BKinase%252BReceptors%26aulast%3DKlutchko%26aufirst%3DSylvester%2BR.%26date%3D2006%26date%3D2006%26volume%3D49%26issue%3D4%26spage%3D1475%26epage%3D1485" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mariano  Pinto-Bazurco</span>, <span class="hlFld-ContribAuthor ">Ivanka  Tsakovska</span>, <span class="hlFld-ContribAuthor ">Ilza  Pajeva</span>. </span><span class="cited-content_cbyCitation_article-title">QSAR and 3D QSAR of inhibitors of the epidermal growth factor receptor. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Quantum Chemistry</span><span> <strong>2006,</strong> <em>106 </em>
                                    (6)
                                     , 1432-1444. <a href="https://doi.org/10.1002/qua.20901" title="DOI URL">https://doi.org/10.1002/qua.20901</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/qua.20901&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fqua.20901%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Quantum%2520Chemistry%26atitle%3DQSAR%252Band%252B3D%252BQSAR%252Bof%252Binhibitors%252Bof%252Bthe%252Bepidermal%252Bgrowth%252Bfactor%252Breceptor%26aulast%3DPinto-Bazurco%26aufirst%3DMariano%26date%3D2006%26date%3D2006%26volume%3D106%26issue%3D6%26spage%3D1432%26epage%3D1444" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei  Deng</span>, <span class="hlFld-ContribAuthor ">Zongru  Guo</span>, <span class="hlFld-ContribAuthor ">Yanshen  Guo</span>, <span class="hlFld-ContribAuthor ">Zhiqiang  Feng</span>, <span class="hlFld-ContribAuthor ">Yi  Jiang</span>, <span class="hlFld-ContribAuthor ">Fengming  Chu</span>. </span><span class="cited-content_cbyCitation_article-title">Acryloylamino-salicylanilides as EGFR PTK inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2006,</strong> <em>16 </em>
                                    (2)
                                     , 469-472. <a href="https://doi.org/10.1016/j.bmcl.2005.06.088" title="DOI URL">https://doi.org/10.1016/j.bmcl.2005.06.088</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2005.06.088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2005.06.088%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DAcryloylamino-salicylanilides%252Bas%252BEGFR%252BPTK%252Binhibitors%26aulast%3DDeng%26aufirst%3DWei%26date%3D2006%26volume%3D16%26issue%3D2%26spage%3D469%26epage%3D472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lori Krim  Gavrin</span>, <span class="hlFld-ContribAuthor ">Neal  Green</span>, <span class="hlFld-ContribAuthor ">Yonghan  Hu</span>, <span class="hlFld-ContribAuthor ">Kristin  Janz</span>, <span class="hlFld-ContribAuthor ">Neelu  Kaila</span>, <span class="hlFld-ContribAuthor ">Huan-Qiu  Li</span>, <span class="hlFld-ContribAuthor ">Steve Y.  Tam</span>, <span class="hlFld-ContribAuthor ">Jennifer R.  Thomason</span>, <span class="hlFld-ContribAuthor ">Ariamala  Gopalsamy</span>, <span class="hlFld-ContribAuthor ">Greg  Ciszewski</span>, <span class="hlFld-ContribAuthor ">John W.  Cuozzo</span>, <span class="hlFld-ContribAuthor ">J. Perry  Hall</span>, <span class="hlFld-ContribAuthor ">Sang  Hsu</span>, <span class="hlFld-ContribAuthor ">Jean-Baptiste  Telliez</span>, <span class="hlFld-ContribAuthor ">Lih-Ling  Lin</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of Tpl2 kinase and TNF-α production with 1,7-naphthyridine-3-carbonitriles: Synthesis and structure–activity relationships. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2005,</strong> <em>15 </em>
                                    (23)
                                     , 5288-5292. <a href="https://doi.org/10.1016/j.bmcl.2005.08.029" title="DOI URL">https://doi.org/10.1016/j.bmcl.2005.08.029</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2005.08.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2005.08.029%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DInhibition%252Bof%252BTpl2%252Bkinase%252Band%252BTNF-%2525CE%2525B1%252Bproduction%252Bwith%252B1%25252C7-naphthyridine-3-carbonitriles%25253A%252BSynthesis%252Band%252Bstructure%2525E2%252580%252593activity%252Brelationships%26aulast%3DGavrin%26aufirst%3DLori%2BKrim%26date%3D2005%26volume%3D15%26issue%3D23%26spage%3D5288%26epage%3D5292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter  Ballard</span>, <span class="hlFld-ContribAuthor ">Robert H.  Bradbury</span>, <span class="hlFld-ContribAuthor ">Laurent F.A.  Hennequin</span>, <span class="hlFld-ContribAuthor ">D. Mark  Hickinson</span>, <span class="hlFld-ContribAuthor ">Paul D.  Johnson</span>, <span class="hlFld-ContribAuthor ">Jason G.  Kettle</span>, <span class="hlFld-ContribAuthor ">Teresa  Klinowska</span>, <span class="hlFld-ContribAuthor ">Remy  Morgentin</span>, <span class="hlFld-ContribAuthor ">Donald J.  Ogilvie</span>, <span class="hlFld-ContribAuthor ">Annie  Olivier</span>. </span><span class="cited-content_cbyCitation_article-title">5-Substituted 4-anilinoquinazolines as potent, selective and orally active inhibitors of erbB2 receptor tyrosine kinase. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2005,</strong> <em>15 </em>
                                    (19)
                                     , 4226-4229. <a href="https://doi.org/10.1016/j.bmcl.2005.06.068" title="DOI URL">https://doi.org/10.1016/j.bmcl.2005.06.068</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2005.06.068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2005.06.068%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3D5-Substituted%252B4-anilinoquinazolines%252Bas%252Bpotent%25252C%252Bselective%252Band%252Borally%252Bactive%252Binhibitors%252Bof%252BerbB2%252Breceptor%252Btyrosine%252Bkinase%26aulast%3DBallard%26aufirst%3DPeter%26date%3D2005%26volume%3D15%26issue%3D19%26spage%3D4226%26epage%3D4229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Carmen  Drahl</span>, <span class="hlFld-ContribAuthor ">Benjamin F.  Cravatt</span>, <span class="hlFld-ContribAuthor ">Erik J.  Sorensen</span>. </span><span class="cited-content_cbyCitation_article-title">Proteinreaktive Naturstoffe. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2005,</strong> <em>117 </em>
                                    (36)
                                     , 5936-5958. <a href="https://doi.org/10.1002/ange.200500900" title="DOI URL">https://doi.org/10.1002/ange.200500900</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.200500900&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.200500900%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DProteinreaktive%252BNaturstoffe%26aulast%3DDrahl%26aufirst%3DCarmen%26date%3D2005%26volume%3D117%26issue%3D36%26spage%3D5936%26epage%3D5958" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Carmen  Drahl</span>, <span class="hlFld-ContribAuthor ">Benjamin F.  Cravatt</span>, <span class="hlFld-ContribAuthor ">Erik J.  Sorensen</span>. </span><span class="cited-content_cbyCitation_article-title">Protein-Reactive Natural Products. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2005,</strong> <em>44 </em>
                                    (36)
                                     , 5788-5809. <a href="https://doi.org/10.1002/anie.200500900" title="DOI URL">https://doi.org/10.1002/anie.200500900</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.200500900&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.200500900%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DProtein-Reactive%252BNatural%252BProducts%26aulast%3DDrahl%26aufirst%3DCarmen%26date%3D2005%26volume%3D44%26issue%3D36%26spage%3D5788%26epage%3D5809" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">B.C.  Baguley</span>, <span class="hlFld-ContribAuthor ">E.S.  Marshall</span>. </span><span class="cited-content_cbyCitation_article-title">In vitro modelling of human tumour behaviour in drug discovery programmes. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Cancer</span><span> <strong>2004,</strong> <em>40 </em>
                                    (6)
                                     , 794-801. <a href="https://doi.org/10.1016/j.ejca.2003.12.019" title="DOI URL">https://doi.org/10.1016/j.ejca.2003.12.019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejca.2003.12.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejca.2003.12.019%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Cancer%26atitle%3DIn%252Bvitro%252Bmodelling%252Bof%252Bhuman%252Btumour%252Bbehaviour%252Bin%252Bdrug%252Bdiscovery%252Bprogrammes%26aulast%3DBaguley%26aufirst%3DB.C.%26date%3D2004%26volume%3D40%26issue%3D6%26spage%3D794%26epage%3D801" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michal  Vieth</span>, <span class="hlFld-ContribAuthor ">Richard E.  Higgs</span>, <span class="hlFld-ContribAuthor ">Daniel H.  Robertson</span>, <span class="hlFld-ContribAuthor ">Michael  Shapiro</span>, <span class="hlFld-ContribAuthor ">Ellen A.  Gragg</span>, <span class="hlFld-ContribAuthor ">Horst  Hemmerle</span>. </span><span class="cited-content_cbyCitation_article-title">Kinomics—structural biology and chemogenomics of kinase inhibitors and targets. </span><span class="cited-content_cbyCitation_journal-name">Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics</span><span> <strong>2004,</strong> <em>1697 </em>
                                    (1-2)
                                     , 243-257. <a href="https://doi.org/10.1016/j.bbapap.2003.11.028" title="DOI URL">https://doi.org/10.1016/j.bbapap.2003.11.028</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbapap.2003.11.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbapap.2003.11.028%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochimica%2520et%2520Biophysica%2520Acta%2520%2528BBA%2529%2520-%2520Proteins%2520and%2520Proteomics%26atitle%3DKinomics%2525E2%252580%252594structural%252Bbiology%252Band%252Bchemogenomics%252Bof%252Bkinase%252Binhibitors%252Band%252Btargets%26aulast%3DVieth%26aufirst%3DMichal%26date%3D2004%26volume%3D1697%26issue%3D1-2%26spage%3D243%26epage%3D257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aparna  Vema</span>, <span class="hlFld-ContribAuthor ">Sunil K.  Panigrahi</span>, <span class="hlFld-ContribAuthor ">G.  Rambabu</span>, <span class="hlFld-ContribAuthor ">B.  Gopalakrishnan</span>, <span class="hlFld-ContribAuthor ">J.A.R.P.  Sarma</span>, <span class="hlFld-ContribAuthor ">Gautam R.  Desiraju</span>. </span><span class="cited-content_cbyCitation_article-title">Design of EGFR kinase inhibitors: A ligand-based approach and its confirmation with structure-based studies. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2003,</strong> <em>11 </em>
                                    (21)
                                     , 4643-4653. <a href="https://doi.org/10.1016/S0968-0896(03)00482-6" title="DOI URL">https://doi.org/10.1016/S0968-0896(03)00482-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/S0968-0896(03)00482-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FS0968-0896%2803%2900482-6%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Bof%252BEGFR%252Bkinase%252Binhibitors%25253A%252BA%252Bligand-based%252Bapproach%252Band%252Bits%252Bconfirmation%252Bwith%252Bstructure-based%252Bstudies%26aulast%3DVema%26aufirst%3DAparna%26date%3D2003%26volume%3D11%26issue%3D21%26spage%3D4643%26epage%3D4653" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rajni  Garg</span>, <span class="hlFld-ContribAuthor ">Alka  Kurup</span>, <span class="hlFld-ContribAuthor ">Suresh B.  Mekapati</span>, <span class="hlFld-ContribAuthor ">Corwin  Hansch</span>. </span><span class="cited-content_cbyCitation_article-title">Searching for allosteric effects via QSAR. Part II. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2003,</strong> <em>11 </em>
                                    (4)
                                     , 621-628. <a href="https://doi.org/10.1016/S0968-0896(02)00382-6" title="DOI URL">https://doi.org/10.1016/S0968-0896(02)00382-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/S0968-0896(02)00382-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FS0968-0896%2802%2900382-6%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSearching%252Bfor%252Ballosteric%252Beffects%252Bvia%252BQSAR.%252BPart%252BII%26aulast%3DGarg%26aufirst%3DRajni%26date%3D2003%26volume%3D11%26issue%3D4%26spage%3D621%26epage%3D628" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">C.M.  Richardson</span>, <span class="hlFld-ContribAuthor ">R.A.  Sharma</span>, <span class="hlFld-ContribAuthor ">G.  Cox</span>, <span class="hlFld-ContribAuthor ">Kenneth J.  O'Byrne</span>. </span><span class="cited-content_cbyCitation_article-title">Epidermal growth factor receptors and cyclooxygenase-2 in the pathogenesis of non-small cell lung cancer: potential targets for chemoprevention and systemic therapy. </span><span class="cited-content_cbyCitation_journal-name">Lung Cancer</span><span> <strong>2003,</strong> <em>39 </em>
                                    (1)
                                     , 1-13. <a href="https://doi.org/10.1016/S0169-5002(02)00382-3" title="DOI URL">https://doi.org/10.1016/S0169-5002(02)00382-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/S0169-5002(02)00382-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FS0169-5002%2802%2900382-3%26sid%3Dliteratum%253Aachs%26jtitle%3DLung%2520Cancer%26atitle%3DEpidermal%252Bgrowth%252Bfactor%252Breceptors%252Band%252Bcyclooxygenase-2%252Bin%252Bthe%252Bpathogenesis%252Bof%252Bnon-small%252Bcell%252Blung%252Bcancer%25253A%252Bpotential%252Btargets%252Bfor%252Bchemoprevention%252Band%252Bsystemic%252Btherapy%26aulast%3DRichardson%26aufirst%3DC.M.%26date%3D2003%26volume%3D39%26issue%3D1%26spage%3D1%26epage%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tao  Peng</span>, <span class="hlFld-ContribAuthor ">Jianfeng  Pei</span>, <span class="hlFld-ContribAuthor ">Jiaju  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">3D-QSAR and Receptor Modeling of Tyrosine Kinase Inhibitors with Flexible Atom Receptor Model (FLARM). </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Computer Sciences</span><span> <strong>2003,</strong> <em>43 </em>
                                    (1)
                                     , 298-303. <a href="https://doi.org/10.1021/ci0256034" title="DOI URL">https://doi.org/10.1021/ci0256034</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ci0256034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fci0256034%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Computer%2520Sciences%26atitle%3D3D-QSAR%252Band%252BReceptor%252BModeling%252Bof%252BTyrosine%252BKinase%252BInhibitors%252Bwith%252BFlexible%252BAtom%252BReceptor%252BModel%252B%252528FLARM%252529%26aulast%3DPeng%26aufirst%3DTao%26date%3D2003%26date%3D2002%26volume%3D43%26issue%3D1%26spage%3D298%26epage%3D303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paul M.  Harari</span>, <span class="hlFld-ContribAuthor ">Shyh-Min  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">Epidermal growth factor receptor modulation of radiation response: Preclinical and clinical development. </span><span class="cited-content_cbyCitation_journal-name">Seminars in Radiation Oncology</span><span> <strong>2002,</strong> <em>12 </em>
                                    (3)
                                     , 21-26. <a href="https://doi.org/10.1053/srao.2002.34865" title="DOI URL">https://doi.org/10.1053/srao.2002.34865</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1053/srao.2002.34865&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1053%2Fsrao.2002.34865%26sid%3Dliteratum%253Aachs%26jtitle%3DSeminars%2520in%2520Radiation%2520Oncology%26atitle%3DEpidermal%252Bgrowth%252Bfactor%252Breceptor%252Bmodulation%252Bof%252Bradiation%252Bresponse%25253A%252BPreclinical%252Band%252Bclinical%252Bdevelopment%26aulast%3DHarari%26aufirst%3DPaul%2BM.%26date%3D2002%26volume%3D12%26issue%3D3%26spage%3D21%26epage%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">William A.  Denny</span>. </span><span class="cited-content_cbyCitation_article-title">Irreversible inhibitors of the erbB family of protein tyrosine kinases. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology & Therapeutics</span><span> <strong>2002,</strong> <em>93 </em>
                                    (2-3)
                                     , 253-261. <a href="https://doi.org/10.1016/S0163-7258(02)00194-8" title="DOI URL">https://doi.org/10.1016/S0163-7258(02)00194-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/S0163-7258(02)00194-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FS0163-7258%2802%2900194-8%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520%2526%2520Therapeutics%26atitle%3DIrreversible%252Binhibitors%252Bof%252Bthe%252BerbB%252Bfamily%252Bof%252Bprotein%252Btyrosine%252Bkinases%26aulast%3DDenny%26aufirst%3DWilliam%2BA.%26date%3D2002%26volume%3D93%26issue%3D2-3%26spage%3D253%26epage%3D261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">William A.  Denny</span>. </span><span class="cited-content_cbyCitation_article-title">The 4-anilinoquinazoline class of inhibitors of the erbB family of receptor tyrosine kinases. </span><span class="cited-content_cbyCitation_journal-name">Il Farmaco</span><span> <strong>2001,</strong> <em>56 </em>
                                    (1-2)
                                     , 51-56. <a href="https://doi.org/10.1016/S0014-827X(01)01026-6" title="DOI URL">https://doi.org/10.1016/S0014-827X(01)01026-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/S0014-827X(01)01026-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FS0014-827X%2801%2901026-6%26sid%3Dliteratum%253Aachs%26jtitle%3DIl%2520Farmaco%26atitle%3DThe%252B4-anilinoquinazoline%252Bclass%252Bof%252Binhibitors%252Bof%252Bthe%252BerbB%252Bfamily%252Bof%252Breceptor%252Btyrosine%252Bkinases%26aulast%3DDenny%26aufirst%3DWilliam%2BA.%26date%3D2001%26volume%3D56%26issue%3D1-2%26spage%3D51%26epage%3D56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2001/jmcmar.2001.44.issue-3/jm000372i/production/images/medium/jm000372in00001.gif" alt="" id="_i2" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2001/jmcmar.2001.44.issue-3/jm000372i/production/images/large/jm000372in00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm000372i&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm000372if1" data-index="1" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2001/jmcmar.2001.44.issue-3/jm000372i/production/images/medium/jm000372if1.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2001/jmcmar.2001.44.issue-3/jm000372i/production/images/large/jm000372if1.jpeg" id="rightTab-_i5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2001/jmcmar.2001.44.issue-3/jm000372i/production/images/large/jm000372if1.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm000372i&amp;id=jm000372if1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm000372if2" data-index="2" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2001/jmcmar.2001.44.issue-3/jm000372i/production/images/medium/jm000372if2.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2001/jmcmar.2001.44.issue-3/jm000372i/production/images/large/jm000372if2.jpeg" id="rightTab-_i7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2001/jmcmar.2001.44.issue-3/jm000372i/production/images/large/jm000372if2.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm000372i&amp;id=jm000372if2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm000372ih00001" data-index="3" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2001/jmcmar.2001.44.issue-3/jm000372i/production/images/medium/jm000372ih00001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2001/jmcmar.2001.44.issue-3/jm000372i/production/images/large/jm000372ih00001.jpeg" id="rightTab-_i9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 1 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> (i) R<sub>3</sub>CH<img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>C(R<sub>2</sub>)CO<sub>2</sub>H/EDCl·HCl/pyridine/THF/DMA; (ii) R<sub>3</sub>CH<img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>C(R<sub>2</sub>)COCl/DMAP (cat.)/THF/Et<sub>3</sub>N; (iii) ClCH<sub>2</sub>CH<sub>2</sub>SO<sub>2</sub>Cl/DMAP (cat.)/THF/Et<sub>3</sub>N.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2001/jmcmar.2001.44.issue-3/jm000372i/production/images/large/jm000372ih00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm000372i&amp;id=jm000372ih00001"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm000372ih00002" data-index="4" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2001/jmcmar.2001.44.issue-3/jm000372i/production/images/medium/jm000372ih00002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2001/jmcmar.2001.44.issue-3/jm000372i/production/images/large/jm000372ih00002.jpeg" id="rightTab-_i12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 2 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> (i) CH<sub>2</sub><img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>CHCO<sub>2</sub>H/EDCl·HCl/pyridine; (ii) CH<sub>2</sub><img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>CHCOCl/DMAP (cat.)/Et<sub>3</sub>N.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2001/jmcmar.2001.44.issue-3/jm000372i/production/images/large/jm000372ih00002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm000372i&amp;id=jm000372ih00002"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm000372ih00003" data-index="5" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2001/jmcmar.2001.44.issue-3/jm000372i/production/images/medium/jm000372ih00003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2001/jmcmar.2001.44.issue-3/jm000372i/production/images/large/jm000372ih00003.jpeg" id="rightTab-_i14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 3 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> (i) Morpholine/<i>p</i>-TsOH/THF; (ii) BH<sub>3</sub>·DMS/THF; (iii) CH<sub>2</sub><img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>CHCO<sub>2</sub>H/EDCl·HCl/Et<sub>3</sub>N/DMF.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2001/jmcmar.2001.44.issue-3/jm000372i/production/images/large/jm000372ih00003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm000372i&amp;id=jm000372ih00003"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm000372ih00004" data-index="6" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2001/jmcmar.2001.44.issue-3/jm000372i/production/images/medium/jm000372ih00004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2001/jmcmar.2001.44.issue-3/jm000372i/production/images/large/jm000372ih00004.jpeg" id="rightTab-_i15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 4 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> (i) ClOCCH<img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>CHCOCl/THF; (ii) Me<sub>2</sub>N(CH<sub>2</sub>)<sub>3</sub>OH/THF; (iii) Me<sub>2</sub>N(CH<sub>2</sub>)<sub>3</sub>NH<sub>2</sub>/THF.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2001/jmcmar.2001.44.issue-3/jm000372i/production/images/large/jm000372ih00004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm000372i&amp;id=jm000372ih00004"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm000372ih00005" data-index="7" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2001/jmcmar.2001.44.issue-3/jm000372i/production/images/medium/jm000372ih00005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2001/jmcmar.2001.44.issue-3/jm000372i/production/images/large/jm000372ih00005.jpeg" id="rightTab-_i17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 5 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> (i) Oxalyl chloride/THF/20 °C/1 h, then RNH<sub>2</sub>; (ii) aq Et<sub>3</sub>N/60 °C/45 min or LiOH/aq MeOH/20 °C/2 h; (iii) EDCl·HCl/pyridine/0 °C/1 h and <b>37</b>, <b>38</b>, or <b>48</b>.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2001/jmcmar.2001.44.issue-3/jm000372i/production/images/large/jm000372ih00005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm000372i&amp;id=jm000372ih00005"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm000372ih00006" data-index="8" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2001/jmcmar.2001.44.issue-3/jm000372i/production/images/medium/jm000372ih00006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2001/jmcmar.2001.44.issue-3/jm000372i/production/images/large/jm000372ih00006.jpeg" id="rightTab-_i18" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 6 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> (i) HSCH<sub>2</sub>CH<sub>2</sub>OH/Cs<sub>2</sub>CO<sub>3</sub>/DMSO/50 °C/2 h; (ii) MCPBA/CHCl<sub>3</sub>/20 °C/4 h; (iii) MsCl/Et<sub>3</sub>N/CH<sub>2</sub>Cl<sub>2</sub>/0−5 °C/2.5 h; (iv) Davis' reagent/CHCl<sub>3</sub>.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2001/jmcmar.2001.44.issue-3/jm000372i/production/images/large/jm000372ih00006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm000372i&amp;id=jm000372ih00006"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"></div><p class="rightTab-references-count">
            This article references 24 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-jm000372ib00001"><div class="reference"><strong class="refLabel"><a href="#jm000372ib00001" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-jm000372ib00001_1"><span><span class="NLM_string-ref">Dowsett, M.; Cooke, T.; Ellis, I.; Gullick, W. J.; Gusterson, B.; Mallon, E.; Walker, R. Assessment of HER2 status in breast cancer:  why, when and how? <i>Eur. J. Cancer</i><b>2000</b>, <i>36</i>, 170−176.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2000&pages=176&author=M.+Dowsett&author=T.+Cooke&author=I.+Ellis&author=W.+J.+Gullick&author=B.+Gusterson&author=E.+Mallon&author=R+Walker&title=Assessment+of+HER2+status+in+breast+cancer%3A%E2%80%89+why%2C+when+and+how"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm000372ib00001_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDowsett%26aufirst%3DM.%26atitle%3DAssessment%2520of%2520HER2%2520status%2520in%2520breast%2520cancer%253A%25E2%2580%2589%2520why%252C%2520when%2520and%2520how%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D2000%26volume%3D36%26spage%3D176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm000372ib00002"><div class="reference"><strong class="refLabel"><a href="#jm000372ib00002" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-jm000372ib00002_1"><span><span class="NLM_string-ref">Kim, H.; Muller, W. J. The role of the epidermal growth factor receptor family in mammary tumorigenesis and metastasis. <i>  Exp. Cell Res.</i><b>1999</b>, <i>253</i>, 78−87.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=253&publication_year=1999&pages=87&author=H.+Kim&author=W.+J+Muller&title=The+role+of+the+epidermal+growth+factor+receptor+family+in+mammary+tumorigenesis+and+metastasis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm000372ib00002_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DH.%26atitle%3DThe%2520role%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%2520family%2520in%2520mammary%2520tumorigenesis%2520and%2520metastasis%26jtitle%3DExp.%2520Cell%2520Res.%26date%3D1999%26volume%3D253%26spage%3D87" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm000372ib00003"><div class="reference"><strong class="refLabel"><a href="#jm000372ib00003" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-jm000372ib00003_1"><span><span class="NLM_string-ref">Fry, D. W. Inhibition of the epidermal growth factor receptor family of tyrosine kinases as an approach to cancer chemotherapy:  Progression from reversible to irreversible inhibitors. <i>  Pharmacol. Ther</i>. <b>1999</b>, <i>82</i>, 207−218.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=1999&pages=218&author=D.+W+Fry&title=Inhibition+of+the+epidermal+growth+factor+receptor+family+of+tyrosine+kinases+as+an+approach+to+cancer+chemotherapy%3A%E2%80%89+Progression+from+reversible+to+irreversible+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm000372ib00003_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFry%26aufirst%3DD.%2BW%26atitle%3DInhibition%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%2520family%2520of%2520tyrosine%2520kinases%2520as%2520an%2520approach%2520to%2520cancer%2520chemotherapy%253A%25E2%2580%2589%2520Progression%2520from%2520reversible%2520to%2520irreversible%2520inhibitors%26jtitle%3DPharmacol.%2520Ther.%26date%3D1999%26volume%3D82%26spage%3D218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm000372ib00004"><div class="reference"><strong class="refLabel"><a href="#jm000372ib00004" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-jm000372ib00004_1"><span><span class="NLM_string-ref">Traxler, P.; Green, J.; Mett, H.; Sequin, U.; Furet, P. Use of a pharmacophore model for the design of EGFR tyrosine kinase inhibitors:  isoflavones and 3-phenyl-4(1H)-quinolones. <i>  J. Med. Chem</i>. <b>1999</b>, <i>42</i>, 1018−1026.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=1026&author=P.+Traxler&author=J.+Green&author=H.+Mett&author=U.+Sequin&author=P+Furet&title=Use+of+a+pharmacophore+model+for+the+design+of+EGFR+tyrosine+kinase+inhibitors%3A%E2%80%89+isoflavones+and+3-phenyl-4%281H%29-quinolones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm000372ib00004_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTraxler%26aufirst%3DP.%26atitle%3DUse%2520of%2520a%2520pharmacophore%2520model%2520for%2520the%2520design%2520of%2520EGFR%2520tyrosine%2520kinase%2520inhibitors%253A%25E2%2580%2589%2520isoflavones%2520and%25203-phenyl-4%25281H%2529-quinolones%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D1026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm000372ib00005"><div class="reference"><strong class="refLabel"><a href="#jm000372ib00005" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-jm000372ib00005_1"><span><span class="NLM_string-ref">Woodburn, J. R. The epidermal growth factor receptor and its inhibition in cancer therapy. <i>  Pharmacol. Ther</i>. <b>1999</b>, <i>82</i>, 241−250.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=1999&pages=250&author=J.+R+Woodburn&title=The+epidermal+growth+factor+receptor+and+its+inhibition+in+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm000372ib00005_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWoodburn%26aufirst%3DJ.%2BR%26atitle%3DThe%2520epidermal%2520growth%2520factor%2520receptor%2520and%2520its%2520inhibition%2520in%2520cancer%2520therapy%26jtitle%3DPharmacol.%2520Ther.%26date%3D1999%26volume%3D82%26spage%3D250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm000372ib00006"><div class="reference"><strong class="refLabel"><a href="#jm000372ib00006" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-jm000372ib00006_1"><span><span class="NLM_string-ref">Palmer, B. D.; Trumpp-Kallmeyer, S.; Fry, D. W.; Nelson, J. M.; Showalter, H. D. H.; Denny, W. A. Tyrosine Kinase Inhibitors. 11. Soluble analogues of pyrrolo- and pyrazinoquinazolines as EGFR inhibitors:  synthesis, biological evaluation and modelling of the mode of binding. <i>  J. Med. Chem</i>. <b>1997</b>, <i>40,</i> 1519−1529.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=1529&author=B.+D.+Palmer&author=S.+Trumpp-Kallmeyer&author=D.+W.+Fry&author=J.+M.+Nelson&author=H.+D.+H.+Showalter&author=W.+A+Denny&title=Tyrosine+Kinase+Inhibitors.+11.+Soluble+analogues+of+pyrrolo-+and+pyrazinoquinazolines+as+EGFR+inhibitors%3A%E2%80%89+synthesis%2C+biological+evaluation+and+modelling+of+the+mode+of+binding"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm000372ib00006_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPalmer%26aufirst%3DB.%2BD.%26atitle%3DTyrosine%2520Kinase%2520Inhibitors.%252011.%2520Soluble%2520analogues%2520of%2520pyrrolo-%2520and%2520pyrazinoquinazolines%2520as%2520EGFR%2520inhibitors%253A%25E2%2580%2589%2520synthesis%252C%2520biological%2520evaluation%2520and%2520modelling%2520of%2520the%2520mode%2520of%2520binding%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D1529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm000372ib00007"><div class="reference"><strong class="refLabel"><a href="#jm000372ib00007" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-jm000372ib00007_1"><span><span class="NLM_string-ref">Shewchuk, L.; Hassell, A.; Wisely, B.; Rocque, W.; Holmes, W.; Veal, J.; Kuyper, L F. Binding mode of the 4-anilinoquinazoline class of protein kinase inhibitor:  X-ray crystallographic studies of 4-anilinoquinazolines bound to cyclin-dependent kinase 2 and p38 kinase.<i> J. Med. Chem</i>. <b>2000</b>, <i>43</i>, 133−138.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=138&author=L.+Shewchuk&author=A.+Hassell&author=B.+Wisely&author=W.+Rocque&author=W.+Holmes&author=J.+Veal&author=L+F+Kuyper&title=Binding+mode+of+the+4-anilinoquinazoline+class+of+protein+kinase+inhibitor%3A%E2%80%89+X-ray+crystallographic+studies+of+4-anilinoquinazolines+bound+to+cyclin-dependent+kinase+2+and+p38+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm000372ib00007_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShewchuk%26aufirst%3DL.%26atitle%3DBinding%2520mode%2520of%2520the%25204-anilinoquinazoline%2520class%2520of%2520protein%2520kinase%2520inhibitor%253A%25E2%2580%2589%2520X-ray%2520crystallographic%2520studies%2520of%25204-anilinoquinazolines%2520bound%2520to%2520cyclin-dependent%2520kinase%25202%2520and%2520p38%2520kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm000372ib00008"><div class="reference"><strong class="refLabel"><a href="#jm000372ib00008" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-jm000372ib00008_1"><span><span class="NLM_string-ref">Pollack, V. A.; Savage, D. M.; Baker, D. A.; Tsaparikos, K. E.; Sloan, D. E.; Moyer, J. D.; Barbacci, E. G.; Pustilnik, L. R.; Smolarek, T. A.; Davis, J. A.; Vaidya, M. P.; Arnold, L. D.; Doty, J. L.; Iwata, K. K.; Morin, M. J. Inhibition of epidermal growth factor receptor-associated tyrosine phosphorylation in human carcinomas with CP-358,774:  Dynamics of receptor inhibition in situ and antitumor effects in athymic mice. <i>  J. </i><i>Pharmacol. Exp. Ther</i>. <b>1999</b>, <i>291</i>, 739−748.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=291&publication_year=1999&pages=748&author=V.+A.+Pollack&author=D.+M.+Savage&author=D.+A.+Baker&author=K.+E.+Tsaparikos&author=D.+E.+Sloan&author=J.+D.+Moyer&author=E.+G.+Barbacci&author=L.+R.+Pustilnik&author=T.+A.+Smolarek&author=J.+A.+Davis&author=M.+P.+Vaidya&author=L.+D.+Arnold&author=J.+L.+Doty&author=K.+K.+Iwata&author=M.+J+Morin&title=Inhibition+of+epidermal+growth+factor+receptor-associated+tyrosine+phosphorylation+in+human+carcinomas+with+CP-358%2C774%3A%E2%80%89+Dynamics+of+receptor+inhibition+in+situ+and+antitumor+effects+in+athymic+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm000372ib00008_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPollack%26aufirst%3DV.%2BA.%26atitle%3DInhibition%2520of%2520epidermal%2520growth%2520factor%2520receptor-associated%2520tyrosine%2520phosphorylation%2520in%2520human%2520carcinomas%2520with%2520CP-358%252C774%253A%25E2%2580%2589%2520Dynamics%2520of%2520receptor%2520inhibition%2520in%2520situ%2520and%2520antitumor%2520effects%2520in%2520athymic%2520mice%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1999%26volume%3D291%26spage%3D748" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm000372ib00009"><div class="reference"><strong class="refLabel"><a href="#jm000372ib00009" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-jm000372ib00009_1"><span><span class="NLM_string-ref">Baselga, J.; Herbst, R.; LoRusso, P.; Rischin, D.; Ranson, M.; Plummer, R.; Raymond, E.; Maddox, A.; Kaye, S. B.; Kieback, D. G.; Harris, A.; Ochs, J. Continuous administration of ZD1839 (Iressa), a novel oral epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI), in patients with five selected tumor types:  evidence of activity and good tolerability. <i>  Proc. </i><i>Am.</i><i> Soc. Clin. Oncol</i>. <b>2000</b>, <i>19</i>, 177a (abstract 686).</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Baselga%2C+J.%3B+Herbst%2C+R.%3B+LoRusso%2C+P.%3B+Rischin%2C+D.%3B+Ranson%2C+M.%3B+Plummer%2C+R.%3B+Raymond%2C+E.%3B+Maddox%2C+A.%3B+Kaye%2C+S.+B.%3B+Kieback%2C+D.+G.%3B+Harris%2C+A.%3B+Ochs%2C+J.+Continuous+administration+of+ZD1839+%28Iressa%29%2C+a+novel+oral+epidermal+growth+factor+receptor+tyrosine+kinase+inhibitor+%28EGFR-TKI%29%2C+in+patients+with+five+selected+tumor+types%3A%E2%80%89+evidence+of+activity+and+good+tolerability.+Proc.+Am.+Soc.+Clin.+Oncol.+2000%2C+19%2C+177a+%28abstract+686%29.+Baselga%2C+J.%3B+Herbst%2C+R.%3B+LoRusso%2C+P.%3B+Rischin%2C+D.%3B+Ranson%2C+M.%3B+Plummer%2C+R.%3B+Raymond%2C+E.%3B+Maddox%2C+A.%3B+Kaye%2C+S.+B.%3B+Kieback%2C+D.+G.%3B+Harris%2C+A.%3B+Ochs%2C+J.+Continuous+administration+of+ZD1839+%28Iressa%29%2C+a+novel+oral+epidermal+growth+factor+receptor+tyrosine+kinase+inhibitor+%28EGFR-TKI%29%2C+in+patients+with+five+selected+tumor+types%3A%E2%80%89+evidence+of+activity+and+good+tolerability.+Proc.+Am.+Soc.+Clin.+Oncol.+2000%2C+19%2C+177a+%28abstract+686%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm000372ib00009_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dother%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm000372ib00010"><div class="reference"><div class="NLM_citation" id="rightTab-jm000372ib00010_1"><span><span class="NLM_string-ref">Bridges, A. J. The rationale and strategy used to develop a series of highly potent, irreversible, inhibitors of the epidermal growth factor receptor family of tyrosine kinases. <i>  Curr. Med. Chem</i>. <b>1999</b>, <i>6</i>, 825−843.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1999&pages=843&author=A.+J+Bridges&title=The+rationale+and+strategy+used+to+develop+a+series+of+highly+potent%2C+irreversible%2C+inhibitors+of+the+epidermal+growth+factor+receptor+family+of+tyrosine+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm000372ib00010_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBridges%26aufirst%3DA.%2BJ%26atitle%3DThe%2520rationale%2520and%2520strategy%2520used%2520to%2520develop%2520a%2520series%2520of%2520highly%2520potent%252C%2520irreversible%252C%2520inhibitors%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%2520family%2520of%2520tyrosine%2520kinases%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D1999%26volume%3D6%26spage%3D843" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm000372ib00011"><div class="reference"><strong class="refLabel"><a href="#jm000372ib00011" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-jm000372ib00011_1"><span><span class="NLM_string-ref">Vincent, P. W.; Bridges, A. J.; Dykes, D. J.; Fry, D. W.; Leopold, W. R.; Patmore, S. J.; Roberts, B. J.; Rose, S.; Sherwood, V.; Zhou, H. R.; Elliott, W. L. Anticancer efficacy of the irreversible EGFr tyrosine kinase inhibitor PD 0169414 against human tumor xenografts. <i>  Cancer Chemother. </i><i>Pharmacol</i>. <b>2000</b>, <i>45</i>, 231−238.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2000&pages=238&author=P.+W.+Vincent&author=A.+J.+Bridges&author=D.+J.+Dykes&author=D.+W.+Fry&author=W.+R.+Leopold&author=S.+J.+Patmore&author=B.+J.+Roberts&author=S.+Rose&author=V.+Sherwood&author=H.+R.+Zhou&author=W.+L+Elliott&title=Anticancer+efficacy+of+the+irreversible+EGFr+tyrosine+kinase+inhibitor+PD+0169414+against+human+tumor+xenografts"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm000372ib00011_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVincent%26aufirst%3DP.%2BW.%26atitle%3DAnticancer%2520efficacy%2520of%2520the%2520irreversible%2520EGFr%2520tyrosine%2520kinase%2520inhibitor%2520PD%25200169414%2520against%2520human%2520tumor%2520xenografts%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2000%26volume%3D45%26spage%3D238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm000372ib00012"><div class="reference"><strong class="refLabel"><a href="#jm000372ib00012" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-jm000372ib00012_1"><span><span class="NLM_string-ref">Wissner, A.; Johnson, B. D.; Floyd, M. B.; Kitchen, D. B. 4-Aminoquinazolines as EGFR inhibitors. U.S. Patent 5,760,041, June 2, 1998. Discafani, C. M.; Carroll, M. L.; Floyd, M. B.; Hollander, I. J.; Husain, Z.; Johnson, B. D.; Kitchen, D.; May, M. K.; Malo, M. S.; Minnick, A. A.; Nilakantan, R.; Shen, R.; Wang, Y.-F.; Wissner, A.; Greenberger, L. M. Irreversible inhibition of epidermal growth factor receptor tyrosine kinase with in vivo activity by N-[4-[(3-bromophenyl)amino]-6-quinazolinyl]-2-butynamide (CL-378,785). <i>  Biochem. Pharmacol</i>. <b>1999</b>, <i>57</i>, 917−925.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1998&author=A.+Wissner&author=B.+D.+Johnson&author=M.+B.+Floyd&author=D.+B.+Kitchen&title=June+2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm000372ib00012_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DWissner%26aufirst%3DA.%26atitle%3D4-Aminoquinazolines%2520as%2520EGFR%2520inhibitors.%2520U.S.%2520Patent%25205%252C760%252C041%26btitle%3DJune%25202%26date%3D1998%26pub%3DPharmacol" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm000372ib00013"><div class="reference"><strong class="refLabel"><a href="#jm000372ib00013" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-jm000372ib00013_1"><span><span class="NLM_string-ref">Fry, D. W.; Bridges, A. J.; Denny, W. A.; Doherty. A.; Gries, K. D.; Hicks, J. L.; Hook, K. E.; Keller, P. R.; Leopold, W. R.; Loo, J. A.; McNamara, D, J.; Nelson, J. M.; Sherwood, V.; Smaill, J. B.; Trumpp-Kallmeyer, S.; Dobrusin, E. M. Specific, irreversible inactivation of the epidermal growth factor receptor and erbB2, by a new class of tyrosine kinase inhibitor. <i>  Proc. </i><i>Natl. Acad. Sci. U.S.A.</i><b>1998</b>, <i>95</i>, 12022−12027.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1998&pages=12027&author=D.+W.+Fry&author=A.+J.+Bridges&author=W.+A.+Denny&author=A.+Doherty&author=K.+D.+Gries&author=J.+L.+Hicks&author=K.+E.+Hook&author=P.+R.+Keller&author=W.+R.+Leopold&author=J.+A.+Loo&author=D%2C+J+McNamara&author=J.+M.+Nelson&author=V.+Sherwood&author=J.+B.+Smaill&author=S.+Trumpp-Kallmeyer&author=E.+M+Dobrusin&title=Specific%2C+irreversible+inactivation+of+the+epidermal+growth+factor+receptor+and+erbB2%2C+by+a+new+class+of+tyrosine+kinase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm000372ib00013_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFry%26aufirst%3DD.%2BW.%26atitle%3DSpecific%252C%2520irreversible%2520inactivation%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%2520and%2520erbB2%252C%2520by%2520a%2520new%2520class%2520of%2520tyrosine%2520kinase%2520inhibitor%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1998%26volume%3D95%26spage%3D12027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm000372ib00014"><div class="reference"><strong class="refLabel"><a href="#jm000372ib00014" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-jm000372ib00014_1"><span><span class="NLM_string-ref">Smaill, J. B.; Palmer, B. D.; Rewcastle, G. W.; Denny, W. A.; McNamara, D. J.; Dobrusin, E. M.; Bridges, A. J.; Zhou, H. R.; Showalter, H. D. H.; Winters, R. T.; Leopold, W. R.; Fry, D. W.; Nelson, J. M.; Slintak, V.; Elliot, W. L.; Roberts, B. J.; Vincent, P. W.; Patmore, S. J. Tyrosine kinase inhibitors. 15. 4-(phenylamino)quinazoline and 4-(phenylamino)pyrido[<i>d</i>]pyrimidine acrylamides as irreversible inhibitors of the ATP binding site of the epidermal growth factor receptor. <i>  J. Med. </i><i>Chem</i>. <b>1999</b>, <i>42</i>, 1803−1815.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=1815&author=J.+B.+Smaill&author=B.+D.+Palmer&author=G.+W.+Rewcastle&author=W.+A.+Denny&author=D.+J.+McNamara&author=E.+M.+Dobrusin&author=A.+J.+Bridges&author=H.+R.+Zhou&author=H.+D.+H.+Showalter&author=R.+T.+Winters&author=W.+R.+Leopold&author=D.+W.+Fry&author=J.+M.+Nelson&author=V.+Slintak&author=W.+L.+Elliot&author=B.+J.+Roberts&author=P.+W.+Vincent&author=S.+J+Patmore&title=Tyrosine+kinase+inhibitors.+15.+4-%28phenylamino%29quinazoline+and+4-%28phenylamino%29pyrido%5Bd%5Dpyrimidine+acrylamides+as+irreversible+inhibitors+of+the+ATP+binding+site+of+the+epidermal+growth+factor+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm000372ib00014_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSmaill%26aufirst%3DJ.%2BB.%26atitle%3DTyrosine%2520kinase%2520inhibitors.%252015.%25204-%2528phenylamino%2529quinazoline%2520and%25204-%2528phenylamino%2529pyrido%255Bd%255Dpyrimidine%2520acrylamides%2520as%2520irreversible%2520inhibitors%2520of%2520the%2520ATP%2520binding%2520site%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D1815" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm000372ib00015"><div class="reference"><strong class="refLabel"><a href="#jm000372ib00015" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-jm000372ib00015_1"><span><span class="NLM_string-ref">Smaill, J. B.; Rewcastle, G. W.; Bridges, A. J.; Zhou, H.; Showalter, H. D. H.; Fry, D. W.; Nelson, J. M.; Sherwood, V.; Elliott, W. L.; Vincent, P. W.; DeJohn, D.; Loo, J. A.; Gries, K. D.; Chan, O. H.; Reyner, E.L.; Lipka, E.; and Denny, W. A. Tyrosine kinase inhibitors. 17. Irreversible inhibitors of the epidermal growth factor receptor:  4-(phenylamino)quinazoline- and 4-(phenylamino)pyrido[3,2-<i>d</i>]pyrimidine-6-acrylamides bearing additional solubilizing functions. <i>  J. Med. Chem</i>. <b>2000</b>, <i>43</i>, 1380−1397.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=1397&author=J.+B.+Smaill&author=G.+W.+Rewcastle&author=A.+J.+Bridges&author=H.+Zhou&author=H.+D.+H.+Showalter&author=D.+W.+Fry&author=J.+M.+Nelson&author=V.+Sherwood&author=W.+L.+Elliott&author=P.+W.+Vincent&author=D.+DeJohn&author=J.+A.+Loo&author=K.+D.+Gries&author=O.+H.+Chan&author=E.L.+Reyner&author=E.+Lipka&author=W.+A.+Denny&title=Tyrosine+kinase+inhibitors.+17.+Irreversible+inhibitors+of+the+epidermal+growth+factor+receptor%3A%E2%80%89+4-%28phenylamino%29quinazoline-+and+4-%28phenylamino%29pyrido%5B3%2C2-d%5Dpyrimidine-6-acrylamides+bearing+additional+solubilizing+functions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm000372ib00015_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSmaill%26aufirst%3DJ.%2BB.%26atitle%3DTyrosine%2520kinase%2520inhibitors.%252017.%2520Irreversible%2520inhibitors%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%253A%25E2%2580%2589%25204-%2528phenylamino%2529quinazoline-%2520and%25204-%2528phenylamino%2529pyrido%255B3%252C2-d%255Dpyrimidine-6-acrylamides%2520bearing%2520additional%2520solubilizing%2520functions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D1397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm000372ib00016"><div class="reference"><strong class="refLabel"><a href="#jm000372ib00016" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-jm000372ib00016_1"><span><span class="NLM_string-ref">Medina, L.; Gomez, L.; Cerna, C.; Kraker, A.; Yochmowitz, M.; Weitman, S. Investigation of the effects of the tyrosine kinase (TK) inhibitor CI-1033 (PD 0183805) against human tumor specimens taken directly from patients. <i>  Proc. </i><i>Am.</i><i> Assoc. Cancer Res</i>. <b>2000</b>, <i>41</i>, 483 (abstract 3078).</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2000&pages=483&author=L.+Medina&author=L.+Gomez&author=C.+Cerna&author=A.+Kraker&author=M.+Yochmowitz&author=S+Weitman&title=Investigation+of+the+effects+of+the+tyrosine+kinase+%28TK%29+inhibitor+CI-1033+%28PD+0183805%29+against+human+tumor+specimens+taken+directly+from+patients"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm000372ib00016_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMedina%26aufirst%3DL.%26atitle%3DInvestigation%2520of%2520the%2520effects%2520of%2520the%2520tyrosine%2520kinase%2520%2528TK%2529%2520inhibitor%2520CI-1033%2520%2528PD%25200183805%2529%2520against%2520human%2520tumor%2520specimens%2520taken%2520directly%2520from%2520patients%26jtitle%3DProc.%2520Am.%2520Assoc.%2520Cancer%2520Res.%26date%3D2000%26volume%3D41%26spage%3D483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm000372ib00017"><div class="reference"><strong class="refLabel"><a href="#jm000372ib00017" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-jm000372ib00017_1"><span><span class="NLM_string-ref">Rewcastle, G. W.; Palmer, B. D.; Thompson, A. M.; Bridges, A. J.; Cody, D. A.; Zhou, H.; Fry, D. J.; McMichael, A.; Denny, W. A. Tyrosine kinase inhibitors. 10. Isomeric 4-[(3-bromophenyl)amino]-pyrido[<i>d</i>]-pyrimidines are potent ATP binding site inhibitors of the tyrosine kinase function of the epidermal growth factor receptor. <i>  J. Med. Chem</i>. <b>1996</b>, <i>39</i>, 1823−1835.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=1835&author=G.+W.+Rewcastle&author=B.+D.+Palmer&author=A.+M.+Thompson&author=A.+J.+Bridges&author=D.+A.+Cody&author=H.+Zhou&author=D.+J.+Fry&author=A.+McMichael&author=W.+A+Denny&title=Tyrosine+kinase+inhibitors.+10.+Isomeric+4-%5B%283-bromophenyl%29amino%5D-pyrido%5Bd%5D-pyrimidines+are+potent+ATP+binding+site+inhibitors+of+the+tyrosine+kinase+function+of+the+epidermal+growth+factor+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm000372ib00017_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRewcastle%26aufirst%3DG.%2BW.%26atitle%3DTyrosine%2520kinase%2520inhibitors.%252010.%2520Isomeric%25204-%255B%25283-bromophenyl%2529amino%255D-pyrido%255Bd%255D-pyrimidines%2520are%2520potent%2520ATP%2520binding%2520site%2520inhibitors%2520of%2520the%2520tyrosine%2520kinase%2520function%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1996%26volume%3D39%26spage%3D1835" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm000372ib00018"><div class="reference"><strong class="refLabel"><a href="#jm000372ib00018" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-jm000372ib00018_1"><span><span class="NLM_string-ref">Rewcastle, G. W.; Denny, W. A.; Zhou, H.; Cody, D. R.; McMichael, A.; Fry, D. W.; Bridges, A.J. Tyrosine kinase inhibitors. 5. Synthesis and structure−activity relationships for 4-(phenylmethyl)amino- and 4-phenylaminoquinazolines as potent adenosine 5‘-triphosphate binding site inhibitors of the tyrosine kinase domain of epidermal growth factor receptor. <i>  J. Med. Chem</i>. <b>1995</b>, <i>38</i>, 3482−3487.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1995&pages=3487&author=G.+W.+Rewcastle&author=W.+A.+Denny&author=H.+Zhou&author=D.+R.+Cody&author=A.+McMichael&author=D.+W.+Fry&author=A.J+Bridges&title=Tyrosine+kinase+inhibitors.+5.+Synthesis+and+structure%E2%88%92activity+relationships+for+4-%28phenylmethyl%29amino-+and+4-phenylaminoquinazolines+as+potent+adenosine+5%E2%80%98-triphosphate+binding+site+inhibitors+of+the+tyrosine+kinase+domain+of+epidermal+growth+factor+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm000372ib00018_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRewcastle%26aufirst%3DG.%2BW.%26atitle%3DTyrosine%2520kinase%2520inhibitors.%25205.%2520Synthesis%2520and%2520structure%25E2%2588%2592activity%2520relationships%2520for%25204-%2528phenylmethyl%2529amino-%2520and%25204-phenylaminoquinazolines%2520as%2520potent%2520adenosine%25205%25E2%2580%2598-triphosphate%2520binding%2520site%2520inhibitors%2520of%2520the%2520tyrosine%2520kinase%2520domain%2520of%2520epidermal%2520growth%2520factor%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1995%26volume%3D38%26spage%3D3487" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm000372ib00019"><div class="reference"><strong class="refLabel"><a href="#jm000372ib00019" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-jm000372ib00019_1"><span><span class="NLM_string-ref">Rewcastle, G. W.; Murray, D. K.; Elliott, W. L.; Fry, D. W.; Howard, C. T.; Nelson, J. M.; Roberts, B. J.; Vincent, P. W.; Showalter, H. D. H.; Winters, R. T.; Denny, W. A. Tyrosine kinase inhibitors. 14. Structure−activity relationships for methylamino-substituted derivatives of 4-[(3-bromophenyl)amino]-6-(methylamino)pyrido[3,4-<i>d</i>]pyrimidine (PD 158780), a potent and specific inhibitor of the tyrosine kinase activity of receptors for the EGF family of growth factors. <i>  J. Med. Chem</i>. <b>1998</b>, <i>41</i>, 742−751.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=751&author=G.+W.+Rewcastle&author=D.+K.+Murray&author=W.+L.+Elliott&author=D.+W.+Fry&author=C.+T.+Howard&author=J.+M.+Nelson&author=B.+J.+Roberts&author=P.+W.+Vincent&author=H.+D.+H.+Showalter&author=R.+T.+Winters&author=W.+A+Denny&title=Tyrosine+kinase+inhibitors.+14.+Structure%E2%88%92activity+relationships+for+methylamino-substituted+derivatives+of+4-%5B%283-bromophenyl%29amino%5D-6-%28methylamino%29pyrido%5B3%2C4-d%5Dpyrimidine+%28PD+158780%29%2C+a+potent+and+specific+inhibitor+of+the+tyrosine+kinase+activity+of+receptors+for+the+EGF+family+of+growth+factors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm000372ib00019_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRewcastle%26aufirst%3DG.%2BW.%26atitle%3DTyrosine%2520kinase%2520inhibitors.%252014.%2520Structure%25E2%2588%2592activity%2520relationships%2520for%2520methylamino-substituted%2520derivatives%2520of%25204-%255B%25283-bromophenyl%2529amino%255D-6-%2528methylamino%2529pyrido%255B3%252C4-d%255Dpyrimidine%2520%2528PD%2520158780%2529%252C%2520a%2520potent%2520and%2520specific%2520inhibitor%2520of%2520the%2520tyrosine%2520kinase%2520activity%2520of%2520receptors%2520for%2520the%2520EGF%2520family%2520of%2520growth%2520factors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D751" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm000372ib00020"><div class="reference"><div class="NLM_citation" id="rightTab-jm000372ib00020_1"><span><span class="NLM_string-ref">Horne, S.; Taylor, N.; Collins, S.; Rodrigo, R. Rapid syntheses of some indole alkaloids of the Calabar bean. <i>  J. Chem. Soc.</i><i>,</i><i> Perkin Trans</i><i>I</i><b>1991</b>, 3047−3051.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3047&publication_year=1991&pages=3051&author=S.+Horne&author=N.+Taylor&author=S.+Collins&author=R+Rodrigo&title=Rapid+syntheses+of+some+indole+alkaloids+of+the+Calabar+bean"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm000372ib00020_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHorne%26aufirst%3DS.%26atitle%3DRapid%2520syntheses%2520of%2520some%2520indole%2520alkaloids%2520of%2520the%2520Calabar%2520bean%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Perkin%2520Trans%2520I%26date%3D1991%26volume%3D3047%26spage%3D3051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm000372ib00021"><div class="reference"><strong class="refLabel"><a href="#jm000372ib00021" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-jm000372ib00021_1"><span><span class="NLM_string-ref">Thompson, A. M.; Murray, D. K.; Elliott, W. L.; Fry, D. W.; Nelson, J. A.; Showalter, H. D. H.; Roberts, B. J.; Vincent, P. W.; Denny, W. A. Tyrosine kinase inhibitors. 13. Structure−activity relationships for soluble 7-substituted 4-[(3-bromophenyl)amino]-pyrido[4,3-<i>d</i>]pyrimidines designed as inhibitors of the tyrosine kinase activity of the epidermal growth factor receptor. <i>  J. Med. Chem</i>. <b>1997</b>, <i>40</i>, 3915−3925.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=3925&author=A.+M.+Thompson&author=D.+K.+Murray&author=W.+L.+Elliott&author=D.+W.+Fry&author=J.+A.+Nelson&author=H.+D.+H.+Showalter&author=B.+J.+Roberts&author=P.+W.+Vincent&author=W.+A+Denny&title=Tyrosine+kinase+inhibitors.+13.+Structure%E2%88%92activity+relationships+for+soluble+7-substituted+4-%5B%283-bromophenyl%29amino%5D-pyrido%5B4%2C3-d%5Dpyrimidines+designed+as+inhibitors+of+the+tyrosine+kinase+activity+of+the+epidermal+growth+factor+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm000372ib00021_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DA.%2BM.%26atitle%3DTyrosine%2520kinase%2520inhibitors.%252013.%2520Structure%25E2%2588%2592activity%2520relationships%2520for%2520soluble%25207-substituted%25204-%255B%25283-bromophenyl%2529amino%255D-pyrido%255B4%252C3-d%255Dpyrimidines%2520designed%2520as%2520inhibitors%2520of%2520the%2520tyrosine%2520kinase%2520activity%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D3925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm000372ib00022"><div class="reference"><strong class="refLabel"><a href="#jm000372ib00022" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-jm000372ib00022_1"><span><span class="NLM_string-ref">Leopold, W. R.; Nelson, J. M.; Plowman, J.; Jackson, R. C. Anthrapyrazoles, a new class of intercalating agents with high-level, broad spectrum activity against murine tumors. <i>  Cancer Res</i>. <b>1985</b>, <i>45</i>, 5532−5539.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1985&pages=5539&author=W.+R.+Leopold&author=J.+M.+Nelson&author=J.+Plowman&author=R.+C+Jackson&title=Anthrapyrazoles%2C+a+new+class+of+intercalating+agents+with+high-level%2C+broad+spectrum+activity+against+murine+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm000372ib00022_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeopold%26aufirst%3DW.%2BR.%26atitle%3DAnthrapyrazoles%252C%2520a%2520new%2520class%2520of%2520intercalating%2520agents%2520with%2520high-level%252C%2520broad%2520spectrum%2520activity%2520against%2520murine%2520tumors%26jtitle%3DCancer%2520Res.%26date%3D1985%26volume%3D45%26spage%3D5539" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm000372ib00023"><div class="reference"><strong class="refLabel"><a href="#jm000372ib00023" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-jm000372ib00023_1"><span><span class="NLM_string-ref">Elliott, W. L.; Howard, C. T.; Dykes, D. J.; Leopold, W. R. Sequence and schedule-dependent synergy of trimetrexate in combination with 5-fluorouracil in vitro and in mice. <i>  Cancer Res</i>. <b>1989</b>, <i>49</i>, 5586−5590.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1989&pages=5590&author=W.+L.+Elliott&author=C.+T.+Howard&author=D.+J.+Dykes&author=W.+R+Leopold&title=Sequence+and+schedule-dependent+synergy+of+trimetrexate+in+combination+with+5-fluorouracil+in+vitro+and+in+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm000372ib00023_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DElliott%26aufirst%3DW.%2BL.%26atitle%3DSequence%2520and%2520schedule-dependent%2520synergy%2520of%2520trimetrexate%2520in%2520combination%2520with%25205-fluorouracil%2520in%2520vitro%2520and%2520in%2520mice%26jtitle%3DCancer%2520Res.%26date%3D1989%26volume%3D49%26spage%3D5590" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm000372ib00024"><div class="reference"><strong class="refLabel"><a href="#jm000372ib00024" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-jm000372ib00024_1"><span><span class="NLM_string-ref">Elliott, W. L.; Roberts, B. J.; Howard, C. T.; Leopold, W. R. Chemotherapy with [SP-4-3-(<i>R</i>)]-[1,1-cyclobutanedicarboxylato(2-)](2-methyl-1,4-butanediamine-N,N')platinum (CI-973, NK121) in combination with standard agents against murine tumors in vivo. <i>  Cancer Res</i>. <b>1994</b>, <i>54</i>, 4412−4418.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1994&pages=4418&author=W.+L.+Elliott&author=B.+J.+Roberts&author=C.+T.+Howard&author=W.+R.+Leopold&author=+Chemotherapy&author=+N%27&title=in+combination+with+standard+agents+against+murine+tumors+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm000372ib00024_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DElliott%26aufirst%3DW.%2BL.%26atitle%3Din%2520combination%2520with%2520standard%2520agents%2520against%2520murine%2520tumors%2520in%2520vivo%26jtitle%3DCancer%2520Res.%26date%3D1994%26volume%3D54%26spage%3D4418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm000372i&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2001.44.issue-3%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3Barticle%3Aarticle%3A10.1021%2Fjm000372i%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm000372i" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                160KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677a6cb9cd442398","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
